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1 Introduction  
A majority of biological signaling and interactions is based on recognition of a 
ligand by its corresponding receptor.[1, 2] Understanding these binding events is 
crucial for the understanding of many diseases such as bacterial and viral 
infections, auto-immune diseases or metastasis of tumor cells.[3, 4] In most 
cases a single ligand-receptor interaction is weak and the ligand dissociates 
from the receptor rapidly. Binding strengths are increased by simultaneous 
multiple ligand-receptor interactions.  
 
1.1 The Phenomenon of Multivalency 
1.1.1 Multivalency in Nature 
Multivalency or polyvalency denominates the phenomenon of simultaneous 
binding of multiple ligands on one entity to multiple receptors on another entity. 
The valency of one unit thereby is defined as its number of ligands of the same 
kind. Figure 1 illustrates bivalent or polyvalent binding compared to a 
monovalent interaction. Multivalent binding leads to enhanced binding 
strength, stabilization of the interaction and enhancement of receptor 
selectivity, amongst others.[1]  
 
Figure 1. Illustration of multivalent (trivalent) interaction and monovalent binding.[1] 
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Multivalent scaffolds in nature range from molecules of low valency, like 
antigens, to those of high valency supramolecular assemblies such as 
receptors in cell membranes. Examples of synthetic scaffolds with different 
valencies are discussed in Chapter 1.2. Nature takes advantage of 
multivalency to enhance numerous originally weak interactions, mainly 
carbohydrate-carbohydrate, carbohydrate-protein and protein-protein 
interactions.[1] This includes, amongst others, key-steps in cell-cell, cell-
bacterium, cell-virus or antibody-antigen recognition (Figure 2). One prominent 
example is the infection of cells with the influenza virus, mediated through the 
multivalent interaction of the hemagglutinin-receptors on the virus with the 
sialic acid motif on glycoprotein receptors of the host cell.[5] Furthermore, E. 
coli attach via multivalent binding of their P fimbrae to a disaccharide motif on 
lectins of endothelial urethral cells.[6] Neutrophil tethering on endothelial cells 
or antibody-antigen recognition by macrophages are two examples in which 
multivalent recognition plays an essential role in human immune response.[7] 
Due to its key role in diverse fundamental interactions, understanding and 
strengthening or inhibiting multivalent interactions provides promising targets 
for interference with and control over essential biological phenomena.  
 
 
Figure 2. Examples of multivalent interactions in nature.[8] 
 
1.1.2 Cooperativity and Multivalent Binding 
Multivalent binding can result in binding affinities that are stronger than the 
equivalent monovalent interaction by magnitudes. Kinetic calculations show 
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that the energy gained by formation of the multivalent binding complex can be 
higher than the sum of the single energetic contributions of the ligand-receptor 
binding.[9] The binding strength increases approximately exponentially with the 
number of possible multivalent binding events.[1] Enhanced binding strength, 
compared to the corresponding monovalent interaction, arises from 
thermodynamic advantages and ligand stabilization due to different 
mechanisms of ligand binding in multivalent interactions.[10] 
Regarding the nature of the receptor and its scaffold, four main multivalent 
binding mechanisms can be described, summarized in Figure 3. 
A) Simultaneous binding of a scaffold with multiple ligands to receptors, that 
themselves are oligomeric, can result in chelation.  In case of chelation, merely 
the first receptor-ligand contact needs to afford the energy for translational 
entropy whereas every subsequent binding interaction can proceed without 
additional penalties.[9]  Thus this effect favors the bound ligand-receptor 
complex.  
B) Some receptors have more than one binding pocket which results in so 
called subsite binding possibilities. These subsites can either bind to the same 
recognition element as the main site or to a different one. Binding energy of 
multivalent interactions can be gained by additional binding to subsites[11] of 
the receptor.  
C) The probably most significant feature of multivalent binding is steric 
stabilization of the ligand-receptor-complex. For example, multivalent 
interaction can result in clustering of glycoproteins, anchored in the membrane, 
which in result stabilize their assembly through additional interactions.[12] 
Multivalent complexes enable steric stabilization and thus adjust the ligand-
receptor-binding equilibrium to the bound state. 
D) Furthermore, multivalent binding increases the probability of statistical 
rebinding. The presence of a large amount of ligands in proximity of the 
receptor leads to a high probability of subsequent rebinding to the next ligand 
once one interaction dispersed. 
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Figure 3. Multivalent mechanisms to enhance ligand-receptor binding strength.[10] 
 
Steric stabilization of the ligand-receptor complex typically comes with inter- 
and intramolecular cooperative effects.[13] After the first intramolecular binding 
to a multivalent entity occurred, subsequent binding of more ligands of the 
same scaffold leads to a multivalent complex. On the other hand, binding of a 
second scaffold to the same multivalent entity leads to the formation of an 
intermolecular aggregate (Figure 4). Ligand-receptor interactions are 
depending on equilibrium constants of their binding. After the initial binding of 
one ligand on a multivalent scaffold to one receptor takes place, subsequent 
binding events are not concentration dependent anymore. Figure 5 illustrates 
the increase in effective ligand concentration around a multivalent entity after 
the first binding to a scaffold with multivalent ligands. The overall concentration 
of ligands in solution, though, remains constant. Depending on the system 
under study, the local proximity induced by the first binding event can either 
lead to positive, none or negative influence on subsequent binding events. For 
example, steric hindrance, due to inflexible scaffolds and insufficient 
possibilities for adjustment of ligand-receptor binding, typically leads to 
negative contributions. In that case the negative binding effect weakens the 
overall strength of the multivalent interaction. Furthermore, cooperativity 
effects are to be taken into account.[14] Ungaro et al. describe cooperativity as 
the “influence of the binding of one ligand on the receptor’s affinity toward 
further binding.” Cooperativity effects are highly dependent on the type of 
interaction and the character of the interaction partners. Although multivalency 
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is often associated with cooperativity, this effect is extremely difficult to 
determine in multivalent systems. The complexity of the determination of 
cooperativity effects in multivalent systems is mainly because the models for 
calculation are limited to monovalent ligands. [9, 13] 
 
 
Figure 4. Cartoon illustrating inter- and intramolecular binding, which lead to a multivalent 
complex or an intermolecular aggregate.[15] 
 
Figure 5. Cartoon illustrating the increase in the effective ligand concentration (ceff) in 
proximity of the multivalent surface after the first binding event. The overall concentration of 
ligands in solution (csol) remains constant.[15] 
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1.2 Synthetic Scaffolds with Multivalent Focus 
1.2.1 Multivalent compounds 
The significant enhancement of ligand-receptor binding affinity via multivalent 
interactions has put the design and synthesis of synthetic multivalent 
compounds into research focus. A large variety of multivalent scaffolds has 
been examined with regard to shape, backbone flexibility, linker length and 
valency. Scaffold classes based on structures such as aromatic compounds, 
peptides, dendrimers, polymers or solid supports have been exploited as 
multivalent scaffolds.[16, 17] However, the mechanisms with which the 
multivalent compounds bind remain essentially unknown.[18] 
Biological interactions targeted with synthetic multivalent compounds are 
numerous. Examples span from lectin and agglutin inhibition to surface 
recognition of proteins. To provide a flavor of the different constructs and their 
features with respect to multivalency and possible binding properties, some 
examples are described briefly in this chapter (Figure 6). For a complete 
overview on the design of multivalent compounds, compound classes 
employed for multivalent tasks and multivalent systems targeted with synthetic 
multivalent substances, the reader is referred to the literature.[1, 17, 19-23] 
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Figure 6. Examples of multivalent scaffolds.[19] a) low-valency and b) high-valency scaffolds. 
 
Scaffolds of lower valency ranging up to ten ligands have been reported 
numerously. In order to provide an idea of the scope of low valency scaffolds, 
examples of calix[n]arenes are discussed here.[15, 24, 25] The compound class of 
the calix[n]arenes, both charged and neutral, is based on aromatic scaffolds. 
Calix[4]arenes have been well studied regarding their backbone flexibility and 
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binding properties to diverse multivalent surfaces.[15] They can be present in a 
variety of distinct conformations (Figure 7) and therefore are considered to be 
rather flexible compared to other small valency scaffolds. 
 
 
Figure 7. The four conformations of calix[4]arenes. Ligands for multivalent interactions can be 
attached in R- and X-position.[15] 
 
Calix[4]arenes carrying glycosidic ligands have been well studied with regard 
to their multivalent interaction with bacteria, lectins and toxins.[15] Studies 
regarding the influence of shape and flexibility of the calixarene scaffold in 
carbohydrate-protein interaction has been performed by Sgarlata and 
coworkers.[26] A cone-blocked tetraminocalix[4]arene and a conformational 
mobile octaminocalix[8]arene (Figure 8) were decorated with multiple copies of 
N-acetyl-D-glucosamin and their multivalent properties were studied employing 
an haemagglutination inhibition assay with wheat germ agglutinin. All 
compounds tested showed much lower minimum inhibitory concentrations than 
N-acetyl-D-glucosamin. Interestingly all multivalent compounds based on the 
cone-blocked calix[4]arene turned out to have a higher inhibitory potency than 
the conformationally mobile calix[8]arene. Furthermore tetravalent 
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calix[4]arene scaffolds had the highest potency even when compared to the 
corresponding octavalent calix[4]arenes. Increase in valency or enhanced 
mobility of the calixarene backbone decreased the inhibitory abilities of the 
compounds in this haemagglutination assay. Apparently, the flexibility of the 
mobile octaminocalix[8]arene does not enable induced fit of the ligands to the 
glycoprotein but seems to result in steric constraints that decrease the overall 
binding potency. Furthermore, the decrease in binding potency obtained by 
increasing the number of ligands per calix[4]arenes scaffold from four to eight 
might result in steric crowding of the ligands on the scaffold. Crowding most 
probably also leads to steric hindrance and causes the decrease in binding 
potency. 
 
 
Figure 8. Examples of different calix[4]arenes provided with gallactose, glucose or lactose.[26] 
 
Other low-valent compound classes such as porphyrins, cyclophanes, 
resorcinarenes and a large variety of small glycomimetics have been 
examined as multivalent scaffolds with decorated glycosides regarding their 
interaction to glycoside-binding proteins.[27] A general tendency in all studies is 
that all multivalent compounds feature much higher activities than their 
monovalent control compounds.[28] In terms of saccharide binding to 
carbohydrate binding proteins, the effect of enhanced multivalent binding is 
referred to as the “cluster glycoside effect”.[22, 27, 29] On the other hand, the 
magnitude of improvement achieved with the multivalent interaction was highly 
dependent on the assay reported. Development of new, more efficient 
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multivalent low valency scaffolds mainly focuses on the optimization of 
backbone flexibility and linker length to achieve ‘induced fit’ to the multivalent 
receptor.[8, 25, 30, 31] However, low valency scaffolds are highly limited in the 
number of multivalent ligands that can be attached to them and in terms of 
backbone flexibility.  
 
To obtain compounds of higher valency, various platforms have been 
developed such as linear polymers, dendrimers, nano particles like beads or 
gold surfaces and self-assembling monolayers (SAMs) (Figure 6).[19, 20, 23] In 
order to provide an idea of the abilities and perspectives of high valency 
scaffolds, one example of dendrimers is discussed at this point. Dendrimers 
are macromolecular branched compounds and have been extensively studied 
as multivalent framework for different applications by various groups. [32-37]  
In the group of Cloninger, dendrimers provided with mannose ligands of 
generation 1 to 6 were synthesized and systematically evaluated concerning 
their ability to inhibit the lectin concanavalin A (con A).[38, 39] The valencies of 
the dendrimers reached from low valency of 8 ligands per scaffold in the 
generation 1 dendrimer up to valencies over 200 mannose ligands per scaffold 
in the generation 6 dendrimer. Compared to methyl mannose as control 
substance generation 1 (8 mannose ligands) and generation 2 (16 mannose 
ligands) dendrimers did not show any increase in activity toward con A. 
Binding of generation 3 dendrimers was enhanced by the factor of two 
whereas biding of generation 4-6 dendrimers was increased by two orders of 
magnitude.[40] These results indicate that generation 1 and 2 dendrimers bind 
to lectins in a monovalent fashion. As could be expected, their scaffolds are 
not large enough to enable spanning of the multiple binding sites of con A. The 
authors suggest that the small increase in binding of generation 3 dendrimers 
probably results from glycoside clustering. Higher generation dendrimers, 
however, are able to span multiple binding sites on one lectin. Apparently, the 
multivalent binding leads to formation of dendrimer-lectin clusters and thus to a 
strong increase in binding. The different binding motifs and their effects on 
binding strength are illustrated in Figure 9. Further studies on dendrimer 
generations 4 to 6 showed that the activity per sugar ligand is dependent on 
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the area each sugar has on the surface of the dendrimer scaffold.[41] Below a 
value of approximately 800 Å2 the activity per mannose ligand decreased 
significantly compared to the same scaffold with less mannose ligands. These 
studies emphasize the need for high valency compounds with an optimized 
spatial distribution of ligands that does not result in steric crowding of the 
binding motifs on the scaffold. 
 
 
Figure 9. The different binding motifs suggested for generation 1 to 6 dendrimers. Small 
binding enhancements are achieved of generation 3 dendrimers presumably due to glycoside 
clustering. Generation 4 to 6 dendrimers apparently bind in a multivalent manner. 
 
A wide range of polymer backbones has been examined as multivalent 
scaffolds with similar biological targets and comparable results to those of the 
dendrimers shown above.[10, 27, 42-44] In general, compared to compounds with 
lower valency, high valency scaffolds exhibit highly efficient inhibition and 
competition due to their ability to bind in different multivalent manners (Figure 
3 and Figure 4).[28] However, high multivalent compounds with polymer-like 
backbones possess limited properties to adapt their molecular structure to the 
requirements of their target. Thus, valency corrected binding does not 
necessarily increase with higher valency as was explained above for the 
dendrimer example. Regardless of the compound class used as covalent 
scaffold for multivalent tasks, the issue of backbone flexibility and optimal 
linker length, to achieve optimal ‘induced fit’ to the multivalent system targeted, 
is still essentially unsolved. 
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1.3 Self-Assembling Supramolecular Architectures 
Compounds that might be able to overcome the current limitations of synthetic 
multivalent systems, such as insufficient flexibility, are self assembling 
supramolecules. Self-assembling supramolecular architectures are systems 
that occur widely in nature. Examples are the bilayer membranes of cells, DNA 
or the tobacco mosaic virus. Synthetic self-assembling supramolecular 
polymers are of great current interest in chemistry, materials science and in 
biology.[45-48] Reported self-assembled systems range from capsules to linear 
polymers to nanostructures such as micelles, vesicles and nanotubes. 
Advantages of self assembling supramolecular architectures are plentiful. Self-
assembling supramolecules possess features such as diverse topology, 
composition, and assembly dynamics. The supramolecules are formed from 
the monomers through specific non-covalent interactions for instance 
hydrogen bonding, π-π stacking or ion pairing. These architectures possess 
well defined shapes and highly organized structures with distinct molecular 
surfaces. Self-assembled materials are close to the thermodynamic minimum 
and acquire high thermodynamic and kinetic stability. The reversibility of their 
non-covalent binding enables self-repairing of structural defects. Furthermore 
most supramolecular assemblies are responsive to their environment. 
Variation of the pH, solvent and temperature enables external control to some 
extent. 
The field of self assembling supramolecular architectures is vast. In this 
chapter examples of self assembling supramolecular architectures are given to 
provide an idea of the current research focus. Examples mentioned here have 
been used for biology related purposes and concern supramolecular assembly 
in aqueous solution. For more detailed information on the examples or reviews 
on supramolecular polymers the reader is referred to the literature.[21, 49-55]   
 
1.3.1 Self assembling Supramolecules with Multivalent Focus  
In order to overcome existing problems with insufficient flexibility of multivalent 
polymeric scaffolds, a limited set of self-assembling architectures has been 
evaluated concerning their potential to enhance multivalent interactions. Self 
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assembling architectures built up macromolecular structures that are able to 
respond to external factors and, when provided with the corresponding ligands, 
can interact with biological material. The usage of dynamic systems as 
multivalent scaffolds is promising, because highly flexible scaffolds have the 
potential to feature fewer steric constraints in ligand-receptor binding.  
 
Only few groups developed approaches to employ self-assembling systems as 
multivalent scaffolds taking advantage of dynamic supramolecular 
nanostructures. One example of self-assembling supramolecular, multivalent 
architectures are the pseudopolyrotaxanes[56] (Figure 6), engaged as 
multivalent interaction partner of galectin-1 by the group of Stoddart.[57] The 
synthesis of these supramolecules is based on a self assembly protocol 
leading to cyclodextrines threaded on a polyviologen string (Figure 10). The 
cyclodextrines decorated with lactosides are able to spin around the chain and 
can move forth and backwards on the polymer string. As illustrated in Figure 
10, these lactoside pseudorotaxanes are big and flexible enough to bind 
galectin-1 in a multivalent fashion and span its binding sites.[57] Rotation of the 
lactoside ligands furthermore enables intermolecular binding to several 
galectins.  
In principle, the ability to rotate and move along the polymer axis should allow 
orientation of the ligand in the most favorable manner for maximal binding 
interaction with the receptors. Nevertheless, subsequent studies revealed that 
these multivalent systems based on pseudopolyrotaxanes seemed to bind in a 
negatively cooperative fashion presumably due to steric hindrance and 
electrostatic repulsion.[58, 59] Additionally, another fact should be taken into 
account at this point: although the pseudopolyrotaxanes display a highly 
flexible multivalent polymer, the order of the cyclodextrins on the string is set 
after the assembly. Threading on the chain locks the sorting of the 
cyclodextrins and does not allow later rearrangement.  
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14 
 
 
Figure 10. Self-assembly of lactoside cyclodextrines and a polyviologen string resulting 
polyrotaxanes. Polyrotaxanes allow rotation and flexible movement of cyclodextrins along the 
string.[57] 
 
Another important class of self-assembling supramolecular architectures are 
nanomaterials such as micelles and vesicles. Stupp and coworkers 
significantly contributed to the field of self-assembling nanostructures and the 
application of nanomaterials in biological systems.[60, 61]. The group designed 
peptide amphiphiles, which form via hydrophobic collapse and promote in vivo 
growth of blood vessels.[62] Self-assembled positively charged peptide 
nanofibers bind negatively charged heparin chains. Interaction of the heparin-
amphiphile complex with FGF-2 and FGF receptors results in stimulation of 
growth of blood vessels (Figure 11). 
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Figure 11. Self-assembled positively charged peptide nanofibers (blue) bind negatively 
charged heparin chains (red). Subsequent interaction of that complex to FGF-2 (yellow) and 
FGF (green) receptors results in stimulation of growth of blood vessels.[62] 
 
Lee and coworkers synthesized aromatic amphiphiles decorated with mono 
saccharides for multivalent interaction.[63, 64] In aqueous solution the 
supramolecules self-assemble into carbohydrate coated nanofibers and 
transform into micellular structures upon addition of the guest molecule Nile 
Red (Figure 12). Studies on lectin binding showed that both objects, fibers and 
micelles, function as multivalent inhibitors. Interestingly, in motility studies on 
E. coli Lee and coworkers found that motility inhibition with the spherical 
micelles was significantly lower than with the nanofibers. Strength and 
efficiency of multivalent interactions are dependent on the shape and the 
surface properties of the interaction system. Apparently, multivalent 
interactions increase with the potential of the multivalent scaffold to adapt to 
the receptors surface. 
 
1. Introduction 
16 
 
 
Figure 12. Self-assembly of carbohydrate coated aromatic amphiphilies. The supramolecules 
self-assemble into carbohydrate coated nanofibers and transform into micellular structures 
upon addition of the guest molecule Nile Red. The aromatic amphiphilies decorated with mono 
saccharides exhibit strong binding to FimH receptors of E.coli.[63] 
 
The above sketched fields and challenges emphasize the need for new, highly 
flexible multivalent architectures, which are able to adapt themselves to the 
multivalent surface in the most ideal mode. In a very recent review on the topic 
of supramolecular multivalent scaffolds Martos et al.[19] concluded: 
“…multivalency has demonstrated that precise design and strong individual 
interactions are not necessary if recognition to a protein surface is to be 
achieved. The sum of weaker contacts in a flexible context around a central 
scaffold can be much more efficient and even selective. Future directions 
should include the use of supramolecular (reversible) contacts around a 
platform that might allow the system to optimize the choice of ligands, linkers 
and geometries to better complement the binding sites of the protein, …” 
Without question, there is a need for new supramolecular synthetic systems, 
with diverse topology, composition, and assembly dynamics which serve as 
multivalent scaffolds.  
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2 Aim of the Thesis 
The question, how to design and synthesize a macromolecule that optimally 
mimics and matches the arrangement of its multiple targets in the membrane 
and adapts itself to the dynamics of these targets, is essentially still unsolved. 
Synthetic supramolecular systems are self-assembling and dynamic scaffolds 
that could provide an entry to target the natural supramolecular polyvalent 
assemblies more effectively.  
There is a need for new, highly flexible multivalent scaffolds with diverse 
topology and mechanisms to flexibly control polymer composition and 
dynamics. Self-assembling supramolecular polymers were envisaged as a new 
compound class for multivalent tasks. The design, synthesis, and biological 
evaluation of a biocompatible, auto-fluorescent, polyvalent supramolecular 
polymer was planned. 
We meant to modify the reported synthesis of self-assembling discotics to 
enable subsequent attachment of ligands in the last step of the synthesis. To 
study the applicability of self-assembling polymers in terms of multivalent 
interactions, easily accessible ligands with well studied biological interactions 
were thought to be attached to the discotics. For example, the discotic 
monomers were foreseen to be functionalized with glycosidic residues to 
induce multivalent binding to lectins and agglutins. Furthermore, mixtures of 
functionalized and unfunctionalized discotics should be studied to examine the 
use of unfunctionalized discotic monomers as spacer between the functional 
groups. Mixtures of different functionalized discotics were foreseen to provide 
easy access to heterovalent assemblies. Synthesis of heterovalent compounds 
is highly challenging and controlled ligand ratios are not accessible so far. 
Furthermore, the applicability of the discotic polymers as modulator for protein 
assembly and interactions was to be evaluated. Therefore discotics were 
planned to be decorated with ligands that enable subsequent protein ligation. 
Discotic monomers linked to proteins were envisaged to induce the assembly 
of these proteins in aqueous solution through self assembly of the discotic 
monomers to their supramolecular polymer. The unfunctionalized discotic 
monomer was foreseen to serve as modulator to control the space between 
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the discotic monomers, ligated to a protein, in a concentration dependent 
manner. Self assembling supramolecules are a compound class with highly 
promising features concerning multivalent interactions and protein modulation. 
3. Results and Discussion 
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3 Results and Discussion 
3.1 Synthesis of Discotic Scaffolds 
 
Biological systems that undergo polyvalent recognition interactions typically 
are dynamic supramolecular assemblies, with the recognition partners in a 
self-reorganizing environment such as the cell-membrane. Induction or 
inhibition of these types of interactions provides entry to targeting diseases 
and infections related to them.[1, 2] The question how to design and synthesize 
a macromolecule that optimally mimics and matches the arrangement of its 
targets in the membrane and adapts itself to the dynamics of these targets is 
essentially unsolved.[63-67] Critical issues are, amongst others, the difficulty to 
control exact ligand placing, backbone folding of synthetic polymers and the 
generation of systems that actively adjust their ligand positioning in response 
to the dynamic rearrangement of the biological interaction partners. Synthetic 
supramolecular systems[51, 52] are self-assembling and dynamic scaffolds that 
could enable targeting the natural supramolecular polyvalent assemblies more 
effectively.  
 
3.1.1 Design of Supramolecules for Biological Tasks 
In order to design a new class of dynamic, supramolecular polymers for 
multivalent interaction and control over the assembly of biomacromolecules, 
the synthesis of a self-assembling supramolecular scaffold was planned. The 
supramolecular system ideally features properties such as self-assembly into 
polymer structures in water, and a strong fluorescence signal of the 
assemblies, useful for detection in biological studies.  
So called ‘discotics’ feature these advantages. Discotics build up highly 
ordered, unique architectures in aqueous solution, even at very dilute 
concentrations.[68] The large aromatic cores of the discotic monomers induce 
self assembly into columnar structures up to the size of biomacromolecules. 
3. Results and Discussion 
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Additionally, the discotic scaffold exhibits a strong fluorescence signal owing to 
its aromatic core.  
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Scheme 1. Retrosynthetic approach for the introduction of functional groups for subsequent 
modification of the discotic with ligands. 
 
The aromatic core is surrounded by glycol side chains which enable water 
solubility and guarantee biological inertness of the discotic scaffold. 
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Furthermore, the glycol side chains of the discotics provide an ideal building 
block to modify the discotic monomers with ligands. Due to their unique 
properties, discotics were selected to develop a flexible platform for multivalent 
interactions and as a modulator of protein assembly.   
The discotics are built up from three main building blocks: a central 
1,3,5-benzenetricarbonyl unit, three 2,2'-bipyridine-3,3'-diamine wedges and 
the outer core consisting of three gallic acid moieties provided with glycol side 
chains (Scheme 1) which guarantee water solubility.  
 
In order to be able to use this scaffold for biological applications, it had to be 
made possible to modify the discotic with diverse biological ligands in the last 
step of the synthesis. Therefore we needed to introduce a functional group in 
the outer core of the discotic, which would allow subsequent synthetic 
modification of the scaffold. The functional groups were supposed to be 
introduced on the termini of the glycol side chains. Furthermore, only the para-
positioned side chain of the gallic acid was supposed to be modified. Although 
a gallic acid derivative with three equal side chains is easier accessible, three 
functionalizable groups per gallic acid would result in nine groups on the final 
discotic. In this case, one monomeric discotic would already be an interaction 
partner with high polyvalent potential. Studying the polyvalent effects of the 
supramolecular columns with those discotics would most probably be difficult 
due to the high valency of the monomers. Besides this, assembly of discotic 
monomers with nine ligands would most probably result in crowding of the 
ligands at the periphery of the supramolecular columns. Crowding would 
complicate the functionalisation of the discotic with ligands and could lead to 
negative cooperative effects in multivalent binding. For these reasons we 
envisaged to synthesize symmetrical trivalent discotics with elongated side 
chains carrying functionalized groups on the termini of the side chains in para-
position of the gallic acid moieties. We planned to elongate the functionalized 
side chain in para-position by one glycol unit. Thus, the ligands could be 
attached to the longer chain and stitch out of the glycol periphery of the 
discotic. This should avoid possible sterical constraints in the interaction 
between the functionalized discotics and the corresponding biological system. 
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Discotics, equipped with reactive groups at the end of the side chains in para-
position of the gallic acid moiety, were envisaged to enable subsequent 
functionalisation of the discotic scaffold with specific ligands. In order to be 
flexible in terms of attachment of ligands we chose to design two differently 
functionalized discotic scaffolds. One discotic scaffold was proposed to be 
provided with an amine functionality. Many biological interesting ligands either 
carry or can be decorated with acids and thus could be attached to an amine 
modified discotic by acylation. Furthermore we planned to introduce an azide 
functionality to the discotic scaffold. Ligands provided with a propargylic 
residue could be attached by Huisgen [2+3] cycloaddition.[69, 70] This reaction is 
highly selective and widely used for attachment of ligands in aqueous 
solutions.[71] These two functionalized discotics were envisaged as key building 
blocks to a variety of discotics carrying different ligands. 
 
3.1.2 Synthesis of the Inert Discotic 
Synthesis of disc-shaped molecules based on trimesic acid and bis-acetylated 
diaminobipyridines has been reported in the literature.[51, 52, 72] According to the 
strategies, discotics were built up with a central 1,3,5-benzenetricarbonyl unit, 
surrounded by three 2,2'-bipyridine-3,3'-diamine wedges attached to gallic acid 
scaffolds provided with glycol side chains in the outer core.  
We first set out to synthesize achiral unfunctionalized discotics as reported. 
These discotics carry equal glycol side chains, capped with methoxy-groups, in 
meta- and para-position of the wedges (Scheme 2). They possess no reactive 
groups for further synthetic modification and were meant to serve as control 
scaffolds and as biologically inert spacers in supramolecular polymers as 
described in Chapters 3.3 and 3.4. 
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Scheme 2. The inert discotic scaffold 1, built up by linking three 2,2'-bipyridine-3,3'-diamine 
wedges to a central 1,3,5-benzenetricarbonyl unit. Glycol side chains ensure water solubility.  
 
Disc-shaped molecules 1 (Scheme 2) were synthesized by a convergent 
approach. The molecules were built up by linking three N-monoacylated 
2,2'-bipyridine-3,3'-diamine wedges to a central 1,3,5-benzenetricarbonyl unit. 
The synthesis of 2,2'-bipyridine-3,3'-diamine 4 (Scheme 3) has been described 
previously.[73, 74] In our hands Ullmann coupling of 2-chloro-3-nitropyridin (2) to 
the bipyridine 3 and subsequent reduction of the nitro-groups was performed in 
25% yield over two steps.  
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Scheme 3. Synthesis of the 2,2'-bipyridine-3,3'-diamine a) Cu, DMF, 110 °C, 34%; b) SnCl2, 
HCl, 72%. 
 
Pentaethylene glycol-monomethylether (10) was prepared according to 
Scheme 4 from the corresponding commercially available glycols 5 and 7. 
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Monobenzylated diethylene glycol 6 was alkylated with tosyl-activated 
triethylene glycol-monomethylether 8 to yield pentaethylene glycol-
monomethylether 10 after debenzylation in 88% yield. The yield is comparable 
to the previously reported coupling of tetraethylene glycol-monomethylether to 
activated benzyl monoethylene glycol (85%).[68] Nevertheless, the starting 
material triethylene glycol-monomethylether is cheaper than the corresponding 
tetraethylene glycol-monomethylether.  
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Scheme 4. Synthesis of the pentaethylenglycol-monomethylether side chain. a) BnBr, NaH, 
THF, 16 h, 80 °C, 73%; b)  tosyl chloride, NaOH, THF/water, 5 h, 0 °C, 65%; c) KOH, THF, 
12 h, 100 °C, 88%; d) H2 (50 bar), Pd/C, HCl, ethanol/water, 12 h, quant.; e) tosyl chloride, 
TEA, CH2Cl2, 12 h, 72%. 
 
Pentaethylene glycol-monomethylether (10) was activated to its tosylate 11 
and introduced threefold on the gallic acid by alkylation of the commercially 
available methyl 3,4,5-trihydroxybenzoate in 81% yield (Scheme 5). The 
methylester of 13 was saponified under basic conditions at 100 °C. The free 
acid 14 was activated to its acid chloride 15 with oxalyl chloride and a catalytic 
amount of DMF. To avoid radical chlorination of the aromatic core the reaction 
was carried out in the absence of light. The crude acid chloride 15 was used 
directly for the subsequent step. 
The synthesis of 1 is based on the consecutive selective acylation of the two 
amino groups of 2,2’-bipyridine-3,3’-diamine 4 (Scheme 5). The condensation 
to the monoacylated bipyridine 16 was carried out by adding a dilute solution 
of the acid chloride 15 to an ice-cooled and dilute solution (both about 0.1 mM) 
of 2,2'-bipyridine-3,3'-diamine 4 and triethylamine (TEA) to obtain a high 
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degree of monoacylation. Monoacylated and diacylated compounds were 
separated by column chromatography. In the final step 16 was attached to 
benzene-1,3,5-tricarbonyl trichloride (17). A slight excess of 16 was used to 
ensure complete threefold reaction of the inner core. The crude compound 
was thoroughly purified by column chromatography using silica gel and size 
exclusion chromatography. Due to the assembly of the discotics in various 
organic solvents[68], chloroform or CH2Cl2 were used for chromatographic 
purification, because the discotics do not assemble in these solvents. 
Compound 1 was isolated in reasonable yields (37% over three steps).  
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Scheme 5. Synthesis of the inert discotic 1. a) 11, K2CO3, DMF, 12 h, 70 °C, 81%; b) KOH, 
ethanol/water, 100 °C, 82%; c) (CO)2Cl2, DMF, CH2Cl2, 12 h, 62%; d) 4, TEA, CH2Cl2, 5 h, 
5°C; e) TEA, CH2Cl2, 59% over 2 steps. 
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3.1.3 Synthesis of the Azide- and Amine Functionalized Discotics 
We set out to generate derivatives of 1 that would allow facile modification with 
ligands. As already mentioned in Chapter 3.1.1, we planned to introduce 
amine or azide functionalities on the discotic scaffold. The amine functionality 
was envisaged to be decorated with ligands via acylation with an acid. This 
reaction gives access to many biologically interesting substances such as 
peptides and for example dyes provided with acid-linkers. On the other hand, 
[2+3] cycloaddition of the azide functionality opens the door to highly selective 
attachment of compounds with propargyl residues. This reaction can be 
carried out selectively, even with ligands carrying unprotected other reactive 
groups. 
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Scheme 6. Discotic scaffold with functional groups at the side chain termini in R2 position offer 
a flexible access to functionalized discotic scaffolds. 18 azide discotic; 19 amine discotic.  
 
Compounds 18 and 19 were designed featuring three selectively introduced 
azide or amine functionalities at the periphery of the molecule. Discotic 
scaffolds 18 and 19 were envisaged to provide a flexible platform for 
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modifications with biological ligands in the final step of the synthesis (Scheme 
6). Compounds 18 and 19 were synthesized in a multistep approach in a 
convergent fashion, resulting in a discotic molecule provided with six inert 
ethylene glycol-monomethylether side chains and three azide- or amine-
functionalized side chains. 
The glycol side chain 22 with an azide functionality was derived from 
hexaethylene glycol (20) in two steps by mono-tosylation and subsequent 
substitution (Scheme 7). Mono-tosylation was carried out using a threefold 
excess of 20 compared to the tosyl chloride to avoid double tosylation. The 
desired compound 21 was isolated in 80% yield, while 30-50% of starting 
material 20 was recovered. Reaction with sodium azide to generate 22 
proceeded in 85% yield. 
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Scheme 7. Synthesis of the azido-hexaethyleneglycol side chain. a) tosyl chloride, TEA, THF, 
12 h, 80%; b) NaN3, DMF, 6 h, 85%; c) tosyl chloride, TEA, CH2Cl2, 12 h, 66%. 
 
Hydrogenation of the azide, catalyzed by palladium on charcoal, was 
performed in high yields. However, Boc-protection of the free amine appeared 
to be less straightforward. First trials of the protection with Boc-anhydride in 
presence of base seemed to result in amine double Boc protection, according 
to NMR and mass-spectrometry. Slow addition of a slight excess (less than 1.2 
equiv.) of Boc-anhydride at 0 °C, addition of base only after 3 h and long 
reaction times of up to 1 d finally yielded the desired hexaethylene glycol 25 
with mono-protected amine functionality in reasonable yield (Scheme 8). 
Compounds 22 and 25 were activated to their respective tosylates (23 and 26). 
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Scheme 8. Synthesis of the amino-hexaethylene glycol side chain. a) H2 (10 bar), Pd/C, 
ethanol/water, 48 h, 96%; b) Boc2O, dioxane, 0 °C-rt, 27 h, 61%; c) tosyl chloride, TEA, THF, 
12 h, 62%. 
 
In order to selectively introduce modified glycol side chains to the discotic 
scaffold, methyl 3,4,5-trihydroxybenzoate was orthogonally protected at the 
4-position (Scheme 9). Therefore, methyl 3,4,5-trihydroxybenzoate was 
allowed to react with acetic anhydride under basic conditions to yield the per-
acetylated compound 27 as colorless crystals. 27 was mono-benzylated in 
para-position with benzyl bromide, in presence of potassium carbonate and 
potassium iodide, to yield 28.[75] Hydrolysis of the acetyl groups gave 
compound 29, selectively protected at the 4-position. Alkylation with activated 
pentaethylene glycol-monomethylether 11 yielded 30. Subsequent 
debenzylation in an autoclave under hydrogen atmosphere gave 31 in 20% 
total yield over five steps. Gallic acid derivative 31 could now be provided with 
the glycol side chains carrying functional groups. Activated glycol chains 23 or 
26 were introduced on 31 by alkylation under basic conditions at 70 °C, to 
provide scaffolds 32 and 33 as modified outer cores of the discotic in 70% and 
90% yield respectively.  
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Scheme 9. Synthesis of the gallic acid derivatives 32 and 33 with amine- or azide-
functionalisation. a) Ac2O, pyridine, 12 h, 80%; b) BnBr, K2CO3, KI, Acetone, 57%; c) K2CO3, 
methanol/water, 70%; d) K2CO3, DMF, 70 °C, 61%; e) H2, Pd/C, HCl, ethanol/water, 94%; 
f) K2CO3, DMF, 70 °C, 70% for 32 and 90% for 33.  
 
Compounds 32 and 33 were saponified under basic conditions at 100 °C 
(Scheme 10). The free acids 34 and 35 were activated to their acid chlorides. 
These reactions were carried out in the absence of light to avoid radical 
chlorination of the aromatic core. Subsequent reaction of 4 with the acid 
chlorides 36 or 37 at 0 °C afforded mono-N-acylated bipyridines 38 and 39 in 
62% and 52% yield, respectively. Pure 38 was obtained after thorough 
purification by column chromatography with silica gel, size exclusion 
chromatography and column chromatography again. However, purification of 
39 turned out to be much more difficult than it had been in case of 16. 
Purification by column chromatography with silica gel, size exclusion 
chromatography and column chromatography again resulted in the desired 
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product 39 containing an impurity of approximately 10%, according to LC/MS. 
However, high purities at this stage were absolutely required for both 
compounds (38 and 39), because the following threefold reaction with trimesic 
acid generates the self-assembling discotics, from which impurities are only 
very difficult removed. Impurities, leading to side reactions in this last step, 
resulting in compounds of similar weight as the discotic product, could most 
probably not be separated from the desired molecules. Thus the crude of 39 
was isolated by preparative LC/MS in fractions of 60 mg to finally result pure 
39. 
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Scheme 10. Synthesis of the discotic scaffold with amine- or azide-functionalisation. a) KOH, 
ethanol/water, 100 °C, quant. for 34 and 94% for 35 ; b) C2O2Cl2, DMF, CH2Cl2, 12 h; c) TEA, 
CH2Cl2, 5 h, 5 °C, 62% for 38 and 52% for 39; d) TEA, CH2Cl2, 39% for 18 and 57% for 19a; 
e) TFA, CH2Cl2, 30 min, quant. 
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In the final step, threefold reaction of trimesic chloride (17) with pure 38 gave 
target compound 18 in reasonable 39% yield, after purification by column 
chromatography over silica gel and size exclusion chromatography.  
Acylation of 39 with trimesic chloride gave 19a in 57% yield. Pure 19a was 
also obtained after purification by column chromatography with silica gel 
followed by size exclusion chromatography. Deprotection of 19a under acidic 
conditions proceeded fast. Purification by size exclusion chromatography 
separated 19 from molecules of low molecular weight. Discotic 19 with free 
amine functionalities was isolated quantitatively (Scheme 6). Having 
compounds 18 and 19 in hand, we could now set out to decorate the discotics 
with ligands for biological studies. 
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3.2 Ligand-functionalisation of Discotics  
 
Compounds 18 and 19 provide flexible scaffolds for modifications with 
biological ligands. Introduction of ligands is possible for example by acylation 
of 19 or by copper catalyzed [2+3] cycloaddition of 18 with alkynes. In this 
chapter the synthesis of a set of functionalized discotics will be described. 
 
3.2.1 Preparation of a Glycoside Modified Discotics 
Mannose was envisaged to be attached to the azide discotic 18 by [2+3] 
cycloaddition as ligand for the interaction with bacterial agglutins and lectins[3]. 
Mannose was chosen, because of its property to bind to the FimH receptors of 
E. coli - an easily accessible bacterial system to study polyvalency as 
described in Chapter 3.3. Furthermore, the corresponding galactose and 
glucose modified discotics were planned to be prepared as well. Galactose 
also targets FimH receptors though with lower affinity than mannose. Glucosyl-
ligands do not bind to these receptors, but are involved in immune response. 
To explore the feasibility of this approach, 1-propargyl-α-D-mannopyranoside 
42 was first prepared in three steps (Scheme 11).[76] 1,2,3,4,6-Penta-O-acetyl-
α-D-mannopyranosid 40 was obtained by acetylation of mannose in 93% yield. 
The propargyl residue was introduced, employing the tin tetrachloride 
catalyzed glycosidation procedure.[76] 1-Propagyl-2,3,4,6-tetra-O-acetyl-α-D-
manno-pyranosid 41 was isolated in 54% yield. Deprotection proceeded 
quantitatively. 1-Propargyl-glucopyranosid (48) and 1-propargyl-
galactopyranosid (45) were prepared accordingly in 50% and 48% respective 
total yield over three steps. 
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Scheme 11. Synthesis of 1-propargyl-α-D-mannopyranosid 42 (above), 1-propargyl-β-D-
galactopyranosid 45 (middle) and 1-propargyl-β-D-glucopyranosid 48 (below); a) 2-propargyl-
alcohol, SnCl4, CH2Cl2, 46-54%; b) NaOMe, methanol/water, 96-100%; The penta-acetylated 
compounds 40, 43 and 46 were prepared from the corresponding glycosides in 90-97% yield, 
using acetic anhydride and pyridine. 
 
For the threefold modification of 18 with this mannose derivative, standard 
conditions of 2 mol-% CuSO4, 5 mol-% of sodium ascorbate, and 15 equiv. of 
1-propargyl-mannose per azide residue in a water/t-butanol mixture were 
applied (Scheme 12).[77] In contrast to many previous reports on the copper 
catalyzed azide-alkyne cycloaddition for sugars,[71] the modification of 18 to 49 
via this reaction was relatively slow. Approximately 30% of the azide 
functionalities reacted rapidly within the first hours, but the complete 
functionalization of all groups required longer times. MALDI-TOF MS spectra 
(Figure 13) show the progression of the [2+3] addition over time. After 4 h the 
mass peak of the mono addition appeared. Nevertheless after 2 weeks there 
was still some starting material left and mono-, di-, and tri-addition products 
were detected. Only after 3 weeks the main mass peak corresponded to the 
desired product. After 4 weeks full conversion to the desired compound 49 was 
detected. Neither addition of the glycoside nor increase of copper catalyst or 
sodium ascorbate seemed to have influence on reaction times. 
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Scheme 12. Synthesis of the glycoside discotics 49, 50 and 51 from azide discotic 18. 
a) Na-ascorbate, CuSO4, t-butanol/water. 
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Figure 13. MALDI-TOF MS Spectra of mannose coupling to azide discotic 18 after a) 4 h, 
b) 2 weeks, c) 3 weeks and d) 4 weeks. After 4 weeks all azides were converted. 
 
One possible explanation for the slow reaction is the coordination of copper to 
the bipyridin core. Thus, decrease of the amount of free copper in solution 
could lead to slow reaction times. Nevertheless, we think that this is not the 
case here. To be able to coordinate copper, a bipyridine core needs to have 
both heterocyclic nitrogens in one plane. The bulky moieties of the bipyridine 
wedges in the discotic would most likely not allow rotation of the bipyridines 
and thus prevent the coordination of copper. This assumption is supported by 
the fact that a copper adduct of the product or side products in MALDI-TOF 
MS has never been detected and that the discotics remain fluorescent during 
the reaction. 
Apparently the high degree of supramolecular polymerization of 18/49 at the 
reaction conditions in water results in molecular crowding (vide infra) of the 
reactive functionalities. Crowding then causes sterical hindrance and prevents 
further reaction of free azides. The dynamic rearrangement of the discotics 
nevertheless allows full conversion of the free azide groups over time, 
probably at the chain-ends of the supramolecular polymer. The pure product 
49 could be isolated in 80% yield after size exclusion chromatography to 
remove the excess of mannose. Unlike the other discotic scaffolds 1, 18 and 
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19 the mannose modified discotic did not dissolve in CH2Cl2 and had to be 
purified in DMF via size exclusion chromatography. 
 
 
Figure 14. MALDI-TOF MS Spectra of a) mannose discotic 49 b) galactose modified 
discotic 50 and c) glucose modified discotic 51 after 4 weeks reaction time.  
 
Click reactions with the corresponding galactose- and glucose-derivatives 
were carried out in the same timeframe. The isolated yields were 72% for the 
galactose modified discotic 50 and 65% for the glucose modified discotic 51. 
Mass spectra of 49, 50 and 51, each after 4 weeks reaction time are shown in 
Figure 14.  
 
In order to prove the hypothesis of molecular crowding on the surface of the 
supramolecular polymers, future experiments could be performed in 
chloroform (monomer state) using a copper catalyst compatible with organic 
solvents.[70] Furthermore mixtures of 1 and 18 could be employed for the 
reaction in water. Compound 1 should serve as spacer in the supramolecular 
columns and could prevent molecular crowding.  
 
3.2.2 Preparation of a Texas Red Discotic 
Heterovalent supramolecular assembly with differently functionalized discotics 
is one anticipated advantage of dynamic supramolecular columns employed 
for interaction with biological systems. Heterovalent polymers could be easily 
accessed by simple mixing of the desired modified discotic scaffolds. In order 
to be able to study the properties of discotic mixtures, a fluorescent dye was 
attached to the scaffold. The dye was meant to provide an independent 
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possibility of detection in binding studies when using mixtures of differently 
functionalized discotics and the discotic attached to the dye. Texas Red was 
chosen with regard to its fluorescent properties such as small Stokes shift and 
an excitation wavelength around 590 nm, avoiding interference with the 
fluorescence of the discotic scaffold. 
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Scheme 13 . Synthesis of the Texas Red discotic 52 via the amine discotic 19. a) Texas Red-
X-NHS, TEA, CH2Cl2, 2 weeks. 
 
The amine disc 19 was allowed to react with an excess of Texas Red®-X, 
activated as its succinimidyl ester, readily available from Invitrogen, for 
2 weeks (Scheme 13). The reaction was monitored by MALDI-TOF MS (Figure 
15). After 12 h 19 had reacted at either one or two of the three free amine 
positions per scaffold (Figure 15). Only little starting material was left. 
However, the reaction seemed not to have continued any further after 3 more 
days. No mass signal of the desired product 52 could be detected. Addition of 
base and more Texas Red succinimide led to further conversion with the main 
fraction of the product consisting of tri-functionalized discotic after 10 days of 
reaction. Unfortunately, unlike the modification of 18 with mannose, complete 
conversion of all starting material could not be achieved. Neither addition of 
extra dye or base nor dilution or concentration of the reaction mixture resulted 
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in further conversion of the mono- and di-functionalized side products over a 
period of another week. Through repeated work up by size exclusion 
chromatography enrichment of the tri-functionalized Texas Red discotic could 
be achieved, but complete isolation from its side products was not possible. 
Separation by preparative affinity chromatography over silica or alumina under 
various conditions was not successful either. Furthermore, no optimized 
conditions for purification of the Texas Red discotic could be found using 
preparative Gel Permeation Chromatography. The difficultness of the 
purification probably lies in the ionic charges of the Texas Red molecule which 
lead to broadening of the fractions during chromatographic purification. 
Nevertheless, each discotic features at least one fluorescent Texas Red 
molecule and thus subsequent studies, described in chapter 3.3, with Texas 
Red discotic 52 were carried out using the mixture containing mono- and di-
Texas Red modified discotic. 
 
 
Figure 15. MALDI-TOF MS MS Spectra of Texas Red coupling to amine disc 19 after a) 12 h, 
b) 3 d, c) 10 d and d) 14 d. After 10 d no further progress in the reaction can be seen. 
 
Again, the quick conversion of all discotics to the mono-functionalized 
intermediate gives rise to the assumption that sterical hindrance causes the 
stagnation in the reaction process. However, the supramolecules do not 
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assemble in CH2Cl2 (monomeric state). Thus, overcrowding of ligands on the 
supramolecular periphery of the columns is not likely. Nevertheless, charges of 
the Texas Red ligand might generate some kind of aggregation, which leads to 
sterical hindrance and prevents further conversion of free amines. In case of 
Texas Red coupling no full conversion over time could be achieved, like it was 
in case of mannose coupling. Nevertheless, the product consists of a 
compound mixture in which all discotics carry at least one Texas Red dye. 
  
3.2.3 Preparation of a Biotin Discotic 
Another ligand that was selected for attachment to the discotic scaffold was 
biotin. Biotin was chosen as ligand because of its well-studied binding 
properties to streptavidin.[78] First trials to modify 19 with biotin were performed 
using N-hydroxysuccinimidyl biotin with a short alkyl spacer, but did not result 
in acylation of any of the three amine functionalities of 19, most probably 
because of the insufficient solubility of the biotin derivative in CH2Cl2. Thus, 
two water soluble biotin substances with glycol side chains spacers, supplied 
as N-hydroxysuccinimide ester, were used in the following reactions. 
BiotinPEO4-X-NHS was coupled to the amine discotic 19 as illustrated in 
Scheme 14. MALDI-TOF MS analysis (Figure 16) was performed on the 
reaction mixture after 4 h, 12 h, 3 d and on the product after purification. 
Already after 4 h the main peak found corresponded to the tri-acylated product 
while only some starting material was left. The reaction was stopped after 3 d 
and the crude product was purified by size exclusion chromatography. 
Compound 53 was isolated in 65% yield. 
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Scheme 14. Synthesis of the Biotin discotics 53 and 54 via the amine discotic 19. a) n = 4: 
BiotinPEO4-X-NHS or n = 12: BiotinPEO12-X-NHS, TEA, CH2Cl2, 4 d, rt.  
 
 
Figure 16. MALDI-TOF MS Spectra of Biotin-Disc 53 after a) 4 h, b) 12 h, c) 3 d and d) size 
exclusion chromatography. 
 
Whereas BiotinPEO4-X-NHS – carrying a glycol spacer of four units and a 
length of approximately 16 Å – reacted relatively fast, coupling of the 
corresponding BiotinPEO12-X-NHS – with about 50 Å length – was not 
complete even after several weeks of reaction. The reaction proceeded within 
the first 2 d and resulted in a main mass peak of the desired product and 
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significant amounts of di-acylated and mono-acylated discotics while no 
starting material 19 was left (Figure 17). After 3 d and 7 d, both additional 
activated ester and base were added but this led to no further conversion. 
After 9 d of total reaction time, the reaction mixture was split into three 
batches. The first portion was stirred like before. To the others either  
DIC/DMAP or HATU/DIPEA were added. The reactions were monitored for 
another 12 d. As shown in Figure 17 addition of coupling reagents did not lead 
to further conversion of free amines. 
 
 
Figure 17. MALDI-TOF MS Spectra of biotin-Disc 54 after a) 1 d, b) 4 d c) 7 d, addition of 
biotin and base plus 2 d reaction time, d) addition of HATU/DIPEA.  
 
The difference between the two biotin derivatives in terms of completion of the 
coupling reaction is another indication of steric crowding. Thus, overcrowding 
might also occur on the isolated molecule. As assumed in case of Texas Red 
coupling already (Chapter 3.2.2), not the stacking of the discotic but interaction 
of the attached ligand might cause aggregation even in CH2Cl2.  
These results indicate that overcrowding is an essential limitation for ligand 
attachment. This problem could be overcome by designing a non-symmetrical 
discotic with only one reactive amine or azide group. The synthesis would 
afford two inert and one functionalized wedge in the outer core of the discotic 
and is not within the scope of this thesis. Nevertheless, functionalisation of 
these monovalent discotics then should prevent overcrowding. 
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3.2.4 Preparation of a Cysteine Discotic 
N-Boc- and S-trityl-protected cysteine was attached as ligand to the discotic to 
provide a possible reaction partner for native chemical ligation of, for example, 
proteins to the supramolecular scaffold. The amino acid was activated as 
N-hydroxy-succinimid ester and allowed to react with the amine discotic 19 
under basic conditions (Scheme 15). After 4 h only traces of diacylated 
compound were left, whereas most free amines had reacted. Coupling of the 
protected cysteine to the amine discotic 19 was complete after 12 h. After size 
exclusion chromatography 85% of cysteine discotic 55 were isolated. 
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Scheme 15. Synthesis of the cysteine discotic 56 via the amine discotic 19. a) Boc-Cys-(Trt)-
NHS,CH2Cl2, 4 h; b) TES, TFA, CH2Cl2, 2h, rt. 
 
Deprotection of the cysteines under acidic conditions with 20% TFA in CH2Cl2 
proceeded quantitatively within 2 h (Figure 18). In order to remove molecules 
of small molecular weight the compound was purified by size exclusion 
chromatography. The deprotected cysteine discotic was stored at -20 °C to 
prevent disulfide formation. Prior to ligation reactions 56 was stirred in 
presence of tris(2-carboxyethyl)phosphine (TCEP) for 30 min to reduce 
potential disulfides.  
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Figure 18. MALDI-TOF MS Spectra of cysteine disc 56 after a) size exclusion chromatography 
and b) 2 h reaction time. 
 
3.2.5 Column Formation 
All discotic compounds dissolve readily in water and form supramolecular 
polymers. It has been shown before that the degree of polymerization is 
dependent on the solvent.[79] Whereas glycol modified discotic compounds 
form supramolecular columns in water, they are in the monomer state when 
dissolved in chloroform. Column formation leads to a red shift in the UV-Vis 
and a strong increase in fluorescence of the polymer compared to the 
monomer. Thus absorption and emission spectra of 49 and 1 were recorded in 
both water (supramolecular polymer state) and chloroform (monomer state). In 
both cases fluorescence intensity in water was roughly a factor of four higher 
than in chloroform (Figure 19). Additionally the red shift in the UV-Vis spectra 
of the local maximum of about 3 nm indicates column formation (Figure 20). 
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Figure 19. Fluorescence spectra of 1 and 49 in water and chloroform. Spectra were taken at 
an excitation wavelength of λex = 340 nm. 
 
 
Figure 20. UV-Vis spectra of 1 (dark blue/indigo) and 49 (red/orange) in water (red/blue) and 
chloroform (green/purple). 
 
3. Results and Discussion 
45 
 
3.3 Polyvalent Properties of Discotics  
 
Mannose and mannose containing polymers are known to bind to the E. coli. 
FimH receptor.[3] The development of molecules with flexible polyvalent 
properties has been the subject of various studies.[38, 80] Prominent examples 
include glycodendrimers, -polymers, -copolymers and other compounds 
provided with mannose as polyvalent scaffold.[8, 15, 30, 31, 39, 81] 
Multivalent architectures based on dynamic supramolecular discotics are 
studied here extensively for polyvalent tasks on bacterial surfaces, on 
streptavidin covered beads and on lectins.  
 
3.3.1 Bacterial Assays 
3.3.1.1 Binding of Mannose Discotic to BL 21α 
The binding of polyvalent supramolecular polymers built up by 1 or 49 and 
mixtures thereof to bacteria was investigated via microscopy studies with the 
E. coli strain BL 21α. The bacteria were cultivated in LB media, washed, 
resuspended and incubated with either nonfunctionalized discotic 1, 
mannosylated discotic 49, or with water, for 1 h at room temperature.[42] The 
total concentration of discotic monomers 1 and 49 was kept highly dilute at 
10-7 M. After washing and mounting on glass slides, binding to the bacteria 
was evaluated with a fluorescent microscope, taking advantage of the strong 
auto-fluorescence of the discotics when present as supramolecular polymer[68, 
79] Images were taken both in brightfield and in fluorescence mode at an 
excitation wavelength of 360 nm and emission of 490 nm. Only when the 
bacteria were incubated with mannose modified discotic 49 a strong 
fluorescence of the bacterial aggregates could be observed, colocalizing with 
the brightfield image (Figure 21). Both the control experiments with non-
functionalized scaffold 1 and with water did not show fluorescence. These 
results show that the polyvalent supramolecular polymers formed by 49 bind to 
the bacteria and that there is no unspecific binding of supramolecular polymers 
of 1 to the bacteria.  
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Figure 21. Microscopy pictures in a) brightfield and b) fluorescence (λex = 360 nm, 
λem = 490 nm) mode on E. coli incubated with 1) water, 2) inert discotic 1, 3) mannose 
discotic 49. 
 
3.3.1.2 Colocalization Studies with Auto-fluorescent E. coli 
E. coli strain BL 21 α, transfected with a plasmid coding for pECFP, was used 
in order to perform exact fluorescence colocalization studies of the bacteria 
and the discotic compound. This bacterial strain expresses Cyan Fluorescent 
Protein (CFP) and therefore can be localized utilizing the fluorescent features 
of the protein. The assay was carried out following the procedure described 
above. In this case microscopy pictures were taken with brightfield, excitation 
wavelength of 360 nm and filters for CFP. Results are summarized in Figure 
22 illustrating the colocalization of the discotic scaffold 49 (green) and the 
bacteria (blue). Control experiments with water and 1 do not result in a 
fluorescent response using filters for the discotic scaffold but show bright cyan 
auto-fluorescence of the bacteria (Figure 22; 1 and 2). Pictures taken after 
incubation of the E. coli with 49 convincingly demonstrate the co-localization of 
the green discotic fluorescence and the auto-fluorescence of the bacteria 
(Figure 22; 3). 
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Figure 22. Microscopy pictures in a) brightfield and b) fluorescence (λex = 360 nm, 
λem = 490 nm) mode c) fluorescence (CFP optical filter) on E. coli incubated with 1) water, 
2) inert discotic 1, 3) mannose discotic 49. 
 
3.3.1.3 Specificity of FimH Interaction 
The specificity of the interaction of supramolecular polymers of 49 with the 
mannose binding FimH receptors on the bacterial surface was evaluated via 
binding studies to two E. coli strains ORN178 and ORN208[82]. These strains 
differ in their mannose-binding-properties due to the over-expression 
(ORN178) or suppression (ORN208) of the FimH receptor respectively.[82] 
Mixtures of 49 and ORN178 featured a strong fluorescence response where 
the bacteria were located, whereas no binding of 49 to ORN208 could be 
detected (Figure 23). These experiments show that the supramolecular 
polymers do not induce any unspecific binding and bind to the bacteria via the 
mannose-FimH receptor interaction selectively.  
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Figure 23. Studies on selective binding of 49 to FimH with E. coli strains ORN178 
(overexpressed FimH) and ORN208 (no FimH); a) brightfield and b) fluorescence (optical 
filters at λex = 360 nm, λem = 490 nm); E. coli incubated with 1) water, 2) inert discotic 1, 
3) mannose discotic 49. A strong green fluorescence of the discotic scaffold is only detected 
on ORN178 incubated with 49 indicating that binding of 49 occurs selectively to FimH. 
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3.3.1.4 Bacterial Aggregation Studies 
The influence of the supramolecular polymers on the clustering behavior of 
bacteria was further investigated. Only polyvalent molecules of sufficient size 
are able to interact with several bacteria at a time and induce clustering as 
indicated in Figure 24. Thus aggregation of bacteria serves as indication of 
columnar polyvalency.  
 
 
Figure 24. Schematic representation of the formation of polyvalent columnar supramolecular 
polymers, with control over ligand density via mixing of monomers, and the binding, clustering, 
and detection of bacteria with these polymers. 
 
The polyvalent effect was evaluated on bacterial samples with dilute bacteria 
concentrations, at which the bacteria are present in non-aggregated state. 
When the bacteria were incubated with 49 the bacteria clustered and a 
colocalized fluorescence of the bacteria could be observed. Control 
experiments with either 1 or water only showed dispersed bacteria (Figure 24). 
This result demonstrates that the polyvalent supramolecular polymers induce 
the formation of bacterial aggregates by virtue of their polyvalent nature. 
Apparently the supramolecular polymers are long enough to function as 
crosslinking scaffolds for the bacteria, just like conventional polymers.[52] The 
outcome is especially interesting, considering that the concentration of 
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discotics is highly dilute at 10-7 M. That concentration corresponds to an 
average column length in water of approximately 7 supramolecules (degree of 
polymerization DP = 2 x √(K x concentration) with Kass = 1 x 108 L x mol-1 at 
20 °C and c = 10-7 mol x L-1).[68] The interaction with the bacteria apparently 
brings the single supramolecular columns in local proximity and thus enables 
formation of longer columns even at this high dilution. Finally these 
supramolecular architectures are large enough to interact with several bacteria 
at a time.  
 
 
Figure 25. Microscopy pictures in brightfield mode on dilute bacterial samples incubated with 
a) 100% 1, b) 99/1 1/49 and c) 100% 49. 
 
In order to evaluate the influence of ligand density, supramolecular polymers 
consisting of mixtures of both 1 and 49 were generated and similarly evaluated 
at dilute bacteria concentrations. These supramolecular copolymers were 
inducing bacterial aggregation at all monomer compositions evaluated (Figure 
25 and Figure 26). A functional monomer percentage of 49 as low as 1% still 
resulted in the formation of bacterial aggregates. Evidently, only a limited 
number of mannose functionalities at the periphery of the supramolecular 
polymer are required to induce clustering of the bacteria around the columnar 
architecture. Furthermore, the supramolecular polymers are sufficiently long to 
bridge the distances between the diluted functional monomers 49 to induce 
bacterial cross-linking (Figure 25). Interestingly, the aggregates observed for 
the supramolecular polymers diluted with non-functionalized discotic 1 were 
typically larger than those induced by polymers consisting of 49 only. This 
indicates that optimal binding to bacteria occurs when only a limited number of 
mannose functionalized monomers is present, surrounded by non-
functionalized monomers. Apparently, overcrowding of the supramolecular 
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polymer with ligands results in sub-optimal binding. The dynamic and flexibility 
of mixed supramolecular columns consisting of 49 and 1, on the other hand, 
facilitate optimal binding to the receptors. The unique supramolecular nature of 
the polymers thus allows easy adjustments and optimization of the monomer 
composition. 
 
 
Figure 26. BL 21 α after incubation with varying mixtures of inert discotic 1 and mannose 
discotic 49. Pictures were taken in brightfield (above) and fluorescence mode (optical filters 
λex = 360 nm, λem = 490 nm) (below). No bacterial aggregation is induced by compound 1, but 
mixtures of 1 and 49 and compound 49 alone strongly induce bacterial aggregation. 
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3.3.1.5 Mannose Competition Assay 
 
 
Figure 27. Mannose competition assay; Excess of mannose compared to 49 ranging from 1:1 
to 1:106; 100% 49 (1:0) and 100% (0:1) mannose were measured as control experiments; 
fluorescence pictures were taken with optical filters at λex = 360 nm, λem = 490 nm. 
 
A competition experiment between the supramolecular polymers formed by 49 
and mannose on bacteria binding was performed to examine the strength of 
the polyvalent binding of the supramolecular polymer. In order to allow the 
most effective competition by the mannose, the bacteria were first incubated 
with different concentrations of mannose for ten minutes, after which discotic 
49 was added, again at the dilute concentration of 10-7 M (Figure 27). The 
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bacteria remained fluorescent over the whole concentration range studied. 
Even at a 106-fold excess of free mannose the bacteria were still highly 
fluorescent and there was no indication that the binding of 49 to the E. coli cell 
surfaces was diminished. These results show that there is a highly efficient 
polyvalent binding of the supramolecular polymers to the bacteria, significantly 
stronger than the monovalent binding of mannose. 
 
3.3.1.6 Influence of the Mannose Discotic on Bacterial Growth  
The microscopic pictures imply that the supramolecular architectures cover the 
bacterial cell surface. It can be expected that this artificial coat influences 
bacterial metabolism and cell division. This could be shown by an experiment 
in which bacteria were grown overnight, washed and resuspended in LB media 
to reach an OD600 of 0.5. Subsequently either water, 1 or 49 was added and 
the cells were incubated for 4 h at 37 °C after which the OD600 was measured 
again. Averages over three experiments are summarized in Table 1. Results 
show that only in case of interaction of the supramolecules with the E. coli 
bacterial cell growth was decelerated approximately twofold. Thus the 
mannose functionalized discotics coat the E. coli and influence their 
metabolism efficiently.  
 
Table 1. Influence of 49 on bacterial cell growth. OD600 4 h after incubation. Mean over three 
experiments. 
 Mean ± standard deviation 
OD600 (water)  1.98 ± 0.12 
OD600 (1)  1.92 ± 0.09  
OD600 (49)  1.14 ± 0.08 
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3.3.2 Polyvalent Binding to Lectins  
A wide range of assays has been developed to evaluate the protein-
carbohydrate binding constants.[28] Typically, the outcome is highly dependent 
on the type of assay, and thorough revision of the results in the context of the 
multivalent interaction is essential. The four most widely used techniques are 
the hemagglutination inhibition assay (HIA),[83] enzyme linked lectine assay 
(ELLA),[84] isothermal titration microcalorimetry (ITC)[85] and surface plasmon 
resonance assay (SPR)[86, 87]. HIA is often used to determine aggregation and 
precipitation properties of multivalent polymers, but high aberration in IC50 
values only allow rough classification of binding affinity. On the other hand, 
ELLA does not involve aggregation but is based on inhibition and polyvalent 
effects. IC50 values are relatively precise, as determined by curve fitting. 
Therefore, ELLA was chosen for our studies on protein-carbohydrate binding. 
In order to quantify the polyvalent binding of the supramolecular polymers of 
49, an enzyme linked lectine assay (ELLA)[28], a variation of the enzyme-linked 
immunosorbant assay (ELISA),[84] was performed. Mannose coated polyvalent 
structures are known to inhibit Concanavalin A (Con A) binding to the yeast 
cell surface receptor mannan competitively. Con A is a tetramer at neutral pH, 
containing four spatially well separated binding sites (6.5 nm) for 
oligosaccharides.[88]   
 
Figure 28. Cartoon to illustrate Con A binding to immobilized mannan and inhibition of binding 
by an inhibitor. 
 
3. Results and Discussion 
55 
 
Experiments using horseradish peroxidase labeled Con A (HRP-Con A) as the 
lectin and yeast mannan as surface fixed ligand were carried out in 96-well 
plates, as illustrated in Figure 28. Optimal concentration of Con A was 
evaluated prior to the inhibition experiments. After pre-incubation with different 
concentrations of 49, binding of HRP-Con A to mannan was measured 
photospectrometrically. Methyl-α-D-mannopyranoside served as reference 
compound. The inhibition of lectin binding was measured in three independent 
experiments and the IC50 values were determined from the corresponding 
inhibition curves (Figure 29). Typically, complete inhibition of lectin binding to 
mannan in the ELLA is seldom observed and maximum inhibition occurs at 
less than 100%.[28] A strong inhibition for 49 compared to α-D-methyl-
mannopyranoside could be observed.   
Control experiments with inert discotic 1 did not indicate unspecific binding or 
other interference of the discotic scaffold. The IC50 value for the methyl-
glycoside was in our assay around 3 mM and the IC50 value for 49 around 
120 μM (360 μM, valency-corrected). The relative valency corrected binding of 
49 was 8.3 times stronger than the reference compound (24.9 per molecule 
49), showing the polyvalent effect of the supramolecular polymers.  
Typically, small trivalent ligands do not show significant valency corrected 
enhancement effects to higher valency in specific lectin–ligand assays, such 
as the ELLA assay, as they cannot span the distances between the binding 
sites on the Con A. [89, 90] For these small individual scaffolds higher valencies 
improve the total potency, but do not improve valency corrected potency, 
which results merely from the ‘cluster glycoside effect’.[22, 28] The 
supramolecular polymers formed by 49, however, allow effective polyvalent 
binding up to high valencies and show high potency per ligand. Apparently, 
because of the polymeric nature of 49, the compounds are capable of 
spanning the distance between the mannose binding sites on Con A. 
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Figure 29. Inhibition curves of mannose modified discotic 49 (above) and methyl-α-D-
mannopyranoside (below) for determination of the IC50. Inhibitor concentrations are valency 
corrected. 
 
In order to investigate the scope of the spanning properties of our 
supramolecular system, the assay was repeated using different mixtures of 49 
with 1. Mixtures with 49/1 ratios of 1/0, 1/1, 1/2, 1/5 and 1/10 were prepared 
12 h prior to the experiments. Controls using 1 alone did not show any 
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unspecific interference of the inert scaffold. In each dilution series the same 
total amount of discotic was used (c[49] + c[1] = constant). Thus the maximum 
amount of inhibitor 49 was different in each case. Figure 30 shows the different 
inhibition curves. On the x-axis the absolute percentage of 49 at each 
determined data point was plotted. The highest amount of inhibitor, with a 
concentration of about 120 µM, was therefore set as 100%. The inhibition 
values plotted on the y-axis of Figure 30 can be directly correlated to the 
amount of inhibitor (c[49]) present at this data point. Thus, data points with the 
same percentage of 49 (= same concentration of 49), but different total 
amounts of discotic mixtures (c[49] + c[1]) illustrate enhanced or decreased 
binding properties of the inhibitor 49 in presence of 1. Pure 49 reached a 
maximum inhibition of about 50% when having 100% inhibitor in solution, 
about 40% inhibition with 50% inhibitor (~60 µM) and about 25% inhibition with 
33% (~40 µM) inhibitor. Maximum of the 1/1 mixture was 53% inhibition with 
50% (~60 µM) inhibitor and the maximum of the 1/2 mixture reached 37% 
inhibition with 33% (~40 µM) inhibitor. 1/5 and 1/10 mixtures were too low in 
inhibitor concentration and did not reach a value high enough in range for 
comparison. Unexpectedly, the inhibition curves of the 1/1 and 1/2 mixtures 
cross the curve of pure 49. This indicates that, with a relative percentage 
higher than 33% of 49, inhibition is more effective in presence of spacer 1. 
Below this value the pure discotic 49 is the better inhibitor.  
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Figure 30. Inhibition curves of mannose modified discotic 49 (blue) and mixtures of 49 and 1 
1/1 (purple); 1/2 (green) and 1/5 (red). 
 
These results give rise to the assumption that below a certain concentration of 
33% inhibitor (~40 µM), the spatial proximity of the different mannose ligands 
enhances the binding abilities of the supramolecules. Above that value 
sufficient inhibitor is present. This leads to the conclusion that there might be a 
maximum in polyvalency for ideal inhibition of Con A binding. 
These results are most probably due to the nature of the protein-carbohydrate 
interaction. As mentioned before, results from protein-carbohydrate binding 
and inhibition studies are highly dependent on the assay performed. In this 
ELLA, the multivalent interaction is based on inhibition of Con A binding to 
mannan. We suggest, that the high potency of Con A inhibition of 49 probably 
results from the ability of the supramolecular columns to span different binding 
sites of the lectins. Furthermore, we assume that interaction with the lectin 
results in stabilization of the columnar structures in proximity of the protein due 
to the cluster glycoside effect. 
In case of mixtures of the different supramolecules 1/49 this stabilization does 
not take place at all concentrations. Most probably this is due to the size 
dependence of the columns according to their concentration. At high 
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concentrations (≥ 40 µM) the mixed supramolecular structures form columns of 
more than 100 supramolecules per polymer.[68] In case of 1/1 and 1/2 mixtures 
the supramolecules are big enough to feature sufficient mannose ligands on 
their periphery and probably are able to span the distances between binding 
pockets. Thus, mixtures of 1 and 49 enhance relative binding potency per 
mannose moiety at higher concentrations. 
On the other hand, ligand concentration on the mixed supramolecular columns 
in dilute solutions (< 40 µM) is low. In this case, we assume that no, or much 
less column stabilization is induced by the interaction with the protein. The 
columnar structures apparently cannot span the distance between two binding 
sites at the protein. Thus the relative decrease of glycoside on the multivalent 
structures leads to decreased inhibition. 
Unlike the results of discotic mixtures applied to multivalent bacterial surfaces, 
which were apparently able to provide steric advantages that led to cross 
linkages of columns between bacteria, in this lectine inhibition assay steric 
flexibility seemed to be of limited advantage for enhanced inhibition. These 
results show that also in case of our supramolecules the outcome of the 
polyvalent interaction is highly dependent on the type of biological polyvalency 
that is assessed. Aggregation in the bacterial assay led to an enhanced cluster 
glycoside effect in case of discotic mixtures. The ELLA is not based on 
aggregation and thus appeared to be concentration dependent when 
performed with discotic mixtures. 
Overall, these results indicate that in case of ELLA, introduction of 1 as spacer 
for ideal spatial rearrangement enhances inhibition properties of the mannose 
discotic at concentrations higher than 40 µM. 
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3.3.3 Studies on Heterovalency  
In order to investigate heterovalent properties of the supramolecular polymers, 
the mannose discotic 49 was mixed with Texas Red discotic 52. The red dye 
provides the possibility to study the behavior of supramolecular scaffolds 
modified with different ligands through independent detection. As illustrated in 
Figure 31, the discotic with the mannose ligand (49) serves as targeting 
element for the discotic with the Texas Red ligand (52). Such a system could 
be applied to any combination of ligands attached to the discotic scaffold. 
 
 
Figure 31. Cartoon demonstrating the localization of Texas Red Discotic at the interaction 
surface of the mannose discotic 49. 49 serves as targeting element for 52. 
 
Mixtures (1/1 and 99/1) of 49 and 52 were prepared four hours prior to the 
experiments to ensure the formation of a random mixture of the two differently 
functionalized discotics in the columns. Bacteria were incubated at a total 
discotic concentration of 10-7 M. Microscopy pictures were taken in brightfield 
and in fluorescence mode with either a filter for the discotic scaffold (λex = 360 
nm, λem = 490 nm) or a filter for the Texas Red dye (λex = 569 nm, λem = 620 
nm). Control experiments were carried out using pure 49 and pure 52.  
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Figure 32. BL 21 α after incubation with varying mixtures of mannose discotic 49 and 52. 
1) 49/52 1/1, 2) 49/52 99/1, 3) 52; Pictures were taken in a) brightfield, b) fluorescence (λex = 
360 nm, λem = 490 nm) mode and c) fluorescence (λex = 569 nm, λem = 620 nm) mode. Control 
experiments 3b)-c) show unspecific binding of 52 to E. coli. 
 
As shown in Figure 32, incubation with the discotic mixtures of 1/1 and 99/1 in 
both cases led to a fluorescent response of the discotic and the Texas Red 
dye on the bacterial cell surface. However, control experiments carried out with 
pure Texas Red discotic 52 also showed fluorescence of Texas Red to the 
bacteria and thus indicate unspecific binding of the pure Texas Red discotic 52 
to E. coli as illustrated in Figure 32; 3c). The strong discotic fluorescence is still 
detected on the bacterial cell surface even if incubated with pure 52 only. 
Though the intensity of Texas Red is decreasing from picture 1c) to 3c), 
change of fluorescence filters from Texas Red filters to the wavelength of the 
discotic shows no change in response of the discotic fluorescence on the cells 
in presence or absence of 49. At these concentrations the Texas Red discotic 
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apparently binds unspecific to E. coli. Reliable quantification of the amount of 
discotics binding to the bacteria in experiments 1-3 was not possible.  
The decrease of the Texas Red intensity detected from experiment 1-3 
nevertheless leads to the assumption that the presence of 49 increases the 
localization of 52 on the bacteria cell surface.  
 
3.3.3.1 Polyvalent Binding to Streptavidin coated Beads 
We decided to evaluate the heterovalent binding of the supramolecular system 
taking advantage of the strong biotin-streptavidin interaction. Binding studies of 
mixtures of Texas Red discotic 52 with biotin discotic 53 to a different surface 
were carried out. 
In order to broaden the scope of the supramolecular interaction to a different 
polyvalent surface, a model system based on streptavidin coated beads[91] was 
investigated. The binding of biotin discotic 53 to magnetic streptavidin beads 
was tested. The beads were incubated with 53 and 1 at concentrations of 
10-7 M. Magnetism of the beads guaranteed comfortable handling and 
washing. The beads were assembled as a pellet on the bottom of the vial with 
help of a magnet and the washing solution was removed carefully with a 
pipette. Subsequently, the beads were mounted on glass slides and 
fluorescent pictures were evaluated. Only when the beads were incubated with 
biotin modified discotic 53 a strong fluorescence of the single beads could be 
observed, colocalizing with the brightfield image (Figure 33; 1). Unspecific 
binding of the discotic scaffold 1 to the beads did not occur (Figure 33; 2). 
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Figure 33. Magnetic Streptavidin beads after incubation with 1) mannose discotic 49 and 
2) inert discotic 1; pictures were taken in a) brightfield, b) fluorescence (λex = 360 nm, 
λem = 490 nm) mode. Control experiments 2a) and b) indicate no unspecific binding of 1 to 
streptavidin. 
 
Using this polyvalent streptavidin surface, heterovalency experiments with the 
Texas Red discotic 52 were carried out. A mixture of 53 and 52 (1/1) was 
prepared twelve hours prior to the experiments to ensure a complete random 
mixture of the two differently functionalized discotics in the columns. Beads 
were incubated with a mixture of 53 and 52 at total concentrations of 10-7 M 
washed and fixed on glass slides. Pure 53 and pure 52 served as controls. 
Microscopy pictures, summarized in Figure 34, were taken in brightfield mode 
and in fluorescent mode, with a filter for the discotic scaffold (λex = 360 nm, λem 
= 490 nm) and a filter for the Texas Red dye (λex = 569 nm, λem = 620 nm). 
Incubation of the streptavidin beads with the mixtures resulted in strong 
fluorescence response of both, the discotic scaffold and the Texas Red dye, 
on the bead surface (Figure 34; 2). Control experiments indicate no unspecific 
binding of the pure Texas Red discotic 52 to the Streptavidin beads (Figure 34; 
3). Control studies with the pure biotin discotic 53 prove that the discotic 
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scaffold was not excited at the 52 excitation wavelength (Figure 34; 1). These 
results demonstrate that the differently functionalized discotics form 
randomized columns. The biotin discotic thus serves as interaction partner with 
the Streptavidin surface and at the same time as transport system for the 
Texas Red discotic. The flexibility of the system therefore provides convenient 
access to polyvalent supramolecules featuring different ligands. As shown in 
this experiment the supramolecular approach gives rise to new highly flexible 
polyvalent substances. Polyvalent scaffolds with multiple ligands of choice for 
different purposes and interactions can be easily prepared by simple mixture of 
the corresponding discotics.  
 
 
Figure 34. Microscopy pictures in a) brightfield, b) fluorescence (λex = 360 nm, λem = 490 nm) 
mode and c) fluorescence (λex = 569 nm, λem = 620 nm) mode on magnetic streptavidin seads 
incubated with 1) 53, 2) 53/52 1/1, 3) 52. 
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3.4 Supramolecular  Modulation of Protein Assembly 
 
Supramolecular chemistry has allowed the development of self-assembling 
systems whose drive to assemble and disassemble is controlled by the 
reversible interactions of specific control elements that are tunable through 
external factors such as light, environment, and exogenous ligands.[54] In 
chemical biology, control over protein localization and assembly and the 
resulting activation and deactivation has been exploited with supramolecules 
for the study of, for example, signal transduction,[92, 93] tubulin stabilization,[94] 
and transcription factors.[95-97] Typically these studies included the use of 
small-molecular tools and their interaction with specific protein domains. 
Synthetic supramolecular constructs have been used to act as binding 
elements to protein substructures.[98-101] The use of synthetic supramolecular 
control elements like cyclodextrin hosts and steroid ligands to effect protein 
localization or function has successfully been applied.[102]  
The use of supramolecular non-covalent recognition by synthetic 
supramolecular elements for the control of protein assembly and subsequent 
inhibition of assembly with an exogenous molecule has been reported by our 
group previously.[102] In this context, concentration dependent self-assembling 
supramolecular discotics provide excellent properties to serve as control 
elements for protein assembly. 
 
3.4.1 Protein-Assembly Controlled by Supramolecular Polymers 
Self-assembling supramolecular discotics are a new class of promising 
multivalent scaffolds (Chapter 3.3). We showed that mixtures of functionalized 
and inert discotics are able to arrange themselves to a multivalent receptor 
functionalized surface in an optimized manner due to the ability to rearrange 
monomers in the supramolecules. In a next step discotics were envisaged to 
serve as platform for control over protein assembly. Discotics were planned to 
be ligated to different proteins and use the self-assembly of the discotics to 
induce the assembly of these proteins. Attachment of the proteins was 
envisaged to be performed using the cysteine discotic 56, which enables 
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native chemical ligation to the protein. Subsequent to protein coupling, the 
supramolecular system was envisaged to modulate the interaction of two 
proteins by varying the concentration of protein-discotics in solution. As an 
additional tool to adjust the protein assembly, inert discotics were foreseen to 
serve as spacer increasing the distance between the protein-functionalized 
discotics. In order to establish the concept of protein assembly along the 
supramolecular polymers a model system based on two proteins that feature 
fluorescence energy transfer, when brought together, was studies. 
The non-radiative transfer of energy, after light absorption by one fluorescent 
substance to another is called Foerster resonance energy transfer (FRET). 
FRET between two fluorescent partners takes place, if the emitted wavelength 
of one fluorescent dye overlaps with the excitation wavelength of a second 
dye. If the two interaction partners are in close proximity (less than 100 Å), the 
energy of the FRET-donor can be transferred non-radiatively to the FRET-
acceptor and emission of the acceptor can be detected.[103]  
 
 
Scheme 16. Concept of supramolecular polymers as scaffold to control protein-protein 
interactions. The spatial distance of the proteins is controlled via concentration change of inert 
discotics. 
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This principle is used here to study the supramolecular assembly of protein 
interaction and is based on a FRET pair attached to different discotics. The 
concept is illustrated in Scheme 16. The FRET donor (red) is excited and 
transfers its energy to the acceptor (yellow). The unmodified discotics control 
the distance between the proteins. Thus, the FRET pair should be influenced 
by the concentration of the dye-carrying discotics and by the amount of inert 
discotics given to the system.  
 
3.4.2 Modification of the Discotic with Yellow Fluorescent Protein  
The influence on modulation of proteins with supramolecular polymers was 
first to be investigated with the protein model system of cyan fluorescent 
protein (CFP) / yellow fluorescent protein (YFP). These two proteins are a well 
known FRET-pair.[104] This property provides excellent conditions to investigate 
control over protein interaction by fluorescence readout. CFP and YFP were 
envisaged to be attached to the discotic scaffold 56 provided with cysteines 
(Chapter 3.2.4) via native chemical ligation. 
 
Scheme 17. Expressed protein ligation of YFP with the cysteine discotic 56. a) Mesna, NaPi, 
2 w, rt. 
YFP was expressed in E.coli using a plasmid, pTWIN1-EYFP, derived from a 
previously described procedure, and isolated.[102] The protein was coupled to 
the discotic 56 by expressed protein ligation using a 10-fold excess of discotic. 
The reaction was monitored by MALDI-TOF MS. The ligation procedure that 
was followed was reported to be complete within 4 h for a monovalent small 
molecule.[102] However, in our case the coupling proceeded extremely slowly. 
Within the first 3 h only a small amount of product 57 was formed and detected 
by MALDI-TOF MS (Figure 35). Even after three days of reaction time, only a 
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small part of protein reacted with the free cysteine as visualized by SDS gel 
(Figure 35; c). Unfortunately, an undesired side reaction took place. Under the 
reaction conditions the cysteine discotics started to cross-link, forming disulfide 
bridges. Polymerization of the discotic 56 via covalent disulfide bridges 
seemed to happen faster than the protein ligation. Though the quantity of the 
desired product 57 seemed to have increased after 2 d, a MALDI-TOF 
spectrum (Figure 35) shows that the main part of the protein is still unligated. 
The remaining free cysteines on the discotic of the desired product 57 
apparently reacted with other discotics in solution. As the mass spectrum 
implies, up to five discotics cross-linked through covalent binding within the 
first 2 d. The protein is so far the largest ligand which was attempted to be 
attached to the discotic scaffold. Apparently, coupling the relatively big protein 
is sterically hindered. Similar to the observation made with the mannose 
discotics in Chapter 3.2.1, again the high degree of supramolecular 
polymerization under the reaction conditions in aqueous solution might result 
in molecular crowding (vide infra) of the reactive functionalities. The fact that 
the attachment of the large YFP proceeds slowly whereas cross-linking of the 
discotics occurs comparably fast is one indication for overcrowding. Sterical 
hindrance caused by the bulky protein could prevent further reaction of the free 
cysteins in the supramolecular column with another large protein. The 
comparably small discotics on the other hand are small enough to overcome 
the hindrance and cross-link with each other. Cleavage of the disulfides under 
mild TCEP conditions without denaturation of the protein was not possible. On 
the other hand, there is no evidence for two- or three-fold addition of YFP to 
one discotic according to mass and SDS analytic.  
Thus, the trivalent discotics are - under these ligation conditions - not an 
appropriate scaffold for protein attachment by expressed protein ligation. The 
cross-linking of cysteine-discotics could be avoided by synthesis of a non-
symmetrical monomeric discotic which carries only one single ligand per 
scaffold. In our case another protein FRET pair was chosen in order to 
proceed with the studies on supramolecular protein assemblies. 
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Figure 35. MALDI-TOF MS Spectra of the YFP-Disc 57 reaction 
mixture after a) 3 h and b) 2 d: Polymerization of cysteine discotic 
56 by covalent disulfide bridges causing a cross-linkage of up to 
five discotics is shown. c) SDS-Gel of YFP and coupled YFP after 
3 d reaction time. Still only a small amount of protein reacted with 
the discotic scaffold.  
 
 
 
 
3.4.3 Streptavidin Binding to the Biotin Discotic 
In order to get a fundamental understanding of the assembly of proteins along 
a supramolecular wire, the binding of proteins to the supramolecular polymers 
was first investigated with one type of protein only. The protein streptavidin 
was chosen due to its property to bind biotin strongly. Streptavidin is a 
tetramer formed out of four equal subunits.[105] Each of the monomers is able 
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to bind one biotin in a non-covalent manner exhibiting a binding strength close 
to a covalent bond.  
Streptavidin was envisaged to bind to the biotin discotic 53 (Chapter 3.2.3). 
The interaction of biotin discotic 53 with streptavidin coated surfaces was 
previously described (Chapter 3.3.3). A fluorophor was attached to the protein 
that would be able to feature FRET with the discotics. To study the spatial 
distribution and the interaction between a protein and its attached 
supramolecular scaffold, titration experiments using the biotin discotic 53 and a 
Cy3 labeled streptavidin (SA-Cy3) were carried out. As illustrated in Figure 36 
the biotin-streptavidin interaction mediates spatial proximity between the Cy3 
dye on the protein and the discotic scaffold. Cy3 has its first excitation 
maximum at 524 nm and an emission maximum at 576 nm.[106] Thus it is an 
ideal FRET acceptor for the discotic scaffold serving as donor.  
 
 
Figure 36. Cartoon demonstrating the FRET interaction with Cy3 and the discotic scaffold 
induced by streptavidin, binding to biotin on 53. 
 
3.4.4 Protein Assembly Mediated by the Biotin Discotic  
Biotin discotic 53 was dissolved in water to reach a final concentration of 
10-6 M. Cy3 labeled streptavidin was added and the mixture was stirred for 
5 min after each titration step to ensure sufficient time for binding of biotin to 
streptavidin. The relative concentration of streptavidin-Cy3 (SA-Cy3) was 
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increased from 1 mol-% to 20 mol-% per discotic scaffold. Emission spectra 
were recorded with an excitation wavelength at 340 nm, the excitation 
wavelength of the discotic FRET donor. Control experiments were carried out 
with the inert discotic 1 to study the interaction between the discotic scaffold 
and streptavidin Cy3 in solution without any binding possibilities. Control 
studies with only water and streptavidin Cy3 showed that self-fluorescence of 
the Cy3 dye at the donor excitation wavelength is negligible. As shown in 
Figure 37, significant emission of the acceptor is achieved starting from 2 
mol-% SA-Cy3. At a concentration of about 10 mol-% of SA-Cy3, the signal of 
the discotic FRET donor is fully quenched and only emission of acceptor is 
detected. Further addition of acceptor does not result in further increase of the 
FRET ratio (= Intensity λmax acceptor (570 nm)/ Intensity λmax donor (524 nm)) as can be 
seen in Figure 39.  
Control studies with 1 under the same conditions show that unspecific 
interaction between the discotic scaffold and SA-Cy3 is negligible. As 
illustrated in Figure 38, only by addition of more than 9 mol-% of SA-Cy3 a first 
weak response of Cy3 could be seen. But even with 33 mol-% of SA-Cy3, 
compared to 1, the FRET ratio does not exceed 0.5. Comparison of the 
highest FRET ratio achieved in both experiments shows that the ratio in 
presence of 53 is about 80 times higher than the ratio when compound 1 is 
used (Figure 39). Thus the FRET effect clearly results from the local proximity 
achieved by binding of biotin to streptavidin.  
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Figure 37. Titration experiment to study the FRET interaction of biotin discotic 53 with 
streptavidin-Cy3. Already at ratios of 1/50 of SA-Cy3/53 (= 2 mol-% SA-Cy3) a strong 
excitation of the acceptor is detected at λex = 340 nm, the excitation wavelength of the donor.                                          
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Figure 38. Control experiment at λex = 340 nm. FRET between inert discotic 1 and 
streptavidinCy3. Only at ratios of higher than 1/10 of SA-Cy3/1 (= 10 mol-% SA-Cy3) a small 
response of the FRET-acceptor can be seen. 
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Figure 39. FRET ratio Max at 570 nm / Max at 524 nm. Biotin discotic 53 (blue plot) with 
1 mol-% to 25 mol-% SA-Cy3 at λex = 340 nm. The purple line shows the FRET ratio 
determined from the control experiment with 1. 
 
Three of the studied concentrations (2 mol-%, 5 mol-%, 7 mol-% SA-Cy3) were 
additionally measured at different time points (after 5 min, 10 min, 30 min, 1 h, 
2h and 24h). Overlay of the corresponding spectra showed no change over 
time in any of the two emission maxima. Thus binding of SA-Cy3 to 53 takes 
place within the first five minutes after mixing.    
 
3.4.5 Protein Modulation with Discotic Mixtures 
To evaluate the effect of dilution of the biotin functionalized monomers, 
experiments were performed with discotic mixtures of 53 and 1. As illustrated 
in Figure 36, the inert discotic 1 was envisaged to serve as spacer between 
the functionalized discotics 53. By testing different ratios of 53 and 1, the 
optimal amount of spacer for this type of FRET interaction between SA-Cy3 
and the discotic scaffold was to be determined. Mixtures were tested ranging 
from a 53/1 ratio of 2/1 till 1/20 to evaluate the ideal spatial distribution of 53 
for maximal interaction with SA-Cy3. Mixtures of the discotics were prepared 
twelve hours prior to the experiments to ensure complete random placement of 
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the two different discotics in columns. In the first experiments carried out with 
discotic mixtures the overall concentration of biotin discotic 53 was kept 
constant at 10-6 M. Thus the overall concentration of discotic scaffold in the 
higher mixtures increases significantly. The same percentage of SA-Cy3 (0.5 
mol-% to 15 mol-% compared to total disc concentration) was added to all 
discotic mixtures. The increase in donor concentration clearly influences the 
FRET ratio. Due to the higher amount of overall discotic concentration 
(c[53]+c[1]), strong differences in the absolute values of FRET ratios of the 
different mixtures were determined (Figure 40). For example, the 
maximum FRET value for interaction of SA-Cy3 with pure biotin discotic 53 
was around 37, whereas the FRET value in case of the 1I1 mixture of 53/1 did 
not exceed 17. Calculated FRET ratios for mixtures of 53/1 below a ratio of 
1/10 did not exceed 1.3 and did not change after adding the first portion of 
SA-Cy3 (0.5 mol-%) and thus were not taken to account for further 
investigation (data not shown). 
 
 
Figure 40. FRET ratio of different mixtures of 53/1 1/0 (blue), 1/1 (purple), 1/2 (green) and 1/5 
(red) plotted against c[SA-Cy3]  compared to c[disc total]  = c[53] + c[53]. 
 
In order to compare the actual amount of donor and acceptor in solution, the 
concentration of the acceptor SA-Cy3 in mol-% was related to the 
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concentration of FRET donor 53 only, and not to the overall concentration of 
discotic scaffold. The FRET ratio on the y-axis is plotted against the relative 
concentration of SA-Cy3 (in mol-% of the concentration of 53). Figure 40 
shows that the point of saturation, at which the plotted FRET ratios stay 
constant, varies in each curve. In case of pure biotin disc 53 a maximum in 
FRET interaction was reached after addition of 7.5 mol-% of SA-Cy3 
compared to biotin disc concentration (Figure 40, blue plot). Further addition of 
FRET acceptor to the solution did not result in a higher FRET ratio. However, 
in case of the 1/1 mixture of 53/1 the FRET signal was still increasing after 
adding 7.5 mol-% of SA-Cy3. Saturation was obtained with more than 
15 mol-% of SA-Cy3 (Figure 40, purple plot). A comparable value around 
15 mol-% SA-Cy3 was determined for maximum FRET interaction of the 
SA-Cy3 dye with a 1/2 mixture of 53/1, plotted in green. Addition of more than 
15 mol-% did not increase the FRET ratio any more. Saturation in FRET ratio 
was reached slightly earlier with a 1/5 mixture of 53/1 at about 12 mol-% SA-
Cy3 (red plot) and 13 mol-% for 1/3 mixtures (not plotted). These results can 
be explained as follows. In a titration series starting from 0% of FRET acceptor 
– while the amount of donor is kept constant – the FRET ratio increases as 
long as a spatial approach of donor and acceptor is possible. In our case the 
FRET ratio increases as long as free biotins, possible binding partners for SA-
Cy3, are available. If all of these biotins are either bound or sterically blocked, 
no more local approximation of Cy-3 acceptor to the discotic donor is possible. 
Further addition of acceptor thus does not result in any further change of the 
fluorescent interaction. Comparison of the saturation points of pure 53 and 1/1 
mixture of 53/1 demonstrates that the presence of 1 as spacer enhances the 
relative amount of streptavidines that interact with the discotic from 7.5 mol-% 
to over 15 mol-%. Thus the inert discotic serves as spacer and creates free 
space between the functionalized discotics to allow a higher percentage of 
biotins to bind to the protein. The ideal mixture of functionalized discotic and 
inert discotic seems to be about one to two inert discotics per binding scaffold. 
Mixtures of 53/1 of 1/3 and 1/5 of 53/1 do not enhance binding properties of 
the supramolecular columns any more.  Mixtures of 1/10 or 1/20 of 53/1 are 
dominated by the donor fluorescence. A spacer of in average ten inert 
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discotics appears to be too large to obtain energy transfer from the complete 
scaffold to the streptavidin acceptor bound to scaffold 53. 
 
The influence of the order of addition of the interaction partners was 
investigated. In the previous experiment the discotics 53 and 1 had been 
mixed prior to the experiment and SA-Cy3 was added afterwards. Thus in a 
second experiment, the FRET pair SA-Cy3 and biotin discotic 53 was mixed in 
advance and the spacer 1 was added subsequently. A mixture of 53 (10-6 M) 
with 20 mol-% SA-Cy3 (2 x 10-7 M) was prepared 1 h prior to the experiment 
and split in five batches. Defined amounts of inert discotic were titrated to each 
batch to result final mixtures of 53/1 of 1/0, 1/1, 1/2, 1/3 and 1/5. Fluorescence 
spectra of each mixture were measured after 10 min, 30 min, 1 h, 2 h, 5 h, 
24 h and 48 h. None of the fluorescence spectra changed over time. Thus, 
only data gained after 10 min was taken for further evaluation. As illustrated in 
Figure 41, addition of only one equivalent of 1 already decreases the FRET 
ratio significantly from 27.3 to 1.6. Higher amounts of discotic 1 decrease the 
FRET ratio to approximately 0.6. Values for the FRET ratio are listed in Table 
2. Comparison with values obtained from the first experiment, with the same 
final conditions but pre-mixing of the discotic scaffold, indicates a complete 
loss of FRET interaction in the second study (Table 2 and Figure 41). 
Apparently the discotics added are not included in the pre-formed columns of 
53 interacting with SA-Cy3. In the first study the discotics 53 and 1 are already 
mixed prior to the addition of streptavidin SA-Cy3. The protein binds to the 
mixed columns and Cy3 interacts with both discotics 53 and 1 included in the 
column. On the other hand, adding the inert discotics 1 to a pre-mixed solution 
of SA-Cy3 and biotin discotic 53 in fact leads to a different result. The protein 
SA-Cy3 immediately binds to the biotin discotic when mixed. As mentioned 
before streptavidin possesses four binding pockets for biotin. It seems that one 
SA-Cy3 binds to the biotin discotic 53 with two or more binding pockets. Firstly, 
multiple binding of one SA-Cy3 would lead to the linkage of two different 
discotics within one supramolecular column. An exchange of the 
supramolecules between the two linked discotics would be harder if not 
impossible. Several cross-linkages of discotics caused by SA-Cy3 could lead 
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to a complete loss of reversibility. Secondly, different supramolecular columns 
could be cross-linked through binding to the same SA-Cy3. In both cases 
cross linkage decreases the flexibility and reversibility of the supramolecules 
and as a result does not allow the exchange of single discotic scaffolds within 
one supramolecular column any more. In the previous experiments reversibility 
was not necessary for the outcome of the experiments. However, the 
subsequent addition of 1 to the pre-formed complex of SA-Cy3 and 53 heavily 
relies on the dynamic of the supramolecular system.  Without reversibility the 
columns formed by 1 can not be included in the FRET interaction system of 53 
and SA-Cy3. This seemed to be the case when adding 1 subsequently. 
Consequently, in the second experiment the fluorescent signal of the free inert 
columns formed by 1 is not quenched by the acceptor and the donor 
fluorescence dominates the comparably weak FRET signal of the rigid pre-
formed columns with 53 and SA-Cy3. 
 
Table 2. Values for the FRET ratio of mixtures of 53/1 with 20 mol-% SA-Cy3. Experiments 
were carried out either with pre-mixed discotics and subsequent addition of SA-Cy3 or with 
titration of inert discotics 1 to the pre-mixed FRET partners 53 and SA-Cy3. 
 
Ratio of concentrations 
of SA-Cy3/53/1 
Discotic Mixtures 
prepared prior to 
experiment –  
FRET ratio Intensity at 
574 nm/Intensity at 
524 nm 
Titration of 1 to mixtures 
of SA-Cy3 and 53  
FRET ratio Intensity at 
570 nm/Intensity at 
524 nm 
0.2/1/0 27.3 27.3 
0.2/1/1 14.3 1.6 
0.2/1/2 6.2 0.9 
0.2/1/3 2.9 0.7 
0.2/1/5 3.5 0.6 
 
Results are visualized in Figure 41. The values illustrated as blue and purple 
bars only differ in the order of compound addition not in the final composition 
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of the solutions. At the same concentrations of all three compounds (SA-Cy3, 
53 and 1) the FRET-ratio is significantly higher if discotics 53 and 1 are pre-
formed than in case of subsequent addition of 1. Comparison of the two 
experiments indicates that not only the biotin discotic scaffolds interact with the 
SA-Cy3 dye but also the inert discotics included in the mixed columns. Thus, in 
premixed supramolecular columns more inert discotics 1 transfer the energy to 
the acceptor. Hence, the donor signal is quenched substantially.  
In all titration steps FRET ratio did not change over time. Even at time periods 
of 48 h the signal stayed constant. These results emphasize the assumption 
that the columns are blocked by the SA-Cy3 binding to biotin right at the 
beginning and no random exchange of the supramolecular columns 53 and 1 
can take place.  
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Figure 41. Plot illustrating the difference in FRET interaction depending on the order of 
compound addition to the FRET system. Experiments were carried out either with pre-mixed 
discotics and subsequent addition of SA-Cy3 (purple) or with titration of inert discotics 1 to the 
pre-mixed FRET partners 53 and SA-Cy3 (blue). 
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3.4.6 Control over Protein Assembly 
To study the supramolecular control over induced protein dimerization a model 
system based on two differently labeled streptavidineswas studied in the 
presence of the biotin functionalized supramolecules 53 (Figure 42). The 
difference between the FRET signal of the two streptavidines with the dyes 
and the FRET signal of the same mixture when added to biotin discotic was to 
be determined. The biotin on the discotic surface binds to streptavidin as 
shown previously (Chapter 3.4.3). This interaction should mediate the 
assembly of streptavidin on the surface of the supramolecular columns and 
should facilitate approximation of the FRET pair. Thus, the FRET in presence 
of the biotin discotics 53 should increase.  
 
Donor
Streptavidin
Acceptor
Streptavidin
 
Figure 42. Cartoon demonstrating the FRET interaction of two different dyes attached to 
streptavidin in presence of biotin discotic 53. The biotin discotic 53 binds to the streptavidin 
and leads to protein assembly on the columnar surface. The proximity of the two dyes 
attached to the protein can be evaluated by FRET.   
 
The dyes used were Alexa Fluor 633 (AF-633; λ max ex = 633 nm; λ max em = 
647 nm) as FRET acceptor and Texas Red (TR; λ max ex = 550 and 586 nm; 
λ max em = 612 nm) as FRET donor, each attached to streptavidin. The labeled 
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proteins are commercially available and the excitation- and emission-spectra 
of the two dyes as provided by the supplier are given in Figure 43.  
 
Figure 43. Excitation- (dashed) and emission- spectra (continous) of Texas Red (red) and 
Alexa Fluor 633 (blue) as provided by invitrogen.[107] 
 
Streptavidin Alexa Fluor 633 (SA-AF633) and streptavidin Texas Red (SA-TR) 
were mixed in a 1/1 ratio (0.05 mg x mL-1 – 2 x 10-6 M of each protein) 2 h prior 
to the experiments, and titrated to a solution of 53 (10-6 M). Titration steps 
reached from 1 to 50 µL of protein mixture (5 x 10-9 M 2.5 x 10-7 M final 
concentration) which corresponds to approximately 0.5 - 25 mol-% of SA-
AF633/SA-TR compared to the biotin discotic 53. After each titration step the 
mixture was allowed to stir for 10 min before the fluorescence spectra was 
measured, to assure sufficient interaction time of the labeled proteins SA-
AF633/SA-TR with the biotins of 53. Control experiments were carried out 
using the same protein mixture and with inert discotic 1 (10-6 M), to examine 
unspecific interaction with the scaffold, and with the pure SA-AF633/SA-TR 
mixture to determine the interaction of the proteins as background. Additionally 
SA-AF633 was measured individually at the same final concentrations as in 
the mixture (5 x 10-9 M - 2.5 x 10-7 M) to determine background fluorescence of 
the AF633 acceptor at the TR donor excitation wavelength. 
Fluorescence spectra of 53 or 1 with several concentrations of the protein 
mixture of SA-AF633/SA-TR are shown in Figure 44 and Figure 45. Control 
experiment with the pure protein mixture is shown in Figure 46. Carrying out 
the experiments as described results in a solution with a constant amount of 
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discotics 53 or 1, to which the mixture of the protein FRET-pair is continuously 
added. Thus the fluorescence signal of SA-AF633 and SA-TR increases 
steadily with their concentration. The increase in signal can be seen in all three 
cases (with discotics 53 or 1 and with the pure proteins). Furthermore, in all 
experiments a strong fluorescence signal of the acceptor was detected. 
Fluorescence intensity at the SA-TR donor maximum (at λ = 612 nm) was 
always lower than the intensity of the SA-AF633 (at λ = 647 nm). However, the 
strong emission of the FRET acceptor AF633 is not merely due to a strong 
FRET interaction but results from direct excitation of AF633 at an excitation 
wavelength of 584 nm. Figure 47 shows the background signal of pure SA-
AF633 as control. The strong background fluorescent of AF633 probably 
arises from the fact that the quantum yield of AF633 is significantly higher than 
the quantum yield of TR.[103] As shown in Figure 43, the excitation of AF633 at 
λ = 612 nm should be relatively low compared to the excitation of TR. 
However, the higher quantum yield of AF633, results in the strong signal of 
AF633, whereas the signal of TR is comparably low. 
Nonetheless, comparison of the spectra gained with 53 to those gained with 1, 
led to an interesting observation. In the presence of 53 the fluorescent 
maximum of the FRET donor SA-TR decreases substantially compared to the 
donor signal in presence of 1. On the other hand spectra achieved with either 
1 or pure protein mixture of SA-AF633/SA-TR yielded similar spectra and both 
did not result in a decrease of donor signal if compared to 53. This result leads 
to the assumption that a major FRET-interaction only takes place in presence 
of biotin discotic 53. Apparently, the discotic binds to both streptavidines 
labeled with the FRET partners SA-AF633 or SA-TR. The binding leads to 
protein assembly on the periphery of the supramolecular column formed by 53. 
The induced proximity of the two proteins SA-AF633 and SA-TR enables non 
radiative energy transfer from SA-TR to SA-AF633.  
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Figure 44. FRET-interaction of SA-AF633/SA-TR (5 x 10-9 M 2.5 x 10-7 M = 0.5-25 mol-%) in 
the presence of 53 (10-6 M = 100 mol-%) at an excitation wavelength of λ = 584 nm. The 
donors signal is quenched significantly. 
 
 
Figure 45. FRET-interaction of SA-AF633/SA-TR (5 x 10-9 M 2.5 x 10-7 M = 0.5-25 mol-%) in 
the presence of 1 (10-6 M = 100 mol-%) at an excitation wavelength of λ = 584 nm. The donors 
signal is high compared to the experiments with 53. 
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Figure 46. FRET-interaction with pure protein mixture of SA-AF633/SA-TR (5 x 10-9 M 2.5 x 
10-7 M) at an excitation wavelength of λ = 584 nm. To gain a comparable value, here mole 
percent of protein mixture are calculated in respect to 100% discotic 53 (10-6 M) used in the 
first experiment (Figure 44). The spectra are very similar to the ones achieved in presence of 1 
indicating no unspecific interaction with the scaffold. 
 
Figure 47. Fluorescence excitation of the pure FRET acceptor SA-AF633 (5 x 10-9 M – 2.5 x 
10-7 M) at an excitation wavelength of λ = 584 nm. To gain a comparable value, here mole 
percent of protein mixture are calculated in respect to 100% discotic 53 (10-6 M) used in the 
first experiment (Figure 44). Spectra indicate that the direct excitation of the FRET acceptor 
SA-AF633 is relatively high. 
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As mentioned before, in the previous experiment the concentration of protein 
mixture of SA-AF633/SA-TR was steadily increased. The different 
concentrations make a reliable comparison of FRET ratios impossible. 
Therefore, subsequent experiments were carried out keeping a constant 
concentration of the protein mixture SA-AF633/SA-TR while 53 (or 1 as 
control) were added stepwise.  
Streptavidin Alexa Fluor 633 (SA-AF633) and streptavidin Texas Red (SA-TR) 
were mixed in a 1/1 ratio (0.05 mg x mL-1, 2 x 10-6 M of each protein) 2 h prior 
to the experiments and diluted to yield a final concentration of 10-7 M. Biotin 
discotic 53 or inert discotic 1 were added in steps between 0.1-20 mol-% 
compared to the single protein concentration. Additionally control experiments 
with the pure protein mixture of SA-AF633/SA-TR and with pure FRET 
acceptor SA-AF633 were carried out. Like the results achieved with the 
previous experiment, again the background fluorescence of SA-AF633 was 
comparably high. As before, the fluorescent signal of SA-AF633 at λ = 648 nm 
was higher than the signal of SA-TR at λ = 612 nm even in all the control 
studies. However, also in this study the obvious decrease in TR donor 
fluorescence indicates FRET interaction of SA-AF633/SA-TR only in presence 
of the biotin discotic. Figure 48 shows the overlay of spectra of the 
experiments in presence 53 or 1 (at 10 mol-%) with the pure protein mixture 
and pure acceptor SA-AF633. The spectra in presence of inert discotic 1 and 
of the pure protein mixture of SA-AF633/SA-TR are very similar indicating that 
no unspecific interaction is induced by the inert discotic scaffold 1. For the 
comparison of the background fluorescence of SA-AF633 with the 
fluorescence maxima of SA-AF633 in presence of SA-TR it needs to be taken 
into account that there is an overlap of the emission spectra of TR with AR633. 
Thus, the maximum of AF633 at λ = 647 nm is not only caused by emission of 
AF633 itself but also by TR emission. 
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Figure 48. Overlay of the experiments with 53 (green), 1 (blue) - both 10 mol-% -, the pure 
protein mixture SA-AF633/SA-TR (purple) and pure acceptor SA-AF633 (light blue). Only in 
presence of 53 the donor signal is quenched. 
 
The FRET ratios were calculated for the experiment in presence of 53 or 1 and 
for the pure protein mixture (Figure 49). FRET ratios determined with biotin 
discotic 53 are shown in blue, those achieved with 1 in green. Control 
experiments with the protein mixture SA-AF633/SA-TR without any discotic, 
resulted in constant FRET ratios around 1.2 at all concentrations tested. At the 
very low concentrations of protein (< 4 mol-% SA-AF633/SA-TR) the FRET 
ratio in presence of the discotic scaffold 1 or 53 was lower than that for the 
interaction between the pure proteins SA-AF633/SA-TR. Apparently, at these 
low concentrations the presence of the supramolecular polymer of 1 or 53 in 
solution reduces the probability of approximation of the two FRET partners SA-
AF633/SA-TR and thus decreases the FRET compared to the pure protein 
control even in presence of 1. In presence of 53, SA-AF633 and SA-TR 
probably are kept away from each other through binding to the columns of 53. 
The distance between two discotics carrying SA-AF633 and SA-TR is probably 
mediated by those discotics not bound to any protein. Unbound discotics 53 
serve as spacer to enhance the distance between SA-AF633/SA-TR. As a 
result, at ratios up to 4 mol-% of SA-AF633/SA-TR, the discotic 53 is able to 
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decrease FRET. At concentrations above 4 mol-%, 53 increases the FRET 
interaction of SA-AF633/SA-TR. The FRET of the control experiment with 1 
stays in the same range as the pure proteins above 4 mol-%. In presence of 
the supramolecular structure 53, the FRET interaction is amplified by a factor 
of two, compared to the supramolecular polymer without biotin and compared 
to the control experiments with pure SA-AF633/SA-TR. Furthermore, the FRET 
interaction in presence of 53 was shown to be concentration dependent. 
Evidently, the discotic, carrying ligands, is able to bind to the corresponding 
proteins and modulate their assembly in the periphery of the supramolecular 
columns in a concentration dependent manner.  
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Figure 49. Plot illustrating the FRET ratio max at 647 nm / max at 612 nm. Biotin disc 53 (blue 
plot) with 1 to 50 µL streptavidin-Alexa Fluor 633 and streptavidin-Texas Red (1/1, 
0.05 mg x mL-1). The green line shows the FRET ratio determined from the control experiment 
with 1. Control experiments with the protein mixture without any discotic, result in constant 
FRET ratios around 1.2 at all protein concentrations. 
 
Studies with a second FRET pair Alexa Fluor 514 (AF-514) and Texas Red 
(TR) were carried out. The dyes used were Alexa Fluor 514 (λ max ex = 514 nm; 
λ max em = 541 nm) as FRET donor and TR (λ max ex = 550 and 586 nm; 
λ max em = 612 nm) as FRET acceptor, each attached to streptavidin. Like the 
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labeled proteins of the previous experiments, the streptavidin labeled with 
AF-514 is commercially available. The excitation- and emission-spectra of the 
AF-514 and TR provided by the supplier are given in Figure 50. 
 
 
Figure 50. Excitation- (dashed) and emission- spectra (continous) of Alexa Fluor 514 (green) 
and Texas Red (red) as provided by invitrogen.[108] 
 
The two proteins SA-AF514 and SA-TR were mixed (0.05 mg x mL-1, 2 x 10-6 
M of each protein) 4 h prior to the experiments. Biotin disc 53 was added in 
portions of 2 µL (c [53 = 10-4] final concentrations between 2 x 10-6 and 1 x 
10-5 M). The resulting fluorescent spectra are shown in Figure 51. As had been 
the case in the previous experiment, using a different FRET pair, also this time 
almost no change in the maximum fluorescence intensity of the acceptor at 
λ = 612 nm was seen. In all spectra measured, the fluorescence intensity of 
the FRET acceptor SA-TR at its maximum (λ max em = 612 nm) stayed nearly 
constant. No increase of the acceptor signal could be achieved neither in 
presence of 53 nor in the control experiments with 1 or the pure proteins. 
Nevertheless, in presence of 53 a clear decrease of the fluorescence intensity 
of the FRET donor SA-AF514 at its maximum (λ max(em) = 541 nm) was 
detected.  
This assumption is supported by the fact that the FRET ratio increases with the 
amount of biotin discotic 53 added (Figure 52). The decrease of the 
fluorescence intensity of the FRET donor AF514 at its maximum, in presence 
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of the biotin discotic 53, while the signal of the FRET acceptor TR stayed 
constant, resulted in the increased FRET ratio. Control of the pure protein 
mixture without 53 resulted in a FRET ratio of 0.51.   
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Figure 51. Titration experiment to study the control over protein assembly using biotin discotic 
53 with FRET interaction of streptavidin-Alexa Fluor 514 and streptavidin-Texas Red. 
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Figure 52. Plot illustrating the FRET ratio (max at 612 nm / max at 541 nm) of the streptavidin-
Alexa Fluor 514 and mtreptavidin-Texas Red interaction. 
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Again, the difference in quantum yield of Alexa Fluorophors and TR is most 
probably the reason for the constant fluorescence signal of the acceptor TR at 
its maximum (λ = 612 nm). Additionally, the overlap in excitation wavelength of 
AF514 and TR seems to result in direct excitation of the FRET acceptor TR 
and thus causes high FRET ratios in the control studies. A change in FRET 
pair could overcome this problem. However, only a limited number of 
streptavidines carrying a fluorescent dye is commercially available. Self 
performed synthesis and purification of a mono-labeled streptavidin, with a 
desired dye would afford a tremendous effort on reaction setup and 
optimization. This was not within the focus of this thesis.  
Nevertheless, experiments with both SA-AF514/SA-TR and SA-TR/SA-AF633 
show that FRET interaction is significantly enhanced in presence of 53. The 
biotin discotic 53 enables protein assembly by binding of the streptavidines to 
the biotins crowded on the supramolecular surface.  
 
3.4.7 Prospective Modulation of Protein-Assembly with Discotics 
Experiments with the model system consisting of biotin discotic and fluorophor 
labeled streptavidin demonstrated that this supramolecular polymer is able to 
induce protein assembly if provided with the corresponding protein-binding 
ligands. Mixtures with inert discotics influence the interaction only if the 
supramolecules have been mixed prior to the studies. In order to be able to 
study the influence of the order of compound addition on the magnitude of 
FRET interaction, a different protein than streptavidin should be chosen in 
future studies. Binding of different biotin discotics to several binding pockets on 
one streptavidin most probably resulted in cross-linkage within and between 
columns. For further studies a mutant streptavidin with only one binding 
pocked labeled with Cy3 could be used.[105] In this case cross-linkage could be 
avoided. On the other hand, changing the model protein from streptavidin to 
another fluorescently labeled protein with a well known ligand could also 
enable advanced studies. In that case, decoration of the discotic with the 
corresponding ligand would be necessary.  
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On the other hand, the FRET pair YFP/CFP could be considered again. 
Synthesis of the discotic provided with only one functional cysteine group per 
scaffold could enable the attachment of CFP and YFP without the co-
occurrence of disulfide cross-linkages of the discotic scaffolds. This FRET pair 
is well studied and does not cause in any background signal arised from 
different quantum yield or overlay of excitation spectra. 
 
Furthermore, experiments on protein assembly are envisaged to be transferred 
to the living cell. First trials using MDCK cells for microinjection have been 
carried out already. SA-Cy3 was injected and shown to distribute in the cells. 
Unfortunately, the setup for microinjection did not allow excitation at the 
relatively low wavelength of the discotic (340 nm) in connection with the setup 
for microinjection. Change of the fluorescent microscope to one with lower 
excitation wavelength is not feasible with the living cells, which need CO2 
atmosphere. For further studies on this challenging experiment a technical 
setup needs to be generated, which enables determination of FRET between 
the discotic scaffold and the SA-Cy3 after microinjection to the living cell.  
Additionally, methods taking advantage of, for example, cell permeability 
should be applied. In this case cell permeation and interaction of the FRET 
partners takes place in the living cells. Subsequently the cells are fixed on a 
glass slide. FRET measurements on fixed cells allow a higher flexibility 
concerning the choice of fluorescent microscope and connected setup. The 
self-assembling discotic scaffold could provide a promising scaffold for 
modulation of protein interactions even for in vivo studies. Future investigation 
on this topic will lead to valuable contributions to the field of protein assembly. 
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4 Summary 
Discotic monomers reversibly assemble into a columnar polymer at low 
concentrations in water and can be decorated with ligands to target 
carbohydrate–lectin polyvalent interactions and bind specific proteins. The 
ligand density in the polymer can be controlled by reversible exchange of 
monomers. This supramolecular polymer features strong binding to bacteria 
and serves as platform for protein assembly. It is easily detected by 
fluorescence microscopy, and the control over its ligand density allows easy 
optimization of adjustment to and control over biological systems. 
Disc-shaped molecules 1 were built up by linking three N-monoacylated 
2,2'-bipyridine-3,3'-diamine wedges to a central 1,3,5-benzenetricarbonyl unit. 
Compounds 18 and 19 were designed featuring three selectively introduced 
azide or amine functionalities at the periphery of the molecule, which provided 
a flexible platform for modifications with biological ligands in the final step of 
the synthesis. They were synthesized in a multistep approach in a convergent 
fashion, resulting in a discotic molecule provided with six inert ethylene glycol-
monomethylether side chains and three azide- or amine-functionalized side 
chains (Scheme 18). 
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Scheme 18. The discotic scaffolds 18 and 19, provided with functionalities for modification 
with ligands and the inert discotic 1. 
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Discotic monomers 18 and 19 were decorated with various ligands. Propargyl-
derivatives of mannose, glucose and gallactose were attached to the discotic 
scaffold 18 via Huisgen [2+3]-cycloaddition. These reactions required 
unusually long reaction times apparently due to ligand crowding on the 
periphery of the supramolecular columns. However, the dynamic 
rearrangement of the monomers allowed full conversion to the tri- 
functionalized discotic after four weeks. Compound 19 was decorated with 
Texas Red, biotin and cysteine. Acylation took place within four hours to three 
days. All discotic compounds dissolve readily in water and form 
supramolecular polymers (Kass ~ 1 x 108 M-1).  
 
The binding of polyvalent supramolecular polymers built up out of 1 or 
mannose modified discotic 49 and mixtures thereof to bacteria was 
investigated by microscopy studies with the E. coli strain BL 21α, taking 
advantage of the strong auto-fluorescence of the discotic monomers when 
present as supramolecular polymer. Only when the bacteria were incubated 
with mannose discotic 49 could a strong fluorescence of the bacterial 
aggregates be observed, colocalizing with the brightfield image (Figure 53). 
Both the control experiments with nonfunctionalized scaffold 1 and with water 
did not show fluorescence. The specificity of the interaction of mannose 
modified discotic 49 with the mannose binding FimH receptors on the bacterial 
surface was confirmed through binding studies on two E. coli strains, ORN178 
and ORN208. The supramolecular polymers thus bind to the bacteria through 
the mannose-FimH receptor interaction selectively and do not induce 
unspecific binding. A competition experiment between mannose discotic 49 
and mannose on binding to bacteria demonstrated highly efficient polyvalent 
binding of the supramolecular polymers to the bacteria.  
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Figure 53. Microscopy pictures demonstrating binding of mannose modified discotic 49 to 
bacteria taken in a) brightfield and b) fluorescence (λex = 360 nm, λem = 490 nm) mode on E. 
coli incubated with 1) water, 2) inert discotic 1, 3) mannose discotic 49. Only in presence of 49 
a strong fluorescence of the bacterial aggregates could be observed, colocalizing with the 
brightfield image. 
 
Supramolecular polymers consisting of mixtures of 1 and mannose discotic 49 
were generated and similarly evaluated at dilute bacteria concentrations. 
These supramolecular copolymers induced bacterial aggregation at all mixture 
compositions evaluated. A functional-monomer percentage as low as 1% of 
mannose discotic 49 still resulted in the formation of bacterial aggregates. 
Evidently, only a limited number of mannose functionalities at the periphery of 
the supramolecular polymer are required to induce clustering of the bacteria 
around the columns. Furthermore, the supramolecular polymers are sufficiently 
long to bridge the distances between the few functional monomers 49 to 
induce bacterial cross-linking. The supramolecular nature of the polymer 
allows for easy adjustments and optimization of this monomer composition.  
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Figure 54. Microscopy pictures demonstrating aggregation of bacteria induced by mannose 
modified discotic 49 and by mixtures with 49 and inert discotic 1. Microscopy pictures were 
taken in brightfield mode on dilute bacterial samples incubated with a) 100% 1, b) 99/1 1/49 
and c) 100% 49. 
 
To quantify the polyvalent binding of the supramolecular polymers of 49, an 
enzyme linked lectin assay (ELLA) was performed using horseradish 
peroxidase labeled Con A as the lectin and yeast mannan as the surfacefixed-
ligand. The IC50 value for the methyl glycoside was around 3000 µM in our 
assay and the IC50 value for 49 around 120 µM (360 µM, valency corrected). 
The relative valency-corrected binding of 49 was 8.3 times stronger than the 
reference compound (24.9 per molecule 49), showing the polyvalent inhibition 
of the supramolecular polymers. The supramolecular polymers formed by 49 
allow effective polyvalent binding up to high valencies and show high potency 
per ligand. Apparently, because of the polymeric nature of 49, the compounds 
are capable of spanning the distance between the mannose binding sites on 
Con A.  
Mixtures of Texas Red discotic 52 and biotin discotic 53 were employed to 
assess the discotic supramolecules as heterovalent scaffold, which carries 
more than one functional ligand. Evaluation of the discotic mixture 52/53 on 
streptavidin coated beads showed that Texas Red discotic 52 is localized on 
the beads surface only in presence of the biotin discotic 53. Apparently, the 
biotin discotics include the Texas Red discotics in the supramolecular columns 
also when they bind to the streptavidin beads. These results confirm that 
mixtures of different functionalized discotic monomers provide convenient 
access to heterovalent supramolecules featuring different ligands. Thus, the 
supramolecular approach gives rise to new highly flexible heterovalent 
substances.  
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Besides their ability to control multivalent interactions on bacterial assembly, 
the discotics were employed as platforms to control protein assembly. The 
discotic 53, decorated with biotin ligands, was used to study the interaction of 
the discotic scaffold with streptavidin. FRET experiments were carried out, 
using a Cy3 labeled streptavidin (SA-Cy3). The fluorescence overlap of the 
discotic scaffold (FRET donor) and Cy3 (FRET acceptor) resulted in their 
FRET interaction. Comparison of FRET between the discotic scaffold and Cy3 
in presence of 53 or 1 showed that FRET interaction clearly results from the 
local proximity of Cy3 with the discotic scaffold of 53 caused by binding of 
biotin to streptavidin. Experiments with mixtures of 53 and 1 demonstrated that 
the presence of 1 as spacer enhances the relative amount of streptavidines 
that interact with the discotic from 7.5 mol-% to over 15 mol-% (Figure 55). 
Thus the inert discotic serves as spacer and creates free room between the 
functionalized discotics to allow a higher percentage of biotins to bind to the 
protein. The ideal mixture of functionalized discotic and inert discotic for 
optimized energy transfer seems to be about one to two inert discotics per 
binding scaffold. However, studies to evaluate the influence of the order of 
compound addition demonstrated that the order in which the interaction 
partners (53, 1 and SA-Cy3) are mixed strongly influences their interaction. 
Supramolecular columns of the biotin discotic 53 bound to SA-Cy3 do not 
include inert discotic 1 into the columnar architecture, if 1 is added 
subsequently to premixed SACy3/53. Apparently, the supramolecules formed 
by 53 can be blocked by SA-Cy3 through cross linking of several discotic 
monomers to one streptavidin to result a rigid polymer carrying the proteins on 
the periphery.   
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Figure 55. Studies on protein assembly of streptavidin-Cy3 (SA-Cy3) induced by the biotin 
discotic 53 and mixtures of  53 with inert discotic 1. FRET interaction of the discotic scaffold 
and Cy3 was detected. The FRET ratio of different mixtures of 53/1 1/0 (blue), 1/1 (purple), 1/2 
(green) and 1/5 (red) plotted against c[SA-Cy3]  compared to c[disc total]  = c[53] + c[53]. The 
plot illustrates that the relative amount of SA-Cy3 that interacts with the discotic mixtures of 
53/1 is highest in case of 1/1 and 1/2 mixtures. 
 
The same supramolecular polymer was used to assemble two different 
proteins along the polymer axis. These experiments on supramolecular control 
over protein interaction were carried out using streptavidin Alexa Fluor 633 
(SA-AF633) and streptavidin Texas Red (SA-TR), taking advantage of the 
overlay in fluorescence of TR and AF633. Results, summarized in Figure 56, 
demonstrate that the biotin discotic 53 binds to both streptavidines labeled with 
the FRET partners SA-AF633 and SA-TR, inducing protein assembly on the 
periphery of the supramolecular column formed by 53. Experiments with SA-
TR/SA-AF633 and studies with a second FRET pair SA-AF514/SA-TR 
evidence that the biotin discotic 53 enables protein assembly of two different 
proteins. 
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Figure 56. Studies on protein assembly induced by biotin discotic 53. The plot shows the 
overlay of the experiments with biotin discotic 53 (green), inert discotic 1 (blue) (both 10 mol-% 
with respect to the protein mixture), the pure protein mixture SA-AF633/SA-TR (purple) and 
pure acceptor SA-AF633 as control (light blue). Spectra are taken at an excitation wavelength 
of 584 nm. Only in presence of 53 the emission of donor SATR is decreased significantly. 
Apparently, the proteins assemble on the periphery of the supramolecular polymers formed 
by 53. 
 
Supramolecular polymers are ideal systems to generate polyvalent 
architectures for binding and modulation of biological interactions. The self-
assembly of monomers in reversible supramolecular polymers provides control 
over ligand density, polymeric architecture, and environmental response, not 
accessible with covalent polymeric systems. Supramolecular polymers thus 
have great potential for all kinds of biological applications where polyvalent 
effects are relevant. The self-assembling character ensures a reversible 
display of multiple ligands in dynamic adjustment to the biological interaction 
partner. The supramolecular nature additionally allows the generation of 
previously not accessible topologies, with possible new properties, and allows 
simple mixing of the required different types of monomers for the optimization 
of the binding event. 
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5 Experimental 
5.1 Material and Methods 
Nuclear Magnetic Resonance Spectroscopy 
1H and 13C NMR spectra were recorded on one of the following instruments:  
Varian Mercury 400 (400 MHz, 1H NMR; 100.6 MHz, 13C NMR)  
Bruker DRX 500 (500 MHz, 1H NMR; 125.8 MHz, 13C NMR) 
Bruker DRX 600 (600 MHz, 1H NMR; 150.9 MHz, 13C NMR)  
with tetramethylsilane as the internal reference. The chemical shifts are 
provided in ppm and the coupling constants in Hz. The following abbreviations 
for multiplicities are used: s, singlet; d, doublet; dd, double doublet; t, triplet; q, 
quadruplet; m, multiplet; br, broad. 
 
Mass Spectrometry 
ESI-mass spectra were recorded on a Finnigan LCQ ESI spectrometer. The 
MALDI-TOF MS spectra were recorded on a Voyager-DE Pro MALDI-TOF MS 
and with 2,5-dihydroxybenzoic acid (DHB) as the matrix (10 mg DHB, 900 μl 
H2O, 90 μl ethanol, 10 μl TFA). 
 
Reversed-Phase High-Pressure Liquid Chromatography 
Analytical HPLC was recorded on an Agilent HPLC (1100 series machine) 
using a 125/21 NUCLEODUR C18 Gravity, 5 μ (Macherey-Nagel) column. The 
standard gradient began at 10% acetonitrile and was raised to 90% over 15 
min. After 3 min at 90% acetonitrile, the column was washed for 5 min with 
100% acetonitrile. The column was then equilibrated for 3 min with 10% 
acetonitrile. Formic acid (0.1% v/v) was added to the HPLC solvents. 
Analytical HPLC-MS measurements were recorded on an Agilent HPLC (1100 
series) coupled to a Finnigan LCQ ESI spectrometer.  
 
Preparative Reversed-Phase High-Pressure Liquid Chromatography 
Preparative MS coupled HPLC was run on an Agilent Series 1100/LC/MSD VL 
(ESI) using a VP50/21 Nucleodur C18 Gravity 21 μm as pre column and a 
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VP125/21 Nucleodur C18 Gravity 21 μm as main column (both Macherey-
Nagel). Compounds were detected at 210 nm and 254 nm and with ESI-MS. 
The flow rate was 25 ml/min. Water was purified with a Milli-Q-System (Q-Gard 
2-cardrige from Millipore). TFA (0.1% v/v) was added to the HPLC solvents. 
 
Thin-Layer Chromatography (TLC) 
Thin-layer chromatography (TLC) plates were obtained from Merck (Silica gel 
60, F254). The TLCs were visualized by UV light (λ = 254 nm, 366 nm) or by 
staining with one of the following stains: 
Stain A: 0.3 g ninhydrin, 3 mL acetic acid, 97 mL ethanol. 
Stain B: 1.6 g KMnO4, 10 g K2CO3, 2.5 mL 5% NaOH, 200 mL H2O. 
The solvent system and Rf values are noted for the synthesized compounds. 
 
Flash Chromatography 
Flash column chromatography was performed using flash silica gel (Merck, 
Darmstadt, 40-64 μm) with pressure ranging from 0.5 -1.0 bar. A 70-100-fold 
excess of silica gel to the crude product was used.  
 
Preparative Size Exclusion Chromatography 
Size Exclusion Chromatography was performed on BIO RAD Bio Beads S-X1 
(200-400 mesh) in a long glass column (1.2 m) and a flow less than 1 mL/min. 
Chromatography was carried out using CH2Cl2 if not noted different. 
 
Ultraviolet Spectroscopy 
UV/VIS spectra were measured with a Cary 100 Spectrometer (Varian Inc.). 
Absorption spectra were recorded on a Tecan infinite M200 at a compound 
concentration of approximately 10-5 M in water or chloroform. Emission spectra 
were recorded on a Jasco Fluoreszenzspectrometer FP-6500 at a compound 
concentration of approximately 10-6 M in water or chloroform and excitation at 
340 nm (if not stated differently). 
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General Microscopy 
Microscopy studies on multivalency were carried out on a microscope from 
Axiovert 200M (Zeiss, Jena) in connection with the software Metamorph 
(Molecular Devices, Downingtown, USA). Pictures were taken with a CoolSnap 
ES camera (Roper Scientific Photometrics, Tucson, USA). Excitation and 
emission wavelengths are noted in the corresponding experiments. 
 
Chemicals 
Chemicals were obtained from the following suppliers and used without further 
purification: Acros, Aldrich, Fluka, Lancaster, Novabiochem. CH2Cl2 was 
distilled prior to use following standard protocols. Dry DMF and THF were 
purchased from Fluka. Additional substances were purchased as follows: 
Texas Red®-X succinimidyl ester, Invitrogen (T10244) 
NHS-PEO4-Biotin, Pierce (No 21330) 
NHS-PEO12-Biotin, Pierce (No 21312) 
CyTM3-Streptavidin, Zymed Laboratories, Invitrogen immunodetection, 
(43-4315) 
Streptavidin Magnetic Beads (1 µm superparamagnetic beads covalently 
coupled to a highly pure form of streptavidin), New England Biolabs (S1420S). 
 
Buffer 
PBS stock solution (0.1 M, 10 fold): 
1) 49.8 g Na2HPO4 x 2 H2O in 700 mL H2O 
2) 19.3 g NaH2PO4 x 1 H2O in 350 mL H2O 
3) 84.1 g NaCl 
2) was added to 1) until the pH reached 7.3 and 3) was added subsequently. 
PBS-Tween (0.1 %): 0.1 % Tween 20 in PBS  
 
Citrate buffer (0.2 M) 
1) 25.8 g sodium citrate in 500 mL H2O 
2) 19.2 g citric acid in 500 mL H2O 
2) was titrated to 1) until the pH reached 4.0. Finally 150 µl H2O2 
(0.015% (v/v)) was added. 
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5.2 Experimental 
 
5.2.1 Synthesis of the Glycol Side Chains 
 
2-(2-{Benzyloxy}-ethoxy)-ethanol (6)[109] 
 
 
 
NaH (14.4 g, 0.62 mol, 60% in paraffin) was washed with THF under Argon 
atmosphere several times and finally suspended in THF (1000 mL). Within 
2.5 h diethyleneglycol (145 mL, 1.53 mol) in THF (500 mL) was added, while 
the reaction mixture was mechanically stirred. Benzylbromide (38 mL, 
340 mmol) was added dropwise over a period of 5 h. After stirring over night at 
80 °C the reaction mixture was cooled down and poured into ice water (1000 
mL). The aqueous layer was extracted with diethlyl ether (3 x 350 mL). The 
combined organic layers were washed with water (3 x 400 mL) and brine (3 x 
300 mL), dried over MgSO4 and the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (flash silica, starting 
with 10% ethylacetate and gradually increasing the polarity to 50% 
ethylacetate in cyclohexane) to yield pure 6 as a colorless oil (220.1 g, 1.13 
mol, 73% in respect to NaH).  
 
1H NMR (400 MHz, CDCl3) δ = 7.27-7.36 (m, 5H, H-benzyl), 4.57 (s, 2H, CH2), 
3.67-3.74 (m, 4H, OCH2CH2O), 3.59-3.65 (m, 4H, OCH2CH2O), 2.60 (br, 1H, 
OH);  
13C NMR (101 MHz, CDCl3) δ = 137.9, 128.4, 127.7, 127.7, 73.3, 72.4, 70.4, 
69.4, 61.8; 
HPLC: Rt = 6.61 min;  
MS (ESI): calcd. for [C11H16O3 + NH4]+ m/z = 214.14 found m/z = 213.98. 
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2-(2-{2-Methoxyethoxy)-ethoxy}-ethyl p-tosylate (8) 
 
 
 
A two-phase system of NaOH (40.8 g, 1.02 mol) in water (200 mL) and 2-(2-{2-
methoxy-ethoxy}-ethoxy)-ethanol (120 mL, 0.67 mol) in THF (100 mL) was 
cooled via an ice-bath with magnetic stirring. p-Toluenesulfonyl chloride 
(146.4 g, 0.76 mol) in THF (200 mL) was added dropwise to the mixture, while 
maintaining the temperature below 5 °C. The solution was stirred at 0 °C for 
another 5 h and then poured into ice-water (100 mL). The mixture was 
extracted with CH2Cl2 (3 x 150 ml) and the combined organic layers were 
washed with 1 N HCl (2 x 300 mL) and brine (1x 300 mL), dried over MgSO4 
and the solvent was evaporated in vacuo. The crude product was purified by 
column chromatography (flash silica, starting with 10% ethylacetate and 
gradually increasing the polarity to 50% ethylacetate in cyclohexane) to yield 
pure 8 as a colourless oil (151.9 g, 0.45 mol, 65%).  
 
1H NMR (400 MHz, CDCl3) δ =  7.78 (d, J = 8.4 Hz, 2H, H-benzyl), 7.33 (d, 
J = 8.4 Hz, 2H, H-benzyl), 4.15 (t, 2H, OCH2CH2OTs), 3.69-3.65 (m, 2H, 
OCH2CH2O), 3.61-3.56 (m, 6H, OCH2CH2O), 3.53-3.50 (m, 2H, OCH2CH2OH), 
3.35 (s, 3H, OCH3), 2.43 (s, 3H, CH3Ar);  
13C NMR (101 MHz, CDCl3) δ = 144.7, 133.0, 129.8, 127.9, 71.9, 70.7, 70.5, 
70.5, 69.2, 68.6, 59.0, 21.6;  
HPLC: Rt = 8.50 min;  
MS (ESI): calcd. for [C14H22O6S + NH4]+ m/z = 336.14 found m/z = 336.00. 
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1-Benzyloxy-2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethane 
(9) 
 
 
  
Compound 8 (123.7 g, 0.37 mol), 6 (60.0 g, 0.30 mol) and KOH (68.7 g, 
1.22 mol) were heated under reflux in THF (500 mL) over night. The reaction 
mixture was poured in ice water and extracted with CH2Cl2 (3 x 400 mL). The 
combined organic layers were washed with brine, dried over MgSO4 and 
evaporated in vacuo. The crude product was purified by column 
chromatography (flash silica, starting with 100% chloroform and gradually 
increasing the polarity to 5% methanol in chloroform) to yield pure compound 9 
as a colorless oil (92.4 g, 0.27 mmol, 88%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.36-7.22 (m, 5H, H-benzyl), 4.55 (s, 2H, CH2), 
3.68-3.60 (m, 18H, OCH2CH2O), 3.55-3.50 (m, 2H, OCH2CH2OTs), 3.36 (s, 
3H, OCH3);  
13C NMR (101 MHz, CDCl3) δ = 138.5, 128.5, 127.9, 127.8, 73.4, 72.1, 70.9, 
70.8-69.7, 59.2;  
HPLC: Rt = 8.07 min;  
MS (ESI): calcd. for [C18H30O6 + NH4]+ m/z = 360.24 found m/z = 360.19. 
 
 
2-(2-{2-[2-(2-Methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethan-1-ol (10) 
 
 
 
To a solution of 9 (55.13 g, 0.16 mol) in ethanol/water (50 mL/5 mL) and conc. 
HCl (0.5 mL) a catalytic amount of Pd/C (10%) (2 mmol) was added. The 
suspension was stirred for 12 h under an H2-atmosphere of 50 bar in an 
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autoclave and then filtered through celite®. The filtrate was evaporated in 
vacuo to yield the product as a colorless oil (40.3 g, 0.16 mol, quant.).  
 
1H NMR (400 MHz, CDCl3) δ = 3.78-3.70 (m, 2H, OCH2CH2O), 3.70-3.59 (m, 
16H, OCH2CH2O), 3.55 (dd, J = 5.8 and 3.5 Hz, 2H, OCH2CH2OH), 3.38 (s, 
3H, OCH3), 2.93 (s, 1H, OH);  
13C NMR (101 MHz, CDCl3) δ = 72.4, 71.8, 70.5-70.2, 61.6, 59.0;  
HPLC: Rt = 6.85 min;  
MS (ESI): calcd. for [C11H24O6 + NH4]+ m/z = 270.19 found m/z = 270.05. 
 
 
2-(2-{2-[2-(2-Methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethyl-1-p-tosylate 
(11) 
 
 
 
To a solution of 10 (40.0 g, 0.16 mol) and triethylamine (25 ml, 0.19 mol) in 
CH2Cl2 (200 mL) p-toluenesulfonyl chloride (35.0 g, 0.18 mol) in CH2Cl2 
(300 mL) was added dropwise. The reaction was stirred over night and then 
washed with 1 N HCl (3 x 100 mL) and brine (100 mL). Drying over MgSO4 
and evaporating the solvent in vacuo yielded the crude product. Purification by 
column chromatography (flash-silica, starting with 100% CH2Cl2 and increasing 
the polarity to 5% methanol in CH2Cl2) yielded pure compound 11 as a 
colorless oil (46.80 g, 0.11 mol, 72%).  
 
1H NMR (400 MHz, CDCl3)  δ =  7.77 (d, J = 8.6 Hz, 2H, H-benzyl), 7.32 (d, 
J = 8.6 Hz, 2H, H-benzyl), 4.13 (t, 2H, OCH2CH2OTs), 3.69-3.64 (m, 2H, 
OCH2CH2O), 3.64-3.54 (m, 14H, OCH2CH2O), 3.54-3.50 (m, 2H, 
OCH2CH2OH), 3.35 (s, 3H, OCH3), 2.42 (s, 3H, CH3Ar);  
13C NMR (101 MHz, CDCl3) = 144.6, 132.9, 129.6, 127.8, 71.7, 70.6-70.3, 
69.0, 68.5, 58.8. 21.4;  
HPLC: Rt = 7.96 min;  
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MS (ESI): calcd. for [C18H30O8S + NH4]+ m/z = 424.20 found m/z = 424.12. 
 
 
2[-2-(2-{2-[2-(2-Hydroxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]- ethyl 
p-tosylate (21) 
 
 
 
To a solution of hexaethyleneglycol (50 g, 177 mmol) and triethylamine 
(14 mL, 100 mmol) in THF (250 mL) p-toluenesulfonyl chloride (13 g, 70 mmol) 
in THF (250 mL) was added and stirred over night. The solution was diluted 
with CH2Cl2 (200 mL) washed with 1N HCl (3 x 150 mL) and brine (150 mL) 
and dried over MgSO4. After evaporating the solvents in vacuo the residue was 
purified by column chromatography (silica, 2% methanol in CH2Cl2) to give 21 
(24.4 g, 56 mmol, 80% compared to p-toluenesulfonyl chloride) as a colorless 
oil.  
 
1H NMR (400 MHz, CDCl3) δ = 7.79 (d, J=8.1, 2H, Ar-CH), 7.33 (d, J = 8.0, 2H, 
H-benzyl), 4.15 (dd, 2H, OCH2CH2OSO2-Ar), 3.74-3.56 (m, 22H, OCH2CH2O), 
2.93 (br, 1H, OH), 2.44 (s, 3H, CH3Ar);   
13C NMR (101 MHz, CDCl3) δ = 145.0, 133.3, 130.0, 128.2, 72.7, 70.9-70.5, 
69.5, 68.9, 61.9, 21.8; 
HPLC: Rt = 7.14 min;  
TLC (5 % methanol in CH2Cl2): Rf = 0.32; 
MS (ESI): calcd. for [C19H32O9S + NH4]+ m/z = 454.21 found m/z = 454.08. 
 
 
2[-2-(2-{2-[2-(2-Hydroxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]- ethyl 
azide (22) 
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Compound 21 (24.4 g, 56 mmol) and NaN3 (3.7 g, 57 mmol) in DMF (150 mL) 
were stirred over night. Subsequently the solvent was evaporated in vacuo. 
The residue was resolved in ethylacetate, filtrated over Celite® and the solvent 
was again evaporated in vacuo to yield pure 22 (14.6 g, 48 mmol, 85%).  
 
1H NMR (400 MHz, CDCl3) δ = 3.72-3.57 (m, 22H, OCH2CH2O), 3.37 (t, 2H, 
CH2N3), 2.80 (s, 1H, OH);  
13C NMR (101 MHz, CDCl3) δ = 72.8, 70.7-70.1, 61.8, 50.7;  
HPLC: Rt = 6.05 min;  
TLC (6 % methanol in CH2Cl2): Rf = 0.38; 
MS (ESI): calcd. for [C12H25N3O6 + NH4]+ m/z = 325.20 found m/z = 325.07. 
 
 
2[-2-(2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]- ethyl p-
tosylate (23) 
 
O O O N3O OOS
O
O  
 
To a solution of 22 (14.6 g, 48 mmol) and triethylamine (13.4 mL, 100 mmol) in 
CH2Cl2 (80 mL) p-toluenesulfonyl chloride (11.9 g, 63 mmol) in CH2Cl2 
(100 mL) was added dropwise at roomtemperature. The reaction was stirred 
over night and then washed with 1N HCl (3 x 100 mL) and brine (100 mL). 
Drying over MgSO4 and evaporating the solvent in vacuo gave the crude 
product. Purification by column chromatography (flash-silica, starting with 
100% CH2Cl2 and increasing the polarity to 4% methanol in CH2Cl2) yielded 
the pure compound as a colorless oil (14.6 g, 32 mmol, 66%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.79 (d, J = 7.9, 2H, H-benzyl), 7.33 (d, J=8.0, 
2H, H-benzyl), 4.15 (t, 2H, OCH2CH2OSO2-Ar), 3.74-3.54 (m, 20H, 
OCH2CH2O), 3.37 (t, 2H, CH2N3), 2.44 (s, 3H, CH3Ar);  
13C NMR (101 MHz, CDCl3) δ = 144.9, 133.2, 130.0, 128.1, 70.9-68.8, 50.8, 
21.8;  
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HPLC: Rt = 9.45 min;  
TLC (5 % methanol in CH2Cl2): Rf = 0.36; 
MS (ESI): calcd. for [C19H31N3O8S + NH4]+ m/z = 479.22 found m/z = 479.12.  
 
 
2[-2-(2-{2-[2-(2-Hydroxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]- ethyl 
amine (24) 
 
 
 
22 (7.2 g, 23 mmol) was dissolved in ethanol (20 mL) and water (5 mL) and 
Pd/C (10%, 0.3 g) was added. The suspension was stirred for 48 h under an 
H2-atmosphere (10 bar) in an autoclave and subsequently filtered through 
celite®. The solvents were evaporated in vacuo to yield 24 (6.2 g, 22 mmol, 
96%).  
 
1H NMR (400 MHz, CDCl3) δ = 3.74-3.50 (m, 22H, OCH2CH2O), 2.93 (s, 2H, 
NH2), 2.87 (t, J=5.1, 2H, CH2NH2);  
13C NMR (101 MHz, CDCl3) δ = 77.54, 77.22, 76.90, 72.92-70.34, 61.79, 
58.64, 19.87; 
HPLC: Rt = 1.91 min;  
MS (ESI): calcd. for [C12H27NO6 + H]+ m/z = 282.18 found m/z = 282.13. 
 
 
2[-2-(2-{2-[2-(2-Hydroxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]- ethyl- 
tert-butylcarbamat (25) 
 
 
 
To a solution of 24 (6.2 g, 22 mmol) in dioxane (30 mL) di-tert-butyldicarbonat 
(6.0 g, 27 mmol) was added at 0 °C and stirred for 3 h. Subsequently 
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triethylamine (4 mL, 30 mmol) was given to the mixture and stirred over night 
at rt. The solvent was evaporated in vacuo and the crude product was purified 
by column chromatography (silica, 3% methanol in CH2Cl2) to yield 25 (5.1 g, 
13 mmol, 59%). 
 
1H NMR (400 MHz, CDCl3) δ = 3.70-3.51 (m, 20H, OCH2CH2O), 3.47 (t, 
J = 5.2, 2H, OCH2CH2NHboc), 3.24 (dd, J = 10.1 and 5.2, 2H, 
OCH2CH2NHboc), 1.37 (s, 9H, OC(CH3)3); 
13C NMR (101 MHz, CDCl3) δ = 155.6, 72.67-70.4, 61.8, 53.6, 40.5, 28.6. 
HPLC: Rt = 6.38 min;  
MS (ESI): calcd. for [C17H35NO8 + H]+ m/z = 382.16 found m/z = 382.02. 
 
 
2[-2-(2-{2-[2-(2-tert-butoxycarbonylamino)-ethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]- ethyl p-tosylate (26) 
 
O O O HNO OO
O
O
S
O
O  
 
To a solution of 25 (5.06 g, 13.3 mmol) and triethylamine (5.0 mL, 38.0 mmol) 
in THF (50 mL) p-toluenesulfonyl chloride (3.04 g, 16.1 mmol) in THF (50 mL) 
was added dropwise. The reaction was stirred over night and then washed 
with 1N HCl (3 x 50 mL) and brine (50 mL). Drying over MgSO4 and 
evaporating the solvent in vacuo gave the crude product. Purification by 
column chromatography (silica, 3% methanol in CH2Cl2) yielded the pure 
compound as a colourless oil (4.41 g, 8.2 mmol, 62%). 
 
1H NMR (400 MHz, CDCl3) δ = 7.79 (d, J = 8.1, 2H, H-benzyl), 7.33 (d, J = 8.1, 
2H, H-benzyl), 5.01 (br, 1H, NH), 4.15 (t, 2H, CH2OSO2-Ar), 3.71-3.49 (m, 
20H, OCH2CH2O), 3.29 (d, J = 4.4, 2H, CH2NHboc), 2.44 (s, 3H, CH3Ar), 1.43 
(s, 9H, OC(CH3)3); 
HPLC: Rt = 8.97 min;  
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MS (ESI): calcd. for [C24H41NO10S + Na]+ m/z = 558.23 found m/z = 558.06. 
 
5.2.2 Synthesis of the Bipyridine Core 
 
3,3’-Dinitro-2,2’-bipyridine (3)[73] 
 
NO2
N
N
O2N  
 
To a solution 2-chloro-3-nitropyridin (24.9 g, 158 mmol) in DMF (125 mL) Cu 
powder (12.6 g, 200 mmol) was added in small portions. The suspension was 
stirred under argon atmosphere for 3 h at 110 °C. Subsequently the hot 
reaction mixture was filtered over Celite®. The filtrate was diluted with 
ammonia (5% in water, 100 mL), the solid was filtered immediately and 
washed. Recrystallisation from ethanol gave the bipyridine 3 (8.5 g, 34 mmol, 
21%) as a yellow solid.  
 
1H NMR (400 MHz, DMSO-D6) δ = 8.92 (dd, J = 4.8 and 1.4, 2H, H-6 and H-
6’), 8.70 (dd, J = 8.3 and 1.4, 2H, H-4 and H-4’), 7.87 (dd, J = 8.3 and 4.8, 2H, 
H-5 and H-5’);  
13C NMR (101 MHz, DMSO-D6) δ = 153.0, 149.2, 144.6, 133.7, 125.4;  
HPLC: Rt = 7.67 min;  
MS (ESI): calcd. for [C10H6N4O4 + H]+ m/z = 247.05  found m/z = 247.10. 
 
 
2,2’-Bipyridyl-3,3’-diamine (4)[73] 
 
NH2
N
N
H2N  
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Tin(II) chloride (47.3 g, 243 mmol) was dissolved in HCl (17%, 190 mL) and 3 
(6.5 g, 27 mmol) was added in portions. The resulting mixture was stirred for 
2.5 h under reflux. The reaction mixture was cooled to rt and the pH was 
adjusted to 14 using NaOH (4 N). The aqueous layer was extracted with 
chloroform (3 x 350 mL). The combined organic layers were dried over MgSO4 
and the solvent was evaporated in vacuo to yield 4 (3.6 g, 19 mmol, 72%) as 
yellow crystals.  
 
1H NMR (400 MHz, DMSO-D6) δ = 7.85 (d, J = 4.4, 2H, H-6 and H-6’), 7.15 (d, 
J = 8.2, 2H, H-4 and H-4’), 7.09 (s, 4H, NH2), 7.06 (dd, J=8.2 and 4.4, 2H, H-5 
and H-5’);  
13C NMR (101 MHz, DMSO-D6) δ = 144.6, 139.2, 133.9, 123.0, 122.8;  
HPLC: Rt = 1.25 min;  
MS (ESI): calcd. for [C10H10N4 + H]+ m/z = 187.10  found m/z = 187.24. 
 
5.2.3 Synthesis of the Inert Discotic 
 
Methyl- 3,4,5-tris[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-
ethoxy]-benzoate (13)  
 
OR1
OR1R1O
O O
O O O OOR
1 =
 
 
A mixture of 11 (3.6 g, 8.8 mmol), methyl 3,4,5-trihydroxybenzoate (0.48 g, 2.6 
mmol) and K2CO3 (4.4 g, 32.0 mmol) was stirred over night at 70 °C in dry 
DMF (20 mL). The reaction mixture was poured in water (50 mL) and extracted 
with CH2Cl2 (3 x 50 mL). The combined organic layers were washed with brine 
(2 x 20 mL), dried over MgSO4 and evaporated in vacuo. The crude product 
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was purified by column chromatography (alumina, 1% ethanol in chloroform) 
affording the pure compound 13 (1.86 g, 2.0 mmol, 81%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.27 (s, 2H, H-benzoyl), 4.20 (t, 4H, 
m-OCH2CH2O), 4.17 (t, 2H, p-OCH2CH2O), 3.86 (s, 3H, COOCH3), 3.83 (t, 4H, 
m-OCH2CH2O), 3.77 (t, 2H, p-OCH2CH2O), 3.72-3.59 (m, 48H, OCH2CH2O), 
3.35 (s, 9H, OCH3);  
13C NMR (101 MHz, CDCl3) δ = 166.5, 152.2, 142.5, 124.9, 108.9, 72.3-68.8, 
58.9, 52.1. 
 
 
3,4,5-Tris[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
benzoic acid (14) 
 
OR1
OR1R1O
HO O
O O O OOR
1 =
 
 
A solution of 13 (1.86 g, 2.0 mmol) and KOH (0.40 g, 7.1 mmol) in ethanol (15 
mL) and water (15 mL) was heated under reflux overnight. Subsequently, the 
solution was cooled, acidified to pH = 2 and extracted with CH2Cl2 (3 x 30 mL). 
The CH2Cl2 layer was washed with brine. Drying over MgSO4, evaporating in 
vacuo and drying over P2O5 afforded the pure compound 14 (1.43 g, 1.6 mmol, 
82%). 
 
1H NMR (400 MHz, CDCl3) δ = 7.34 (s, 2H, H-benzoyl), 4.23 (t, 4H, 
m-OCH2CH2O), 4.21 (t, 2H, p-OCH2CH2O), 3.84 (t, 4H, m-OCH2CH2O), 3.87 
(t, 2H, p-OCH2CH2O), 3.73-3.50 (m, 48H, OCH2CH2O), 3.36 (s, 9H, m-OCH3 
and p-OCH3);  
13C NMR (101 MHz, CDCl3) δ = 168.9, 152.2, 142.9, 124.6, 109.3, 72.5-68.8, 
58.9;  
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HPLC: Rt = 6.59 min;  
MS (ESI): calcd. for [C40H74O20 + NH4]+ m/z = 890.50 found m/z = 890.76. 
 
 
3’-{3,4,5-Tris[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-
ethoxy]- benzoylamino}-2,2’-bipyridine-3-amine (16) 
 
H2N N
N
N
H
O
OR1
OR1
OR1
O O O OOR1 =
 
  
A solution of oxalyl chloride (0.23 g, 1.8 mmol) in dry CH2Cl2 (5 ml) containing 
a catalytic amount of DMF was added dropwise to a solution of 14 (1.43 g, 1.6 
mmol) in dry CH2Cl2 (10 mL). The reaction mixture was stirred overnight at rt in 
the absence of light. Evaporating the solvent in vacuo afforded the crude 
product 15 (1.33 g, 1.5 mmol, 94%). This product was dissolved in dry CH2Cl2 
(20 mL) and added dropwise to a stirred solution of 2,2’-bipyridyl-3,3’-diamine 
4 (0.31 g, 1.7 mmol) and triethylamine (0.25 mL, 1.7 mmol) in dry CH2Cl2 (20 
mL), while the temperature was kept below 5 °C. After stirring for 3 h the 
solution was diluted with CH2Cl2, washed with water (3 x 20 mL) and brine (1 x 
20 mL) and dried over MgSO4. After evaporation of the solvents in vacuo the 
crude product was purified by column chromatography (silica, ethylacetate 
followed by 5% methanol in chloroform) and size exclusion chromatography. 
Drying over P2O5 gave compound 16 (1.03 g, 1.0 mmol, 62%).  
 
1H NMR (400 MHz, CDCl3) δ = 14.40 (s, 1H, NHCO), 9.21 (dd, J = 8.4 and 
1.8 Hz, 1H, H-4’), 8.34 (dd, J = 4.5 and 1.5 Hz, 1H, H-6’), 8.04 (dd, J = 2.9 and 
2.7 Hz, 1H, H-6), 7.33 (s, 2H, H-benzoyl), 7.31 (dd, J = 9.0 and 4.2 Hz, 1H, 
H-5’), 7.15 (m, 2H, H-4 and H-5), 6.59 (s, 2H, NH2), 4.25 (m, 6H, benzoyl-
OCH2), 3.89 (t, 4H, m-OCH2CH2O), 3.82 (t, 2H, p-OCH2CH2), 3.75-3.52 (m, 
48H, OCH2CH2O), 3.37 (s, 6H, m-OCH3), 3.36 (s, 3H, p-OCH3);  
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13C NMR (101 MHz, CDCl3) δ = 165.7, 152.6, 145.1, 143.6, 142.0, 140.8, 
138.5, 136.1, 135.0, 130.8, 128.6, 125.3, 124.3, 122.7, 107.8, 72.4-69.2, 59.0;  
HPLC: Rt = 7.18 min;  
MS (ESI): calcd. for [C50H80N4O19 + H]+ m/z = 1041.55 found m/z = 1041.89. 
 
 
N,N’,N’’-Tris{3[3’-(3,4,5-tris{2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy})-benzoylamino]-2,2’-bipyridyl}benzene-1,3,5-
tricarboxamide (1)  
 
O O O OOR1 =
RO
H
N
O R
N
N
N
H
O
R1O
R1O
OR1
O
R =
 
 
To a solution of 16 (1.00 g, 0.96 mmol) and triethylamine (0.14 mL) in dry 
CH2Cl2 (10 mL), a solution of trimesic chloride (80 mg, 0.3 mmol) in dry CH2Cl2 
(5 mL) was added dropwise at room temperature. Stirring was continued 
overnight, after which the solution was diluted with CH2Cl2 and washed with 
water (2 x 25 mL). The combined water layers were extracted with CH2Cl2 (4 x 
25 mL). The combined dichloromethane layers were washed with brine (1 x 
20 mL), dried over MgSO4 and evaporated in vacuo. The crude product was 
purified by column chromatography (silica, 2% methanol in chloroform) and 
size exclusion chromatography (in CH2Cl2). Thoroughly drying over P2O5 
afforded 1 (0.58 g, 0.18 mmol, 59%). 
 
1H NMR (400 MHz, CDCl3) δ =  15.61 (s, 3H, NHCO), 14.33 (s, 3H, NH’CO), 
9.55 (br, 3H, H-4), 9.36 (d, 3H, H-4’), 9.24 (s, 3H, o-H), 9.01 (d, 3H, H-6’), 8.52 
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(dd, 3H, H-6), 7.57 (dd, 6H, H-5 and H-5’), 7.34 (s, 6H, H-benzoyl), 4.26 (t, 
12H, m-OCH2CH2O), 4.22 (t, 6H, p-OCH2CH2O), 3.91 (t, 12H, m-OCH2CH2O), 
3.88 (t, 6H, p-OCH2CH2O), 3.76-3.58 (m, 147H, OCH2CH2O), 3.36 (s, 9H, 
p-OCH3), 3.34 (s, 18H, m-OCH3);  
13C NMR (101 MHz, CDCl3) δ = 166.0, 163.8, 153.0, 142.6, 142.3, 141.7, 
141.0, 137.6, 137.6, 136.2, 130.7, 130.6, 130.0, 129.8, 125.1, 124.9, 108.2, 
72.7-69.6, 59.2;  
MS (MALDI-TOF): calcd. for [C159H240N12O60 + Na]+ m/z = 3300.6 found m/z = 
3300.1. 
 
 
5.2.4 Synthesis of the Azide Modified Discotic Scaffold 
 
Methyl-3,4,5-triacetoxy-benzoat (27)[75] 
 
 
 
To a solution methyl-3,4,5-trihydroxybenzoate (30.0 g, 165 mmol) in pyridine 
(60 mL) acetic anhydride (150 mL) was added dropwise. The mixture was 
stirred over night, poured in CH2Cl2 (500 mL) and washed with brine 
(3 x 200 mL). The combined water layers were extracted with ethylacetate (3 x 
200 mL). The combined organic layers were dried over MgSO4 and evaporated 
in vacuo. The crude product was purified by column chromatography (silica, 
30% ethylacetate in cyclohexane) affording the pure compound (41.2 g, 
132 mmol, 80%) as colorless crystals.  
 
mp: 127.8 °C;  
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1H NMR (400 MHz, CDCl3) δ = 7.80 (s, 2H, H-benzoyl), 3.90 (s, 3H, COOCH3), 
2.29 (s, 9H, OCCH3); 
13C NMR (101 MHz, CDCl3) δ = 166.0, 164.8, 162.8, 141.81, 137.1, 126.1, 
120.3, 50.9, 18.8, 18.4;  
HPLC: Rt = 8.41 min;  
MS (ESI): calcd. for [C14H14O8 + NH4]+ m/z = 328.10 found m/z = 327.97. 
 
 
 Methyl-3,5-diacetoxy-4-benzyloxybenzoat (28)[75] 
 
 
 
Compound 27 (41.0 g, 132 mmol), K2CO3 (54.3 g, 302 mmol), KI (3.5 g, 24 
mmol) and benzyl bromide (18.8 g, 150 mmol, 16.8 mL) in acetone (dry, 
1000 mL) were stirred over night under reflux, after which the reaction mixture 
was cooled to rt and water (1000 mL) was added. The mixture was extracted 
with ethylacetate (3 x 500 mL). The combined organic layers were washed 
with brine (2 x 500 mL), dried over MgSO4 and evaporated in vacuo. The crude 
product was re-crystallized from ethanol affording the pure compound 28 (26.9 
g, 75 mmol, 57%) as yellow crystals.  
 
mp: 109.6 °C;  
1H NMR (400 MHz, CDCl3) δ = 7.69 (s, 2H, H-benzoyl), 7.40-7.31 (m, 5H, H-
benzyl), 5.05 (s, 2H, CH2Ar), 3.89 (s, 3H, COOCH3), 2.19 (s, 6H, m-OCCH3);  
13C NMR (101 MHz, CDCl3) δ = 168.4, 165.1, 147.4, 144.1, 136.6, 128.5, 
128.3, 127.6, 125.5, 122.6, 75.6, 52.3, 20.5;  
HPLC: Rt = 9.75 min;  
MS (ESI): calcd. for [C19H18O7 + NH4]+ m/z = 376.14 found m/z = 376.00. 
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Methyl-4-benzyloxy-3,5-dihydroxybenzoat (29)[75] 
 
 
 
To a solution of 28 (18.5 g, 49 mmol) in methanol (300 mL) a solution of K2CO3 
(50.8 g, 368 mmol) in water (300 mL) was added and stirred for 2 h under 
reflux. The solution was acidified to pH=2, cooled and extracted with 
ethylacetate (3 x 200 mL). The combined organic layers were washed with 
brine (2 x 200 mL) and water (200 mL), dried over MgSO4 and evaporated in 
vacuo. Re-crystallization from chloroform afforded pure compound 29 (10.1 g, 
37 mmol, 70%) as orange crystals. 
 
mp: 135.2 °C;  
1H NMR (400 MHz, CDCl3) δ = 7.39 (s, 5H, H-benzyl), 7.24 (s, 2H, H-benzoyl), 
5.15 (s, 2H, CH2Ar), 3.89 (s, 3H, COOCH3);  
13C NMR (101 MHz, CDCl3) δ = 166.8, 149.1, 137.5, 136.4, 129.4, 128.9, 
126.0, 110.0, 75.9, 52.6;  
HPLC: Rt = 7.78 min;  
MS (ESI): calcd. for [C15H14O5 + NH4]+ m/z = 292.12 found m/z = 292.29. 
 
 
Methyl-4-benzyloxy-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]-benzoate (30) 
 
O
OR1
OR1
O
O
O O O OOR
1 =
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A mixture of 11 (27.8 g, 69 mmol), 29 (9.4 g, 34 mmol) and K2CO3 (17.0 g, 123 
mmol) was stirred over night at 70 °C in dry DMF (100 mL). The reaction 
mixture was poured into water (150 mL) and extracted with CH2Cl2 (4 x 150 
mL). The combined organic layers were washed with brine (100 mL), dried 
over MgSO4 and evaporated in vacuo. The crude product was purified by 
column chromatography (alumina, 2% methanol in CH2Cl2) affording the pure 
compound (20.00 g, 27 mmol, 61%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.47 (d, 2H, H-benzyl), 7.35-7.26 (m, 3H, H-
benzyl), 7.27 (s, 2H, H-benzoyl), 5.10 (s, 2H, CH2Ar), 4.16 (t, 4H, 
m-OCH2CH2O), 3.87 (s, 3H, COOCH3), 3.84 (t, 4H, m-OCH2CH2O), 3.73-3.58 
(m, 28H, OCH2CH2O), 3.55-3.50 (m, 4H, OCH2CH2O), 3.35 (s, 6H, OCH3); 
13C NMR (101 MHz, CDCl3) δ = 166.7, 163.5, 152.7, 142.2, 137.9, 128.5, 
128.3, 128.0, 125.3, 108.8, 75.0, 72.0-70.6, 69.8, 68.9, 59.1, 52.3;  
HPLC: Rt = 8.65 min;  
MS (ESI): calcd. for [C37H58O15 + NH4]+ m/z = 760.41 found m/z = 760.25. 
 
 
Methyl-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-
ethoxy]- 4-hydroxybenzoate (31) 
 
OH
OR1
OR1
O
O
O O O OOR
1 =
 
 
A suspension of 30 (20.0 g, 27 mmol) and Pd/C (1 g) in H2O (5 mL) and 
ethanol (80 mL) with a catalytic amount of conc. HCl (0.1 mL) was stirred for 3 
d under hydrogen atmosphere (50 bar) in an autoclave. The mixture was then 
filtered through celite® and the solvents were removed in vacuo to yield pure 
31 (16.6 g, 25 mmol, 94%).  
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1H NMR (400 MHz, CDCl3) δ = 7.32 (s, 2H, H-benzoyl), 4.23 (t, 4H, 
m-OCH2CH2O), 3.84 (t, 4H, m-OCH2CH2O), 3.83 (s, 3H, COOCH3), 3.71-3.59 
(m, 28H, OCH2CH2O), 3.51 (dd, 4H, OCH2CH2O), 3.34 (s, 6H, OCH3);  
13C NMR (101 MHz, CDCl3) δ = 166.6, 146.3, 142.1, 120.4, 110.4, 71.8, 70.6-
69.4, 58.90, 51.86;  
HPLC: Rt = 7.32 min;  
MS (ESI): calcd. for [C30H52O15 + NH4]+ m/z = 670.36 found m/z = 670.23. 
 
 
Methyl-4-{2[-2-(2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-
ethoxy]-benzoat (32) 
 
OR2
OR1
OR1
O
O
O O O OOR
1 =
O O O OOR
2 = N3  
 
A mixture of 31 (5.76 g, 12.5 mmol), 23 (9.05 g, 9.6 mmol) and K2CO3 (17.0 g, 
123 mmol) was stirred over night at 70 °C in dry DMF (100 mL). The reaction 
mixture was poured into water (150 mL) and extracted with CH2Cl2 (3 x 100 
mL). The combined organic layers were washed with brine (80 mL), dried over 
MgSO4 and evaporated in vacuo. The crude product was purified by column 
chromatography (alumina, 1% ethanol in chloroform) affording pure compound 
32 (6.3 g, 6.7 mmol, 70%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.23 (s, 2H, H-benzoyl), 4.16 (t, 4H, 
m-OCH2CH2O), 4.13 (t, 2H, p-OCH2CH2O),  3.82 (s, 3H, COOCH3), 3.80 (t, 
4H, m-OCH2CH2O), 3.73 (m, 2H, p-OCH2CH2O), 3.62 (m, 46H, OCH2CH2O), 
3.48 (dd, 4H, OCH2CH2OCH3), 3.32 (d, 2H, OCH2CH2N3), 3.31 (s, 6H, OCH3);  
13C NMR (101 MHz, CDCl3) δ = 166.7, 152.5, 142.8, 125.1, 109.3, 72.6, 72.1, 
71.0-69.1, 61.9, 59.2, 52.3, 50.9;  
HPLC: Rt = 7.95 min;  
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MS (ESI): calcd. for [C42H75N3O20 + NH4]+ m/z = 959.52 found m/z = 959.43. 
 
 
4-{2[-2-(2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethyl}-
3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
benzoic acid (34) 
 
OR2
OR1
OR1
HO
O
O O O OOR
1 =
O O O OOR
2 = N3  
 
A solution of 32 (6.3 g, 6.7 mmol) and KOH (1.1 g, 20.1 mmol) in ethanol 
(40 mL) and water (40 mL) was heated under reflux overnight. Subsequently, 
the solution was acidified to pH = 2, cooled and extracted with CH2Cl2 (3 x 
50 mL). The CH2Cl2 layer was washed with brine. Drying over MgSO4, 
evaporating in vacuo and drying over P2O5 afforded the pure compound 34 
(6.3 g, 6.7 mmol, quant.).  
 
1H NMR (400 MHz, CDCl3) δ = 7.36 (s, 2H, H-benzoyl), 4.20 (t, 4H, 
m-OCH2CH2O), 4.22 (t, 2H, p-OCH2CH2O), 3.84 (t, J = 4.9, 4H, 
m-OCH2CH2O), 3.78 (t, J = 5.0, 2H, p-OCH2CH2O), 3.75-3.51 (m, 56H, 
OCH2CH2O), 3.39 (d, 2H, OCH2CH2N3), 3.38 (s, 6H, OCH3);  
13C NMR (101 MHz, CDCl3) δ = 169.1, 152.5, 143.3, 110.2, 72.6-69.2, 59.2, 
50.9;  
HPLC: Rt = 7.25 min;  
MS (ESI): calcd. for [C41H73N3O20 + NH4]+ m/z = 945.51 found m/z = 945.37. 
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3’-(4-{2[-2-(2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-
ethoxy]-benzoylamino)-2,2’-bipyridine-3-amine (38) 
 
H2N N
N
N
H
O
OR2
OR1
OR1
O O O OOR1 =
O O O OOR2 = N3
 
A solution of oxalyl chloride (132 mg, 1.10 mmol, 0.1 mL) in dry CH2Cl2 (2 mL) 
containing a catalytic amount of DMF was added dropwise to a solution of 34 
(852 mg, 0.92 mmol) in dry CH2Cl2 (3 mL) at 0 °C. The reaction mixture was 
stirred overnight at rt in the absence of light. Evaporating the solvent in vacuo 
afforded the crude product 36 (1.33 g, 1.5 mmol, 94%). This product was 
dissolved in dry CH2Cl2 (8 mL) and added dropwise to a stirred solution of 2,2’-
bipyridyl-3,3’-diamine 4 (258 mg, 1.43 mmol) and triethylamine (0.17 mL, 1.22 
mmol) in dry CH2Cl2 (8 mL), while the temperature was kept below 5 °C. After 
stirring for 3 h the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography (silica, ethylacetate followed by 5% 
methanol in chloroform) and size exclusion chromatography. Drying over P2O5 
gave compound 38 (753 mg, 0.69 mmol, 62%).  
 
1H NMR (400 MHz, CDCl3) δ =  9.01 (d, 1H, H-4’), 8.35 (d, 1H, H-6’), 8.00 (dd, 
J = 1.5, 4.4, 1H, H-6), 7.32 (d, 1H, H-5’), 7.31 (s, 2H, H-benzoyl), 7.19 (m, 2H, 
H-4 and H-5), 4.23 (t, 4H, m-OCH2CH2O), 4.21 (t, 2H, p-OCH2CH2O), 3.85 (t, 
4H, m-OCH2CH2O), 3.78 (t, 2H, p-OCH2CH2O), 3.73-3.56 (m, 46H, 
OCH2CH2O), 3.50 (dd, 4H, OCH2CH2O), 3.35 (t, 2H, p- OCH2CH2N3), 3.32 (s, 
6H, m-OCH3);  
13C NMR (101 MHz, CDCl3) δ = 165.6, 152.8, 152.5, 145.0, 144.0, 141.9, 
141.7, 135.7, 134.0, 130.2, 126.2, 125.3, 124.5, 123.1, 107.7, 72.3, 71.8, 70.7-
70.4, 69.9, 69.6, 69.2, 58.9, 50.6;  
HPLC: Rt = 8.34 min;  
MS (ESI): calcd. for [C51H81N7O19 + H]+ m/z = 1096.56 found m/z = 1096.47. 
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N,N’,N’’-Tris{3[3’-(4-{2[-2-(2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-
ethoxy}-ethoxy)-ethoxy]-benzoylamino]-2,2’-bipyridyl}benzene-1,3,5-
tricarboxamide (18)  
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N
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To a solution of 38 (0.7 g, 0.64 mmol) and triethylamine (0.1 mL, 0.8 mmol) in 
dry CH2Cl2 (8 mL), a solution of trimesic chloride (53 mg, 0.19 mmol) in dry 
CH2Cl2 (4 mL) was added dropwise at room temperature. Stirring was 
continued overnight, after which the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (silica, 5% methanol in 
chloroform) and size exclusion chromatography (in CH2Cl2). Drying over P2O5 
afforded 0.25 g of 18 (0.07 mmol, 39%).  
 
1H NMR (600 MHz, CDCl3) δ =  15.41 (s, 3H, NHCO), 14.36 (s, 3H, NH’CO), 
9.57 (br, 3H, H-4), 9.36 (d, J = 7.8, 3H, H-4’ ), 9.25 (s, 3H, o-H), 9.03 (br, 3H, 
H- 6’), 8.52 (br, 3H, H-6), 7.57 (br, 6H, H-5 and H-5’), 7.35 (s, 6H, H-benzoyl), 
4.26 (t, 12H, m-OCH2CH2O), 4.26 (t, 6H, p-OCH2CH2O), 3.90 (t, J = 4.8, 12H, 
m-OCH2CH2O), 3.82 (t, 6H, p-OCH2CH2O), 3.79-3.47 (m, 150H, OCH2CH2O), 
3.37 (t, 6H, p- OCH2CH2N3), 3.34 (s, 18H, m-OCH3);  
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13C NMR (151 MHz, CDCl3) δ = 165.9, 164.4, 152.7, 142.6, 142.3, 141.7, 
141.5, 137.7, 137.6, 135.8, 130.7, 130.5, 130.0 129.9, 124.9, 124.7, 108.3, 
72.7-69.6, 59.5, 50.3, 29.9;  
MS (MALDI-TOF): calcd. for [C162H243N21O60 + Na]+ m/z = 3465.7, found m/z = 
3464.9. 
 
5.2.5 Synthesis of the Amine Modified Discotic Scaffold 
 
Methyl-4-{2[-2-(2-{2-[2-(2-tert-butoxycarbonylamino-ethoxy)-ethoxy]-
ethoxy}-ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-
ethoxy]-ethoxy}-ethoxy)-ethoxy]-benzoat (33) 
 
OR2
OR1
OR1
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1 =
R2 = O O O HNO O
O
O
 
 
A mixture of 26 (5.60 g, 10.5 mmol), 31 (6.52 g, 10.0 mmol) and K2CO3 (17.11 
g, 124 mmol) was stirred 4 h at 100 °C in dry DMF (100 mL). The reaction 
mixture was poured into water (150 mL) and extracted with CH2Cl2 (3 x 150 
mL). The combined organic layers were washed with brine (100 mL), dried 
over MgSO4 and evaporated in vacuo. The crude product was purified by 
column chromatography (alumina, 1% ethanol in chloroform) affording pure 
compound 33 (9.57 g, 9.4 mmol, 90%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.26 (s, 2H, H-benzoyl), 5.01 (br, 1H, NH), 4.18 
(t, 4H, m-OCH2CH2O), 4.16 (t, 2H, p-OCH2CH2O), 4.07 (t, 2H, m-OCH2CH2O), 
3.85 (s, 3H, COOCH3), 3.83 (t, 4H, p-OCH2CH2O), 3.79-3.45 (m, 46H, 
OCH2CH2O), 3.34 (s, 6H, OCH3), 3.27 (d, 2H, OCH2CH2NHboc), 1.41 (s, 9H, 
OC(CH3)3); 
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13C NMR (101 MHz, CDCl3) δ = 171.3, 152.3, 144.6, 127.0, 109.1, 71.9, 
70.8-70.2, 69.6, 68.9, 59.0, 28.4; 
HPLC: Rt = 8.16 min;  
MS (ESI): calcd. for [C47H85NO22 + NH4]+ m/z = 1033.59 found m/z = 1033.33. 
 
 
4-{2[-2-(2-{2-[2-(2-tert-butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-
ethoxy}-ethoxy)-ethoxy]-benzoic acid (35) 
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A solution of 33 (9.57 g, 9.4 mmol) and KOH (5.4 g, 28.1 mmol) in ethanol 
(40 mL) and water (40 mL) was heated under reflux overnight. Subsequently, 
the solution was acidified to pH = 2, cooled and extracted with CH2Cl2 (4 x 
100 mL). The CH2Cl2 layer was washed with brine (70 mL). Drying over 
MgSO4, evaporating in vacuo and drying over P2O5 afforded the pure 
compound 35 (8.81 g, 8.8 mmol, 94%).  
 
1H NMR (400 MHz, CDCl3) δ = 7.35 (s, 2H, H-benzoyl), 4.23 (t, 4H, 
m-OCH2CH2O), 4.19 (t, 2H, p-OCH2CH2O), 3.85 (t, 4H, m-OCH2CH2O), 3.82 
(t, 2H, p-OCH2CH2O), 3.79-3.49 (m, 90H, OCH2CH2O), 3.36 (s, 6H, OCH3), 
3.30 (d, 2H, OCH2CH2NHboc), 1.43 (s, 9H, OC(CH3)3); 
13C NMR (101 MHz, CDCl3) δ = 161.5, 156.3, 142.8, 124.6, 98.3, 72.0, 70.9-
69.8, 59.0, 28.4; 
HPLC: Rt = 7.41 min;  
MS (ESI): calcd. for [C46H83NO22 + NH4]+ m/z = 1019.57 found m/z = 1019.31. 
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3’-(4-{2[-2-(2-{2-[2-(2-tert-butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-
ethoxy}-ethoxy)-ethoxy]-benzoylamino)-2,2’-bipyridine-3-amine (39) 
 
O O O OOR
1 =
R2 = O O O HNO O
O
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N
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A solution of oxalyl chloride (330 mg, 2.6 mmol, 0.22 mL) in dry CH2Cl2 (5 mL) 
containing a catalytic amount of DMF (3 drops) was added dropwise to a 
solution of 35 (2.17 g, 2.17 mmol) in dry CH2Cl2 (5 mL). The reaction mixture 
was stirred overnight at rt in the absence of light. Evaporating the solvent in 
vacuo afforded the crude product 37 (2.38 g, 2.17 mmol, quant.). This product 
was dissolved in dry CH2Cl2 (25 mL) and added dropwise to a stirred solution 
of 2,2’-bipyridyl-3,3’-diamine 4 (504 mg, 2.7 mmol) and triethylamine (0.17 mL, 
1.22 mmol) in dry CH2Cl2 (25 mL) within 1.5 h, while the temperature was kept 
below 5 °C. After stirring for 2 h the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (silica, ethylacetate 
followed by 5% methanol in chloroform) and size exclusion chromatography to 
yield 39 (1.34 g, 1.14 mmol, 52%) containing an impurification. Some amount 
(500 mg) of the crude was purified by preparative HPLC (10-50% acetonitrile 
in water) resulting pure 39. 
 
1H NMR (400 MHz, CDCl3) δ = 9.19 (dd, J = 8.4 and 1.4, 1H, H-4’), 8.31 (dd, 
J = 4.5 and 1.4, 1H, H-6’), 8.02 (t, J = 2.9, 1H, H-6), 7.30 (s, 2H, H-benzoyl), 
7.28 (m, 1H, H-5’), 7.13 (d, J = 2.9, 2H, H-4 and H-5), 5.05 (s, 1H, NH), 4.24 (t, 
4H, m-OCH2CH2O), 4.23 (t, 4H, p-OCH2CH2O), 3.86 (t, 4H, m-OCH2CH2O), 
3.80 (t, 2H, p-OCH2CH2O), 3.72-3.50 (m, 46H, OCH2CH2O), 3.34 (s, 6H, 
m-OCH3), 3.28 (d, 2H, OCH2CH2NHboc), 1.42 (s, 9H, OC(CH3)3); 
HPLC: Rt = 7.92 min;  
MS (ESI): calcd. for [C56H91NO21 + H]+ m/z = 1170.63 found m/z = 1170.37. 
5. Experimental 
125 
 
N,N’,N’’-Tris{3[3’-(4-{2[-2-(2-{2-[2-(2-tert-butoxycarbonylamino-ethoxy)-
ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-
methoxyethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-benzoylamino]-2,2’-
bipyridyl}benzene-1,3,5-tricarboxamide (19a)  
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To a solution of 39 (375 mg, 0.32 mmol) and triethylamine (55 µL, 0.4 mmol) in 
dry CH2Cl2 (6 mL), a solution of trimesic chloride (26.5 mg, 0.10 mmol) in dry 
CH2Cl2 (4 mL) was added dropwise at room temperature. Stirring was 
continued overnight, after which the solution was diluted with CH2Cl2 (10 mL) 
and washed with water (2 x 10 mL). The combined water layers were extracted 
with CH2Cl2 (4 x 15 mL). The combined dichloromethane layers were washed 
with brine (10 mL), dried over MgSO4 and evaporated in vacuo. The crude 
product was purified by size exclusion chromatography (in CH2Cl2), column 
chromatography (silica, 10% methanol with 1% triethylamine in chloroform) 
and size exclusion chromatography (in CH2Cl2). Drying over P2O5 afforded 19a 
(210 mg, 57 µmol, 57%).  
 
1H NMR (400 MHz, CDCl3) δ = 15.52 (s, 3H, NHCO), 14.35 (s, 3H, NH’CO), 
9.60 (dd, J = 8.5 and 1.4, 3H, H-4), 9.40 (dd, J = 8.6 and 1.5, 3H, H-4’), 9.29 
(s, 3H, o-H), 9.06 (dd, J = 4.6 and 1.4, 3H, H-6’), 8.52 (dd, J = 4.6 and 1.5, 3H, 
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H-6), 7.57 (dd, J = 8.6 and 4.6, 6H, H-5 and H-5’), 7.36 (s, 6H, H-benzoyl), 
4.29 (t, 12H, m-OCH2CH2O), 4.27 (t, 6H, p-OCH2CH2O), 3.91 (t, J = 4.9, 12H, 
m-OCH2CH2O), 3.91 (m, 6H, p-OCH2CH2O), 3.74-3.48 (m, 150H, OCH2CH2O), 
3.35 (s, 18H, m-OCH3), 3.31 (d, 6H, p- OCH2CH2NHboc), 1.44 (s, 27H, 
OC(CH3)3). 
13C NMR (151 MHz, CDCl3) δ = 169.1, 166.0, 164.9, 153.0, 142.6, 142.0, 
141.8, 141.7, 137.8, 135.2, 132.0, 131.8, 130.2, 128.8, 128.7, 124.9, 124.6, 
108.3, 72.7-69.6, 59.2, 46.0, 28.7, 8.8. 
MS (MALDI-TOF): calcd. for [C177H273N15O66 + Na]+ m/z = 3688.9, found m/z = 
3689.0.  
 
 
N,N’,N’’-Tris{3[3’-(4-{2[-2-(2-{2-[2-(2-amino-ethoxy)-ethoxy]-ethoxy}-
ethoxy)-ethoxy]-ethyl}-3,5-bis[2-(2-{2-[2-(2-methoxyethoxy)-ethoxy]-
ethoxy}-ethoxy)-ethoxy]-benzoylamino]-2,2’-bipyridyl}benzene-1,3,5-
tricarboxamide (19)  
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19a (200 mg, 54 µmol) and trifluoracetic acid (1 mL) in CH2Cl2 (3 mL) were 
stirred for 3 h. Toluene (3 mL) was added and the solvents were evaporated in 
vacuo. The crude product was purified by size exclusion chromatography (in 
CH2Cl2) affording 19 (186 mg, 54 µmol, quant.). 
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1H NMR (400 MHz, CDCl3) δ = 15.43 (s, 3H, NHCO), 14.45 (s, 3H, NH’CO), 
9.57 (d, J = 8.4, 3H, H-4), 9.32 (d, J = 8.4, 3H, H-4’), 9.19 (s, 3H, o-H), 9.03 (d, 
J = 4.1, 3H, H-6’), 8.45 (s, 3H, H-6), 7.55 (br, 6H, H-5 and H-5’), 7.30 (s, 6H, 
H-benzoyl), 4.27 (br, 12H, m-OCH2CH2O), 4.26 (br, 6H, p-OCH2CH2O), 3.91 
(br, 12H, m-OCH2CH2O), 3.84 (br, 6H, p-OCH2CH2O), 3.77-3.49 (m, 150H, 
OCH2CH2O), 3.33 (s, 18H, m-OCH3), 3.21 (br, 6H, p- OCH2CH2NH2);  
13C NMR (151 MHz, CDCl3) δ =  169.1, 164.7, 152.8, 141.8, 141.7, 141.1, 
140.7, 139.5, 137.7, 135.2, 131.4, 131.2, 130.2, 129.7, 127.5, 124.9, 124.7, 
107.5, 89.5, 72.7-69.3, 67.2, 59.2, 40.4, 29.9. 
MS (MALDI-TOF): calcd. for [C162H249N15O60 + H]+ m/z = 3387.63, found m/z = 
3388.71.  
 
 
5.2.6 Synthesis of the Glycosidic Ligands (Chapter 3.2.1) 
 
1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranosid (40) 
 
O
O O
O
O
O
O
O
O
O
O
 
 
To a solution of D(+)-mannose (2.05 g, 11.1 mmol) in pyridine (20 mL) acetic 
anhydride (40 mL, 420 mmol) was added tropwise at 0 °C. The mixture was 
stirred overnight at rt and the solvent was co-evaporated in vacuo using 
toluene. Purification by column chromatography (silica, 20% ethylacetate in 
cyclohexane) yielded 40 (4.04 g, 10.4 mmol, 93%).  
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1H NMR (400 MHz, CDCl3) δ = 6.06 (d, J = 1.9, 1H), 5.35-5.30 (m, 2H), 5.24 (t, 
J = 2.2, 1H), 4.33-4.19 (m, 1H), 4.16-3.97 (m, 3H), 2.15 (d, J = 3.2, 6H), 2.07 
(s, 3H), 2.03 (s, 3H), 1.98 (s, 3H);  
13C NMR (101 MHz, CDCl3) δ = 170.8, 170.2, 169.9, 169.7, 168.3, 90.8, 70.8, 
69.0, 68.6, 65.8, 62.3, 21.1, 21.0, 20.9, 20.9, 20.8;  
HPLC: Rt = 8.05 min;  
MS (ESI): calcd. for [C16H22O11 + NH4]+ m/z = 408.12 found m/z = 407.89. 
 
 
1-Propargyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranosid (41)[76] 
 
O
O O
O
O
O
O
O
O
O  
A solution of 40 (4.02 g, 10.3 mmol) and SnCl4 (1.2 ml, 10.3 mmol) in CH2Cl2 
(17 mL) was stirred for 30 min. Subsequently 2-propargylalcohol (0.9 mL, 
15.4 mmol) was added and stirred for another 4 h. The reaction mixture was 
washed with NaHCO3 (5% in water, 25 mL). The aqueous layer was extracted 
with CH2Cl2 (3 x 25 mL). The combined organic layers were washed with 1N 
HCl (50 mL) and brine (50 mL), dried over MgSO4 and evaporated in vacuo. 
Purification by column chromatography (silica, 30% ethylacetate in 
cyclohexane) yielded 41 (2.15 g, 5.6 mmol, 54 %).  
 
1H NMR (400 MHz, CDCl3) δ = 5.36-5.24 (m, 3H), 5.02 (d, J = 1.8, 1H), 
4.30-4.23 (m, 3H), 4.10 (dd, J = 2.5, 12.2, 1H), 4.01 (ddd, J = 2.4, 5.2, 9.2, 
1H), 2.46 (q, J = 2.8, OCH2CCH, 1H), 2.15 (s, 3H, COCH3), 2.09 (s, 3H, 
COCH3), 2.03 (s, 3H, COCH3), 1.98 (s, 3H, COCH3);  
13C NMR (101 MHz, CDCl3) δ = 170.9, 170.2, 170.1, 169.9, 96.5, 78.1, 77.4, 
75.8, 69.6, 69.2, 69.2, 66.3, 55.2, 21.1, 21.0, 20.9, 20.9;  
HPLC: Rt = 8.93 min;  
MS (ESI): calcd. for [C17H22O10 + NH4]+ m/z = 404.15 found m/z = 404.00. 
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1-Propargyl-α-D-mannopyranosid (42)[76] 
 
O
O OH
OH
OH
HO
 
 
To a solution of 41 (2 g, 5.18 mmol) in methanol (10 mL) a catalytic amount of 
sodium-methanolat was added. The reaction was stirred for 3 h at rt. 
Subsequently the solution was filtered through celite®. The solvent was 
evaporated in vacuo to yield 1.13 g (5.18 mmol, quant.) of crude 42. A small 
amount (200 mg) of the crude was purified by preparative HPLC (10-50% 
acetonitrile in water) resulting compound 42.  
 
1H NMR (400 MHz, D2O)  δ = 4.90 (d, J = 1.8, 1H, H-1α), 4.20 (dq, J = 15.9 
and 2.4, 2H, OCH2CCH), 3.82 (dd, J = 3.4 and 1.8, 1H, H-2), 3.75 (dd, J = 12.2 
and 1.9, 1H, H-4), 3.68 -3.60 (m, 2H, H-3 and H-5), 3.58-3.49 (m, 2H, CH2OH), 
2.79 (t, J = 2.4, 1H, OCH2CCH);  
13C NMR (101 MHz, CDCl3) δ = 98.9, 79.0, 76.3, 73.3, 70.6, 70.1, 66.8, 61.0, 
54.7;  
HPLC: Rt = 2.39 min;  
MS (ESI): calcd. for [C9H14O6 + NH4]+ m/z = 236.11 found m/z = 235.95. 
 
 
1,2,3,4,6-Penta-O-acetyl-α,β-D-galactopyranosid (43) 
 
O
O
O
O
O
O
O
O
O
OO  
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To a solution of D(+)-galactose (21 g, 117 mmol) in pyridine (105 mL) acetic 
anhydride (150 mL, 1.6 mol) was added tropwise at 0 °C. The mixture was 
stirred overnight at rt and the solvent was co-evaporated in vacuo using 
toluene. Purification by column chromatography (silica, 20% ethylacetate in 
cyclohexane) yielded the pure compound as colorless oil (41.13 g, 105 mmol, 
90%).  
 
1H NMR (400 MHz, CDCl3) δ = 6.37 (d, 1H, J = 2.0, H-1α), 5.69 (d,1H, J = 8.0, 
H-1β), 5.49 (dd, 1H, J = 2.8 and 1.2, H-3), 5.34 (m, 2H, H-2 and H-4), 
4.32-4.35 (m, 1H, H-5),  4.07-4.13 (m, 2H, H-6a and H-6b), 2.15 (d, J = 3.2, 
6H, COCH3), 2.03 (s, 3H, COCH3), 2.01 (s, 3H, COCH3), 2.00 (s, 3H, COCH3);  
13C NMR (101 MHz, CDCl3) δ = 170.3, 170.1, 170.1, 169.8, 168.9, 89.7, 68.7, 
67.4, 67.3, 66.4, 61.2, 20.8, 20.6, 20.6, 20.5, 20.5;  
TLC (25 % ethylacetate in cyclohexane): Rf = 0.77; 
HPLC: Rt = 8.12 min;  
MS (ESI): calcd. for [C16H22O11 + NH4]+ m/z = 408.12 found m/z = 407.93. 
 
 
1-Propargyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranosid (44)[76] 
 
O
O
O
O
O
O
O
O
O
O  
 
A solution of 43 (5.0 g, 13 mmol) and SnCl4 (1.4 ml, 13 mmol) in CH2Cl2 
(20 mL) was stirred for 1 h. Subsequently 2-propargylalcohol (1.5 mL, 
20 mmol) was added and stirred for another 12 h. The reaction mixture was 
washed with NaHCO3 (5% in water, 25 mL). The aqueous layer was extracted 
with CH2Cl2 (3 x 75 mL). The combined organic layers were washed with 1N 
HCl (50 mL) and brine (50 mL), dried over MgSO4 and evaporated in vacuo. 
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Purification by column chromatography (silica, 30% ethylacetate in 
cyclohexane) yielded 44 (2.17 g, 5.6 mmol, 46%).  
 
1H NMR (400 MHz, CDCl3) δ = 5.40 (d, J = 3.2, 1H, H-4), 5.22 (d, J = 7.7, 1H, 
H-2), 5.06 (dd, J = 10.0 und 3.2, 1H, H-3), 4.73 (d, J = 7.6, 1H, H-1β), 4.38 (d, 
J = 2.4, 2H, OCH2CCH), 4.16 (m, 2H, H-6b and H-5), 3.94 (t, J = 6.4, 1H, 
H-6a), 2.46 (q, J = 2.4, OCH2CCH, 1H), 2.16 (s, 3H, COCH3), 2.08 (s, 3H, 
COCH3), 2.06 (s, 3H, COCH3), 1.99 (s, 3H, COCH3);  
13C NMR (101 MHz, CDCl3) δ = 170.9, 170.7, 170.5, 170.1, 98.9, 75.6, 71.1, 
71.0, 68.8, 67.3, 61.5, 56.1, 21.0, 20.9, 20.8, 20.7;  
TLC (30 % ethylacetate in cyclohexane): Rf = 0.3; 
HPLC: Rt = 9.04 min;  
MS (ESI): calcd. for [C17H22O10 + NH4]+ m/z = 404.15 found m/z = 404.06. 
 
 
1-Propargyl-β-D-galactopyranosid (45)[76] 
 
O
OH
OH
HO
HO
O
 
 
To a solution of 44 (375 mg, 0.97 mmol) in methanol (abs., 3.5 mL) a catalytic 
amount of sodium-methanolat was added. The reaction was stirred for 12 h at 
rt. Subsequently the solution was filtered through celite®. The solvent was 
evaporated in vacuo to yield 209.4 mg (0.96 mmol, 98%) of crude 45. A small 
amount (100 mg) of the crude was purified by preparative HPLC (10-50% 
acetonitrile in water) resulting pure compound 45.  
 
1H NMR (400 MHz, CDCl3) δ = 4.46 (d, J = 8.0, 1H, H-1β), 3.97 (dd, J = 9.6 
and 3.2, 1H, H-3), 3.82 (dd, J = 3.2 and 0.8, 1H, H-4), 3.66 (d, J = 12.4 and 
4.0, 1H, H-6b), 4.38 (d, J = 1.8, 2H, OCH2CCH), 3.57-3.61 (m, 1H, H-5), 3.54 
(m, J = 12.4 and 7.2, 1H, H-6a), 3.51-3.44 (m, 2H, CH2OH), 3.42 (t, J = 9.6 
and 8.0, 1H, H-2), 2.79 (t, J = 2.4, 1H, OCH2CCH); 
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TLC (30 % ethylacetate in cyclohexane): Rf = 0.0; 
HPLC: Rt = 2.21 min;  
MS (ESI): calcd. for [C9H14O6 + NH4]+ m/z = 236.11 found m/z = 235.98. 
 
 
1,2,3,4,6-Penta-O-acetyl-α,β-D-glucopyranosid (46) 
 
O
O
O
O O
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O
O
O
O
O  
 
To a solution of D(+)-glucose (20.0 g, 111 mmol) in pyridine (100 mL) acetic 
anhydride (140 mL, 1.5 mol) was added tropwise at 0 °C. The mixture was 
stirred overnight at rt and the solvent was co-evaporated in vacuo using 
toluene. The crude compound was recrystallized (10% ethylacetate in 
cyclohexane) to yield pure 46 as colorless crystalls (42.0 g, 108 mmol, 97%).  
 
1H NMR (400 MHz, CDCl3) δ = 6.32 (d, 1H, J = 3.6, H-1α), 5.70 (d, 1H, J = 8.0, 
H-1β), 5.46 (t, 1H, J = 10.0, H-3), 5.12-5.15 (m, 1H, H-4), 5.09 (dd, 1H, 
J = 10.0 and 3.6, H-2), 4.25 (dd, 1H, J = 12.4 and 4.0, H-6b), 4.08 (dd, 1H, 
J = 12.4 and 2.0, H-6a), 3.38 (ddd, 1H, J = 10.0, 4.0 and 2.0, H-5), 2.15 (s, 3H, 
COCH3), 2.08 (s, 3H, COCH3), 2.03 (s, 3H, COCH3), 2.02 (s, 3H, COCH3), 
2.00 (s, 3H, COCH3);  
13C NMR (101 MHz, CDCl3) δ = 170.8, 170.4, 169.8, 169.6, 168.9, 89.3, 70.0, 
70.0, 69.4, 68.1, 61.7, 21.1, 20.9, 20.9, 20.8, 20.6;  
TLC (25 % ethylacetate in cyclohexane): Rf = 0.75; 
HPLC: Rt = 8.06 min;  
MS (ESI): calcd. for [C16H22O11 + NH4]+ m/z = 408.12 found m/z = 407.97. 
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1-Propargyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosid (47)[76] 
 
O
O
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O
O
O
O
O
O
 
 
A solution of 46 (5.0 g, 13 mmol) and SnCl4 (1.4 ml, 13 mmol) in CH2Cl2 
(20 mL) was stirred for 1 h. Subsequently 2-propargylalcohol (1.5 mL, 
20 mmol) was added and stirred for another 12 h. The reaction mixture was 
washed with NaHCO3 (5% in water, 25 mL). The aqueous layer was extracted 
with CH2Cl2 (3 x 75 mL). The combined organic layers were washed with 1N 
HCl (50 mL) and brine (50 mL), dried over MgSO4 and evaporated in vacuo. 
Purification by column chromatography (silica, 30% ethylacetate in 
cyclohexane) yielded 47 (2.6 g, 7.0 mmol, 54%).  
 
1H NMR (400 MHz, CDCl3) δ = 5.24 (t, J = 9.6, 1H, H-3), 5.08-5.16 (m, 1H, 
H-4), 5.01 (dd, J = 9.6 and 8.0, 1H, H-2), 4.77 (d, J = 8.0, 1H, H-1β), 4.37 (d, 
J = 2.4, 2H, OCH2CCH), 4.24-4.29 (m, 1H, H-6b), 4.14 (dd, 1H, J = 12.0 and 
2.4, H-6a), 3.72 (ddd, J = 10.0, 4.4 and 2.4, 1H, H-5), 2.46 (t, J = 2.4, 1H, 
OCH2CCH), 2.09 (s, 3H, COCH3), 2.03 (s, 3H, COCH3), 2.02 (s, 3H, COCH3), 
2.01 (s, 3H, COCH3);  
13C NMR (101 MHz, CDCl3) δ = 170.6, 170.2, 169.6, 168.7, 98.1, 89.0, 75.4, 
69.8, 69.1, 67.9, 61.4, 55.9, 29.8, 20.6, 20.5, 20.4;  
TLC (30 % ethylacetate in cyclohexane): Rf = 0.36; 
HPLC: Rt = 9.11 min;  
MS (ESI): calcd. for [C17H22O10 + NH4]+ m/z = 404.15 found m/z = 404.11. 
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1-Propargyl-β-D-glucopyranosid (48)[76] 
 
O
OH
OHO
HO
OH
 
 
To a solution of 47 (2.0 g, 5.2 mmol) in methanol (abs., 19 mL) a catalytic 
amount of sodium-methanolat was added. The reaction was stirred for 4 h at 
rt. Subsequently the solution was filtered through celite®. The solvent was 
evaporated in vacuo to yield 1.1 g (5 mmol, 96%) of crude 48. A small amount 
(200 mg) of the crude was purified by preparative HPLC (10-50% acetonitrile 
in water) resulting pure compound 48.  
 
1H NMR (400 MHz, CDCl3) δ = 4.53 (d, J = 8.0, 1H, H-1β), 4.36 (d, J = 2.4, 2H, 
OCH2CCH), 3.81 (d, J = 12.4 and 2.0, 1H, H-6b), 3.61 (dd, J = 12.4 and 6.0, 
1H, H-6a), 3.39 (t, J = 9.0, 1H, H-4), 3.34-3.38 (m, 1H, H-5), 3.28 (t, J = 9.0, 
1H, H-3), 3.42 (dd, J = 9.0 and 8.0, 1H, H-2), 2.81 (t, J = 2.4, 1H, OCH2CCH); 
13C NMR (101 MHz, CDCl3) δ = 101.8, 76.5, 76.2, 73.1, 69.8, 69.6, 62.3, 60.9, 
56.7;  
TLC (30 % ethylacetate in cyclohexane): Rf = 0.0; 
HPLC: Rt = 2.21 min;  
MS (ESI): calcd. for [C9H14O6 + NH4]+ m/z = 236.11 found m/z = 236.07. 
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5.2.7 Synthesis of Functionalized Discotics (3.2) 
 
Mannose Discotic (49) (Chapter 3.2.1 ) 
 
O O O OOR1 =
RO
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A solution of 18 (10 mg, 3 µmol) and 42 (30 mg, 140 µmol) in water (50 µL) 
and t-butanol (50 µl) with catalytic amounts of sodium-ascorbate (5 mol-%) and 
CuSO4 (2 mol-%) was stirred at rt for 4 weeks. The crude product was purified 
by size exclusion chromatography (in CH2Cl2) followed by repeated size 
exclusion chromatography (in DMF). Drying over P2O5 afforded of 49 (12 mg, 
2.5 µmol, 80%).  
 
1H NMR (400 MHz, CDCl3) δ = 14.56 (s, 3H, NHCO), 13.56 (s, 3H, NH’CO), 
8.74 (br, 3H, H-4), 8.48 (br, 3H, H-4’), 8.22 (s, 3H, o-H), 8.07 (br, 3H, H-6’), 
7.65 (br, 3H, H-6), 7.39 (s, 6H, H-5 and H-5’), 7.2 (s, 6H, H-benzoyl), 4.13 (m, 
12H, m-OCH2CH2O), 4.02 (m, 6H, p-OCH2CH2O), 3.85 (m, 12H, m-OCH2CH2), 
3.75 (m, 6H, mannose-H), 3.61-3.38 (m, 21H, mannose-H and p-OCH2CH2), 
3.26-2.57 (m, 183H, OCH2CH2O), 2.50 (s, 18H, m-OCH3);  
MS (MALDI-TOF): calcd. for [C189H285N21O78 + H]+ m/z = 4096.9, found m/z = 
4098.1. 
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Galactose Discotic (50) (Chapter 3.2.1 ) 
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A solution of 18 (2.1 mg, 0.6 µmol) and 45 (10 mg, 46 µmol) in water (50 µL) 
and t-butanol (50 µl) with catalytic amounts of sodium-ascorbate (5 mol-%) and 
CuSO4 (2 mol-%) was stirred at rt for 4 weeks. The crude product was purified 
by size exclusion chromatography (in CH2Cl2) followed by repeated size 
exclusion chromatography (in DMF). Drying over P2O5 afforded of 50 (1.9 mg, 
0.5 µmol, 78%).  
 
MS (MALDI-TOF): calcd. for [C189H285N21O78 + NH4]+ m/z = 4118.6, found m/z 
= 4116.7. 
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Glucose Discotic (51) (Chapter 3.2.1 ) 
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A solution of 18 (1.9 mg, 0.6 µmol) and 48 (10 mg, 46 µmol) in water (50 µL) 
and t-butanol (50 µl) with catalytic amounts of sodium-ascorbate (5 mol-%) and 
CuSO4 (2 mol-%) was stirred at rt for 4 weeks. The crude product was purified 
by size exclusion chromatography (in CH2Cl2) followed by repeated size 
exclusion chromatography (in DMF). Drying over P2O5 afforded of 51 (1.5 mg, 
0.4 µmol, 61%).  
 
MS (MALDI-TOF): calcd. for [C189H285N21O78 + H]+ m/z = 4096.9, found m/z = 
4098.1. 
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Texas Red Discotic (52) (Chapter 3.2.2) 
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To a solution of 19 (2.5mg, 0.8 µmol) in CH2Cl2 (0.3 mL) Texas Red®-X 
succinimidyl ester (2.5 mg, 3 µmol) was slowly added. After stirring for 30 min, 
triethylamine (5 µL) was added to the mixture and stirring was continued. The 
reaction was monitored by MALDI-TOF MS. After 4 days additional Texas 
Red®-X succinimidyl ester (2 mg, 2.5 µmol) and triethylamine (8 µL) was 
added. After 2 weeks no further conversion of intermediates could be 
observed. The solvent was evaporated in vacuo and the crude product was 
purified by size exclusion chromatography (in CH2Cl2) affording 52 with its side 
products. 
 
Triacylated compound: Exact Mass: 5468.4 
MS (MALDI-TOF): calcd. for [C273H366N24O81S6 + K]+ m/z = 5508.3 found m/z = 
5509.4; 
Diacylated compound: Exact Mass: 4767.1 
MS (MALDI-TOF): calcd. for [C236H327N21O74S4 + Na]+ m/z = 4790.1 found m/z 
= 4790.6;  
Monoacylated compound: Exact Mass: 4065.9 
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MS (MALDI-TOF): calcd. for [C199H288N18O67S2 + Na]+ m/z = 4088.9 found m/z 
= 4090.0. 
 
 
Biotin Discotic (53) (Chapter 3.2.3) 
 
O
S
NHHN
O
RO
H
N
O R
N
N
N
H
O
R2O
R1O
OR1
O
R =
O O O OOR1 =
R2 = O HN O HN
5 O 4
 
 
To a solution of 19 (5 mg, 1.5 µmol) in CH2Cl2 (0.3 mL) BiotinPEO4-NHS 
(8 mg, 13.5 µmol) was slowly added. After stirring for 1 h, triethylamine (8 µL) 
was given dropwise to the mixture and stirred for another 4 h. The reaction 
was monitored by MALDI-TOF MS. After 4 h only traces of mono- and double-
acylated side products were left. After adding more BiotinPEO4-NHS (3 mg, 
5.0 µmol) and stirring for another 24 h no change could be observed. The 
solvent was evaporated in vacuo and the crude product was purified by size 
exclusion chromatography (in DMF) affording 53 (4.6 mg, 1 µmol, 65%). 
 
1H NMR (500 MHz, CDCl3) δ = 15.32 (s, 3H, NHCO), 14.28 (s, 3H, NH’CO), 
9.60 (d, J = 8.0, 3H, H-4), 9.39 (d, J = 8.8, 3H, H-4’), 9.29 (s, 3H, o-H), 9.06 (d, 
J = 3.7, 3H, H-6’), 8.53 (d, J = 4.8, 3H, H-6), 7.57 (dd, J = 2.7, 7.2, 6H, H-5 and 
H-5’), 7.36 (s, 6H, H-benzoyl), 4.50 (m, 3H, biotin-NHCH), 4.30 (t, 12H, 
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m-OCH2CH2O), 4.29 (m, 3H, biotin-NHCH), 4.28 (t, 6H, p-OCH2CH2O), 3.91 (t, 
12H, m-OCH2CH2O), 3.83 (t, 6H, p-OCH2CH2O), 3.79-3.50 (m, 216H, 
OCH2CH2O), 3.46-3.39 (m, 12H, biotin-SCH2), 3.36 (s, 18H, m-OCH3), 
3.19-3.09 (m, 3H, biotin-SCH2), 2.55-2.41 (m, 6H, H-Alkyl), 2.27-2.14 (m, 6H, 
H-Alkyl), 1.51-1.38 (m, 6H, H-Alkyl), 1.27-1.22 (m, 6H, H-Alkyl); 
MS (MALDI-TOF): calcd. for [C225H354N24O81S3 + Na]+ m/z = 4807.34, found 
m/z = 4810.33.  
 
 
Biotin Discotic (54) (Chapter 3.2.3) 
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To a solution of 19 (5 mg, 1.5 µmol) in CH2Cl2 (0.3 mL) BiotinPEO12-NHS 
(13 mg, 13.5 µmol) was slowly added. After stirring for 1 h, triethylamine 
(10 µL) was added dropwise to the mixture and stirred for another 4 h. The 
reaction was monitored by MALDI-TOF MS. After 4 h the starting material had 
reacted completely and mono-, double- and triacylated side products could be 
found. After adding more BiotinPEO12-NHS (3 mg, 3.1 µmol) and stirring for 
another 48 h no change could be observed. The solvent was evaporated in 
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vacuo and the crude product was purified by size exclusion chromatography 
(in DMF) affording 54 with traces of side products. 
 
54 triacylated compound: Exact Mass: 5840.98 
MS (MALDI-TOF): calcd. for [C199H316N18O75S + Na]+ m/z =, found m/z = 
5846.18.  
Diacylated compound: Exact Mass: 5015.55 
MS (MALDI-TOF): calcd. for [C236H383N21O90S2 + K]+ m/z = 5055.4, found m/z 
= 5055.2. 
Monoacylated compound: Exact Mass: 4190.12 
MS (MALDI-TOF): calcd. for [C273H450N24O105S3 + Na]+ m/z = 4213.1, found 
m/z = 4211.3.  
 
 
Boc-Cys(Trt) Discotic (55) (Chapter 3.2.4) 
 
NHBoc
STrt
O
N
H
RO
H
N
O R
N
N
N
H
O
R2O
R1O
OR1
O
R =
O O O OOR
1 =
R2 = O O OO O
 
 
To a solution of 19 (10 mg, 3 µmol) in CH2Cl2 (0.3 mL) Boc-Cys(Trt)-NHS 
(10 mg, 25 µmol) was slowly added. After stirring for 30 min, triethylamine 
(8.4 µL) was added dropwise to the mixture and stirred over night. The 
reaction was monitored by MALDI-TOF MS. The solvent was evaporated in 
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vacuo and the crude product was purified by size exclusion chromatography 
(in CH2Cl2) affording 55 (12 mg, 2.5 µmol, 85%). 
 
1H NMR (400 MHz, CDCl3) δ = 15.52 (s, 3H, NHCO), 14.49 (s, 3H, NH’CO), 
9.60 (d, J = 8.5, 3H, H-4), 9.39 (d, J = 8.6, 3H, H-4’), 9.29 (s, 3H, o-H), 9.05 (d, 
J = 4.6, 3H, H-6’), 8.52 (d, J = 3.0, 3H, H- H-46), 7.57 (dd, J = 4.6, 8.5, 6H, H-5 
and H-5’), 7.40 (d, J = 7.4, 18H, H-trityl), 7.36 (s, 6H, H-benzoyl), 7.29 (d, 
J = 7.2, 18H, H-trityl), 7.21 (t, J = 7.2, 9H, H-trityl), 4.28 (t, 12H, 
m-OCH2CH2O), 4.26 (t, 6H, p-OCH2CH2O) 3.90 (t, 12H, m-OCH2CH2O), 3.83 
(t, 6H, p-OCH2CH2O), 3.77-3.47 (m, 182H), 3.39 (t, J = 5.3, 6H, 
p-OCH2CH2NHCys), 3.35 (s, 18H, m-OCH3), 2.74-2.53 (m, 6H, H-Cys), 1.41 
(s, 27H, OC(CH3)3). 
MS (MALDI-TOF): calcd. for [C243H330N18O69S3 + Na]+ m/z = 4723.19, found 
m/z = 4727.09.  
 
 
Cysteine-Discotic (56) (Chapter 3.2.4) 
 
NH2
SH
O
N
H
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H
N
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N
N
N
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O
R2O
R1O
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O
R =
O O O OOR
1 =
R2 = O O OO O
 
 
A solution of 55 (6 mg, 1.3 µmol) in CH2Cl2 (0.4 mL) with TFA (0.1 mL) and 
triethylsilane (10 µL) was stirred for 2 h. The reaction was monitored by 
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MALDI-TOF MS. The solvent was co-evaporated with toluene (3 x 2 mL) in 
vacuo and the crude product was purified by size exclusion chromatography 
(in CH2Cl2) affording 56 (4.5 mg, 1.2 µmol, 98%). 
 
1H NMR (400 MHz, CDCl3) δ = 15.52 (s, 3H, NHCO), 14.49 (s, 3H, NH’CO), 
9.60 (d, J = 8.5, 3H, H-4), 9.39 (d, J = 8.6, 3H, H-4’), 9.29 (s, 3H, o-H), 9.05 (d, 
J = 4.6, 3H, H-6’), 8.52 (d, J = 3.0, 3H, H- H-46), 7.57 (dd, J = 4.6 and 8.5, 6H, 
H-5 and H-5’), 7.36 (s, 6H, H-benzoyl), 4.28 (t, 12H, m-OCH2CH2O), 4.26 (t, 
6H, p-OCH2CH2O) 3.90 (t, 12H, m-OCH2CH2O), 3.83 (t, 6H, p-OCH2CH2O), 
3.77-3.47 (m, 182H), 3.39 (t, J = 5.3, 6H, p-OCH2CH2NHCys), 3.35 (s, 18H, 
m-OCH3), 2.74-2.53 (m, 6H, H-Cys), 1.41 (s, 27H, OC(CH3)3). 
MS (MALDI-TOF): calcd. for [C171H264N18O63S3 + Na]+ m/z = 3695.12, found 
m/z = 3692.94.  
 
 
Ligation of 56 to YFP (57) (Chapter 3.4.2) 
 
A solution of 56 (4.5 mg, 1.2 µmol) and TCEP (400 mM, pH 7) in ligation buffer 
(30 mM Na2HPO4, pH 7.5, 50 mM NaCl degassed by bubbling argon through 
the buffer) was stirred over night in order to reduce disulfide bridges of 56. This 
solution was diluted (1.5 mM 56) and 100 µL (0.15 µmol) of 56 were added to 
a solution of YFP (0.014 µmol, 50 µL in 30 mM Na2HPO4, 50 mM NaCl, 0.1 m 
MEDTA, 0.04 % NaN3,) in ligation buffer (400 µL) with MESNA (50 µL). The 
reaction mixture was incubated on a rotating wheel at rt over several days. The 
mixture was analyzed by SDS-PAGE and MALDI-TOF MS spectrometry. 
 
MS (MALDI-TOF): calcd. for [YFP + C171H264N18O63S3 + Na]+ m/z = 30981, 
found m/z = 31008. 
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5.2.8 Bacterial Assays (Chapter 3.3.1) 
  
5.2.8.1  General Bacterial Microscopy Experiments (Chapter 3.3.1.1) 
100 µL frozen culture of E. coli strain BL 21 α were grown overnight in 4 ml LB 
media with Ampicilin (0.1 mg/mL) in a shaker at 37 °C. The OD600 was 
measured and the culture was diluted to reach an OD600 of 1. The bacterial 
culture was split in portions of 200 µL and centrifuged for 5 min at 3000 rpm. 
The liquid was removed and the pellet was re-suspended in 200 µL of PBS 
buffer and washed three times with this buffer. Finally the pellet was re-
suspended in 200 µL PBS containing MnCl2 and CaCl2 (1 mM). The bacteria 
were incubated with either compound 1 or 49, at a total overall concentration 
of 1 of 10-7 M, for 1 h at rt. Incubation with water was carried out as a control. 
Subsequently, the bacteria were washed with PBS buffer as described. The 
pellet was re-suspended in 50 µL PBS. 20 µL of this suspension were fixed on 
microscope slides using Aqua Poly Mount, covered with glass slides and left to 
dry over night at 5 °C. 
Microscopic observation was carried out on a Zeiss fluorescent microscope 
using brightfield and an optical filter corresponding to the spectroscopic profile 
of compounds 1 and 49 (λex = 360 nm, λem = 490 nm). 
 
5.2.8.2  Bacterial Microscopy Experiments with Fluorescent E. coli 
(Chapter 3.3.1.2) 
The assay was performed as described in 5.2.8.1, however using E. coli strain 
BL 21 α pECFP, for exact fluorescence colocalization studies of the bacteria 
with compound 49. Microscopic observation was carried out on a Zeiss 
fluorescent microscope using brightfield and an optical filter corresponding to 
the spectroscopic profile of compounds 1 and 49 (λex = 360 nm, λem = 490 nm) 
or of CFP expressed in the bacteria (CFP optical filter). 
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5.2.8.3 Bacterial Microscopy Experiments with ORN178 and ORN208 
(Chapter 3.3.1.3) 
The assay was performed using E. coli strains ORN178 (overexpressing FimH) 
and ORN 208 (not expressing FimH). The strains were a kind gift from Prof. 
Paul Orndorff (North Carolina State University).  
100 µL frozen culture of E. coli strain ORN178 and ORN208 were grown 
overnight in 4 mL LB media in a shaker at 37 °C. ORN178 does not carry any 
plasmid encoding for any antibiotic resistance. Therefore only ORN208 was 
grown in presence of with Ampicilin (0.1 mg/mL). The OD600 was measured 
and the culture was diluted to reach an OD600 of 1. The bacterial culture was 
split in portions of 200 µL and centrifuged for 5 min at 3000 rpm. The liquid 
was removed and the pellet was re-suspended in 200 µL of PBS buffer and 
washed three times with this buffer. Finally the pellet was re-suspended in 
200 µL PBS containing MnCl2 and CaCl2 (1 mM). The bacteria were incubated 
with either compound 1 or 49 as described under 5.2.8.1, and fixed on 
microscope slides using Aqua Poly Mount. Microscopic observation was 
carried out on a Zeiss fluorescent microscope using brightfield and an optical 
filter corresponding to the spectroscopic profile of compounds 1 and 49 
(λex = 360 nm, λem = 490 nm). 
 
5.2.8.4  Bacterial Experiments with Mixtures of 1 and 49 (Chapter 3.3.1.4) 
E. coli strain BL 21 α was cultured as described in 5.2.8.1. Discotic mixtures of 
1 and 49 with ratios of 1/1, 2/1, 3/1, 5/1, 10/1, 20/1 and 99/1 were prepared 12 
h prior to the incubation with bacteria to ensure complete mixing of the 
individual compounds. The bacteria were incubated with the different mixtures 
of 1 and 49 at rt for 1 h. The overall concentration of discotics (c[1] + c[49] = 
10-7 M) was kept constant. After washing as described, the pellet was re-
suspended in 200 µL PBS. 10 µL of this suspension were fixed on microscope 
slides using Aqua Poly Mount, covered with glass slides and left to dry over 
night at 5 °C. Microscopic observation was carried out on a Zeiss fluorescent 
microscope using brightfield and an optical filter corresponding to the 
spectroscopic profile of compounds 1 and 49 (λex = 360 nm, λem = 490 nm). 
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5.2.8.5 Bacterial Mannose Competition Experiments (Chapter 3.3.1.5) 
E. coli strain BL 21 α was cultured as described in 5.2.8.1. The bacteria were 
pre-incubated with different concentrations of methyl-α-D-mannopyranoside 
ranging from 3 x 10-1 M to 3 x 10-7 M for 10 min at rt. Compound 49 was then 
added to each vial to reach a final concentration of 10-7 M and incubated for 
1 h at rt. Subsequently, the suspension was centrifuged for 5 min at 3000 rpm. 
The liquid was removed and the pellet was re-suspended in 200 µL of PBS 
buffer and washed three times with this buffer. The pellet was re-suspended in 
50 µL PBS. 20 µL of this suspension were fixed on microscope slides using 
Aqua Poly Mount, covered with glass slides and left to dry over night at 5 °C. 
Controls were performed with pure methyl-α-D-mannopyranoside, water, and 
49. Mounting and microscopic observation was performed as described.  
 
5.2.8.6 Bacterial growth control (Chapter 3.3.1.6) 
E. coli strain BL 21 α was cultured as described under 5.2.8.1. 200 µl of cell 
culture per vial were washed and re-suspended in LB medium to reach an 
OD600 of 0.5. 49 or 1, at final concentrations of 10-7 M, or water were added to 
three vials each and incubated for 4 h at 37 °C. Subsequently the bacteria 
were washed and the OD600 was measured again. 
 
5.2.8.7 Colocalization studies with 52 (Chapter 3.3.3) 
E. coli strain BL 21 α was cultured as described under 5.2.8.1. Discotic 
mixtures of 1 and 52 with ratios of 1/1, 9/1 and 99/1 were prepared 12 h prior 
to the incubation with bacteria to ensure complete mixing of the individual 
compounds. The bacteria were incubated with the different mixtures of 1 and 
52 and with compound 52 at room temperature. The overall concentration of 
discotics (c[1] + c[52] = 10-7 M) was kept constant. After washing as described, 
the pellet was re-suspended in 200 µL PBS. 10 µL of this suspension were 
fixed on microscope slides using Aqua Poly Mount, covered with glass slides 
and left to dry over night at 5 °C. Microscopic observation was carried out on a 
Zeiss fluorescent microscope using brightfield and an optical filter 
corresponding to the spectroscopic profile of compounds 1 and 52 (λex = 360 
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nm, λem = 490 nm) and to the spectroscopic profile of Texas Red (λex = 569 nm, 
λem = 620 nm). 
 
5.2.9 Experiments with Streptavidin Beads  
5.2.9.1 Binding to Streptavidin Beads (Chapter 3.3.3.1) 
Streptavidin Magnetic Beads were washed with PBS buffer. A magnet was 
used to gather the beads on the bottom of the vial.  The liquid was removed 
and the pellet was re-suspended in 200 µL of PBS buffer and washed three 
times with this buffer. The beads were incubated with either compound 1 or 53 
at a total overall concentration of 1 of 10-7 M, for 1 h at rt. Incubation with water 
was carried out as control. Subsequently, the bacteria were washed with PBS 
buffer as described. The pellet was re-suspended in 50 µL PBS. 20 µL of this 
suspension were fixed on microscope slides using Aqua Poly Mount, covered 
with glass slides and left to dry over night at 5 °C. Microscopic observation was 
carried out on a Zeiss fluorescent microscope using brightfield and an optical 
filter corresponding to the spectroscopic profile of compounds 1 and 53 (λex = 
360 nm, λem = 490 nm). 
 
5.2.9.2 Streptavidin Beads with 52 and 1 (Chapter 3.3.3.1) 
Discotic mixtures of 52 and 53 with ratios of 1/1, 9/1 and 99/1 were prepared 
12 h prior to the incubation with bacteria to ensure complete mixing of the 
individual compounds. The beads were incubated with the different mixtures of 
52 and 53 at room temperature. The overall concentration of discotics (c[52] + 
c[53] = 10-7 M) was kept constant. The beads were washed as described. 
Subsequently the beads were washed with PBS buffer as described. The 
pellet was re-suspended in 50 µL PBS. 20 µL of this suspension were fixed on 
microscope slides using Aqua Poly Mount, covered with glass slides and left to 
dry over night at 5 °C.  
Microscopic observation was carried out on a Zeiss fluorescent microscope 
using brightfield and an optical filter corresponding to the spectroscopic profile 
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of compounds 52 and 53 (λex = 360 nm, λem = 490 nm) and to the 
spectroscopic profile of Texas Red (λex = 569 nm, λem = 620 nm). 
 
5.2.10 Enzyme Linked Lectine Assay (Chapter 3.3.2)[90] 
5.2.10.1 Determination of Enzyme concentration 
 
Nunc Immuno Maxi-SorpTM plates were incubated with 100 µL/well mannan 
(10 µg/ml in 0.01 M PBS, pH = 7.3 with 0.1 mM Mn2+ and Ca2+) overnight at 
room temperature. Subsequently each well was washed three times with 
300 µL washing buffer (PBS with 0.05 % (v/v) Tween). The wells were then 
blocked for 1 h at 37 °C using 150 µL/well BSA (1% in PBS). Washing was 
repeated as described. Afterwards the plates were incubated for 1 h at 37 °C 
with different dilutions of Horseradish Peroxidase labeled Con A in buffer, 
ranging from 10-1 to 10-5 mg/mL. The washing step was repeated and 50 
µL/well ABTS (0.25 mg/mL citrate buffer 0.2 M, pH = 4.0 with 0.015 % (v/v) 
H2O2) were added. Color development was stopped after 20 min by adding 
50 µL/well 1M H2SO4. Light absorption was measured at 415 nm. The 
concentration of Con A-HRP with the readout between 0.8 and 1 was used for 
inhibition studies (Figure 57). 
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Figure 57. Determination of Con A concentration for assay procedure. 
 
5.2.10.2 Inhibition Experiments 
Nunc Immuno Maxi-SorpTM plates were coated, washed and blocked as 
described above. Independently, 60 µL/well of serial dilutions of inhibitor 
(either methyl-α-D-mannopyranoside or 49) were made in a Nunclon 96 well 
plate. To each of these wells 60 µL of Con-A HRP was added and incubated 
for 1 h at 37 °C. 100 µL/well of these inhibitor-lectin mixtures were transferred 
to the mannan coated plate and incubated for 1 h at 37 °C. The wells were 
washed and treated with ABTS. The reaction was stopped after 20 min. 
Absorption was measured at 415 nm and the % inhibition was calculated as 
follows: 
 
% Inhibition = {[A(no inhibitor) – A(with inhibitor)] / A(no inhibitor)} x 100 
 
The calculated IC50 values were 3020 µM in case of methyl-α-D-
mannopyranoside and 120 µM for 49. The valency corrected value (360 µM) 
was obtained multiplying the calculated IC50 by the amount of mannose per 
single discotic scaffold (= 3). 
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5.2.11 Foerster Resonance Energy Transfer Experiments 
(Chapter 3.4 )  
5.2.11.1 Interaction of SA-Cy3 and 53 (Chapter 3.4.4) 
Cy3 labeled streptavidin (10-5 M in PBS) was titrated to 53 or 1 (each 10-6 M in 
PBS) or water in serial concentrations from 10-7 to 0.5 10-6 M (ratio 53/SA-Cy3 
from 100/1 till 2/1) at 20 °C and stirred for 5 min after each titration step. 
Fluorescence- (λex = 340 nm, λem = 350 till 770 nm) and UV- (200 till 750 nm) 
spectra were measured after each titration step. FRET-ratios were determined 
as follows: FRET-ratio = (Emission at λmax Cy3 / Emission at λmax Discotic) = 
(Emission at 570 nm / Emission at 524 nm). 
 
 
5.2.11.2 Titration of SA-Cy3 to mixtures of 1/53 (Chapter 3.4.5 ) 
Stock solutions (10-5 M) of 53 and 1 in PBS (0.01 M, pH = 7.3) were prepared 
and diluted until the emission was approximately the same. Different ratios of 
53 and 1 (1/0, 1/1, 1/2, 1/3, 1/5, 1/10 and 1/20) were mixed and left overnight 
at room temperature to assure equilibration of the discotic columns. Each 
mixture was diluted in PBS to reach a final concentration of 53 of 10-6 M. Cy3 
labeled streptavidin was added in serial concentrations from 10-7 to 0.5 10-6 M 
at 20 °C and stirred for 5 min. Fluorescence- (λex = 340 nm, λem = 350 till 770 
nm) and UV- (200 till 750 nm) spectra were measured after each titration step. 
FRET-ratios were determined as follows: Emission at (λmax Cy3 / Emission at 
λmax Discotic) = Emission at (570 nm / Emission at 524 nm). 
 
 
5.2.11.3 Titration of 1 to mixtures of SA-Cy3/53 (Chapter 3.4.5) 
Cy3 labeled streptavidin (10-5 M in PBS) and 53 were mixed 1 h prior to the 
experiment with a ratio of 5/1 53/SA-Cy3 at 20 °C. Each mixture was diluted in 
PBS to reach a final concentration of 53 of 10-6 M. 1 was added to each 
mixture in serial concentrations to yield final ratios of 53/1 (1/0, 1/1, 1/2, 1/3, 
1/5, 1/10 and 1/20). Fluorescence- (λex = 340 nm, λem = 350 till 770 nm) and 
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UV- (200 till 750 nm) spectra were measured after 5 min, 30 min, 1 h, 2 h, 
1 day and 2 days. FRET-ratios were determined as follows: (Emission at 
λmax Cy3 / Emission at λmax Discotic) = Emission at (570 nm / Emission at 524 nm). 
 
 
5.2.11.4 Titration of SA-TR and SA-AF633 to 53 (Chapter 3.4.6) 
Texas Red labeled streptavidin (SA-TR) and Alexa Fluor 633 labeled 
streptavidin (SA-AF633) were mixed 2 h prior to the experiments to reach a 
final concentration of 0.05 mg/mL-1 of each protein. This protein mixture was 
titrated to 53 or 1 (each 10-6 M in PBS) or water in serial volumes ranging from 
1 to 50 µL at 20 °C and stirred for 10 min after each titration step. 
Fluorescence- (λex = 340 nm, λem = 350 till 770 nm) and UV- (200 till 750 nm) 
spectra were measured after each titration step. FRET-ratios were determined 
as follows: FRET-ratio = (Emission at λmax Alexa Fluor 633 / Emission at 
λmax Texas Red) = (Emission at 647 nm / Emission at 612 nm). 
 
 
5.2.11.5 Titration of 53 to SA-TR and SA-AF633 (Chapter 3.4.6) 
Texas Red labeled streptavidin (SA-TR) and Alexa Fluor 633 labeled 
streptavidin (SA-AF633) were mixed 4 h prior to the experiments to reach a 
final concentration of 0.05 mg/mL-1 of each protein. From a stock solution of 53 
(c [53 = 10-4]) portions of 1-5 µL were added to reach final concentrations 
between 2 x 10-6 M and 1 x 10-5 M (0.5-25 mol-% compared to the single 
protein concentration). Resulting mixtures were stirred for 10 min after each 
titration step. Fluorescence- (λex = 340 nm, λem = 350 till 770 nm) and UV- (200 
till 750 nm) spectra were measured after each titration step. FRET-ratios were 
determined as follows: FRET-ratio = (Emission at λmax Alexa Fluor 633 / Emission at 
λmax Texas Red) = (Emission at 647 nm / Emission at 612 nm). 
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5.2.11.6 Titration of 53 to SA-TR and SA-AF514 (Chapter 3.4.6) 
Texas Red labeled streptavidin (SA-TR) and Alexa Fluor 514 labeled 
streptavidin (SA-AF514) were mixed 4 h prior to the experiments to reach a 
final concentration of 0.05 mg/mL-1 of each protein. From a stock solution of 53 
(c [53 = 10-4]) portions of 2 µL were added to reach final concentrations 
between 2 x 10-6 M and 1 x 10-5 M. Resulting mixtures were stirred for 10 min 
after each titration step. Fluorescence- (λex = 340 nm, λem = 350 till 770 nm) 
and UV- (200 till 750 nm) spectra were measured after each titration step. 
FRET-ratios were determined as follows: FRET-ratio = Emission at (λmax Texas 
Red / Emission at λmax Alexa Fuor 514) = (Emission at 612 nm / Emission at 541 nm). 
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6 Abbreviations 
Å Angstroem 
ABTS 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic 
acid)diammonium salt 
ar aromatic 
BIACORE surface plasmon resonance based biosensors 
Boc tert-butoxy-carbonyl 
br broad 
calcd. calculated 
CFP cyan fluorescent protein 
Con A concanavalin A (lectin) 
d doublet 
dd doublet of a doublet 
δ ppm parts per million 
DHB 2,5-dihydroxybenzoic acid 
DIC diisopropylcarbodiimide 
DIPEA N,N-diisopropylethylamine 
DMAP 4-dimethylaminopyridine 
DMF dimethylformamide 
DP Degree of polymerization 
E. Coli Escherischia Coli 
EDTA ethylenediaminetetraacetic acid 
ELISA Enzyme linked immunosorbent assay 
ELLA Enzyme linked lectin assay 
equiv. equivalent 
ESI electron spray ionization 
et al. et alii 
FimH fimbrae H - receptors of E. coli that recognize 
mannose 
FRET Foerster resonance energy transfer 
g gram 
gCOSY gradient enhanced Correlation Spectroscopy 
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HATU 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl 
uronium hexafluorophosphate  
HIA hemagglutination assay 
HPLC high pressure liquid chromatography 
HRP Horseradish-peroxidase 
IC50 half maximal inhibitory concentration 
ITC isothermal titration calorimetry 
J coupling constant 
Kass association constant 
λ wavelength in nm 
L liter 
LB lysogenic broth - nutrient solution to grow E. coli 
LC/MS liquid chromatography followed by mass 
spectroscopy 
M molar 
m meter 
m/z mass per charge 
MALDI-TOF matrix-assisted laser desorption/ionization time of 
flight 
Max maximum 
MDCK Madin Darby canine kidney from dog 
mg milligram 
MHz megahertz 
min  minute 
mL milliliter  
mM millimolar 
mmol millimole 
mol mole 
mol-% mole percent 
mp melting point 
nm nanometer 
NMR nuclear magnetic resonance 
OD600 optical density at 600 nm 
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ORN178 E. coli strain with overexpressed FimH 
ORN208 E. coli strain with supressed FimH 
PBS phosphate buffer saline 
PBS-T phosphate buffer saline with 5% Tween  
Pd/C palladium on charcoal 
pECFP plasmid encoding CFP 
pTWIN1-EYFP plasmid encoding YFP 
quant. quantitative 
Rf retention factor 
rpm revolutions per minute 
rt room temperature 
Rt retention time 
s singlet 
SA streptavidin 
SA-AF514 streptavidin labeled with Alexa Fluor 514 
SA-AF633 streptavidin labeled with Alexa Fluor 633 
SA-Cy3 streptavidin labeled with Cy3 
SA-TR streptavidin labeled with Texas Red 
TES triethylsilane 
TFA trifluoric acid 
THF tetrahydrofuran 
µ micro 
µg microgram 
µM micro molar 
µm micromole 
UV ultra violet 
UV-Vis ultra violet-visible spectroscopy 
v/v percent volume 
YFP yellow fluorescent protein 
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Supramolekulare Multivalenz 
 
 
Diskotische Monomere assemblieren schon bei geringen Konzentrationen in 
Wasser reversibel zu säulenartigen Polymeren. Mit den entprechenden 
Liganden ausgestattet, können diese Supramoleküle gezielt Kohlenhydrat-
Rezeptor-Wechselwirkungen beeinflussen und Proteine spezifisch binden. Die 
Ligandendichte des Polymers kann dabei durch den reversiblen Austausch 
einzelner Monomere gesteuert werden. Dieses supramolekulare Polymer 
bindet an Bakterien und dient als Plattform zur Steuerung von Protein-
Aggregationen.  
Die discotischen Moleküle 1 wurden durch Verlinkung von drei 
N-monoacylierten 2,2'-Bipyridin-3,3'-diamin-Flügeln zu einer zentralen 1,3,5-
Benzoltricarbonyl-Einheit aufgebaut. Durch selektiv eingeführte Azid- oder 
Amin-Funktionalitäten dienten die diskotischen Grundgerüste 2 und 3 als 
flexible Plattform zur Modifikation mit biologisch aktiven Liganden im letzten 
Schritt der Synthese. Der konvergente Aufbau der Monomere führte zu 
diskotischen Molekülen, die je mit sechs inerten Ethylenglycol- 
Monomethylether-Seitenketten und mit drei Azid- oder Amin-funktionalisierten 
Seitenketten ausgestattet waren (Abb. 1). 
Des Weiteren wurden die diskotischen Monomere 2 und 3 mit 
unterschiedlichen Liganden dekoriert. Propargyl-Derivate von Mannose, 
Glucose und Gallactose wurden mittels Huisgen-[2+3]-Zykloaddition an das 
diskotische Grundgerüst 2 angebracht. Die Zykloaddition beanspruchte 
ungewöhnlich lange Reaktionszeiten, was durch die hohe Ligandendichte, die 
sich um die supramolekularen Säulen generierte, erklärt wurde. Nach vier 
Wochen ermöglichte der dynamische, reversible Austausch der Monomere  
die volle Umsetzung zum trifunktionalisierten diskotischen Molekül. Die 
Acylierung des Grundgerüsts 3 mit Texas Red-, Biotin- und Cystein-Derivaten 
benötigte Reaktionszeiten zwischen vier Stunden und drei Tagen. Alle 
diskotischen Verbindungen sind gut in Wasser löslich und bilden 
supramolekulare Säulen (Kass ~ 1 x 108 M-1). 
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Abb. 1.: Die diskotischen Grundgerüste 2 und 3, ausgestattet mit funktionellen Gruppen für 
weitere synthetische Modifikationen. 
 
Die Eigenschaft der Mannose-modifizierten Diskoten, der inerten Diskoten 1 
und Mischungen beider an Bakterien zu binden, wurde durch mikroskopische 
Studien mit dem E. coli BL 21α Stamm verifiziert. Hierbei wurde die starke 
Fluoreszenz des diskotischen Kerns zur Autodetektion der Supramoleküle 
genutzt. Nur wenn die Bakterien mit dem Mannose-modifizierten Diskoten 
inkubiert wurden, konnte eine starke Fluoreszenz der Bakterien-Aggregate 
detektiert werden, die mit dem Durchlichtbild kolokalisierte (Abb. 2). Beide 
Kontrollexperimente, Bakterien ohne Substrat und in Anwesenheit des inerten 
Diskoten, zeigten keinerlei Fluoreszenz. Die Spezifität der Interaktion zwischen 
dem Mannose-modifizierten Diskoten und dem FimH-Rezeptor auf der 
Bakterienoberfläche wurde durch Bindungsstudien mit den Bakterienstämmen 
ORN208 und ORN178 bestätigt. Die Experimente ergaben, dass die 
supramolekularen Diskoten selektiv über die Interaktion von Mannose an den 
FimH-Rezeptoren binden und zeigen, dass keine unspezifische 
Wechselwirkung vorliegt. Die Durchführung eines Konkurrenz Experiments 
zwischen dem Mannose-modifizierten Diskoten und Mannose bezüglich ihrer 
Bindungsstärke zu den Bakterien zeigte, dass die multivalenten Diskoten 
hocheffizient an Bakterien binden. Selbst bei einem 106-fachen Überschuss, 
wurden die Diskoten nicht von der freien Mannose verdrängt. 
 
 
Abb. 2.: Mikroskopbilder im a) Durchlicht und b) Fluoreszenz (λex = 360 nm, λem = 490 nm) 
Modus von E. coli, die mit 1) Wasser, 2) inertem Diskoten 1 oder 3) Mannose-modifiziertem 
Diskoten inkubiert wurden. Nur in Anwesenheit des Mannose-modifizierten Diskoten wurde die 
starke Fluoreszenz des diskotischen Grundgerüsts auf den Bakterien detektiert. 
 
Mischungen der Supramoleküle aus den Mannose-modifizierten Diskoten und 
den inerten Diskoten 1 wurden generiert und auf verdünnten Bakterienproben 
evaluiert. Alle getesteten supramolekularen Mischungen induzierten 
Aggregation der Bakterien. Selbst eine Verdünnung mit nur 1% funktionellem 
Monomer führte noch zur Ausbildung bakterieller Aggregate. Offensichtlich 
wird nur eine begrenzte Anzahl an Mannose Einheiten auf der Oberfläche der 
supramolekularen Säulen benötigt, um die Cluster-Bildung der Bakterien um 
die Säule herum hervorzurufen. Des Weiteren scheinen die supramolekularen 
Strukturen groß genug zu sein, um die Distanzen  zwischen den Mannose 
fuktionalisierten Monomeren zu überbrücken und die Bakterien zu verlinken.  
Die supramolekularen Eigenschaften des Moleküls ermöglichen offensichtlich 
eine unkomplizierte Adaption und Optimierung der Zusammensetzung aus 
Monomeren.  
 
 
Abb. 3.: Mikroskopbilder zur Veranschaulichung der Bakterienaggregation in Anwesenheit des 
Mannose-modifizierten Diskoten und Mischungen des Mannose-modifizierten Diskoten mit 
dem inerten Diskoten 1. Die Bilder wurden im Durchlicht Modus mit verdünnten 
Bakterienproben, die mit a) 100% inerten-Diskoten 1, b) 99/1 inerten Diskoten 1/Mannose-
modifizierten Diskoten and c) 100% Mannose-modifizierten Diskoten inkubiert worden waren, 
aufgenommen. 
 
Um die polyvalenten Eigenschaften der supramolekularen Polymere zu 
quantifizieren wurden Enzym-gekoppelte Lektin Studien (enzyme linked lectin 
assay, ELLA) mit Hilfe von Meerrettich-Peroxidase-markiertem Concanavalin A 
und immobilisiertem Mannan durchgeführt. In unseren Studien wurde ein 
IC50-Wert für die Methylglykosid Kontrolle um 3000 µM erhalten. Der IC50-Wert 
der Mannose-modifizierten Diskoten lag bei 120 µM (360 µM, valenzkorrigiert). 
Die relative valenzkorrigierte Bindungstärke des Mannose-modifizierten 
Diskoten war damit 8.3 fach höher als die der Referenzverbindung (dies 
entspricht einer 24.9 fachen Erhöhung pro Mannose-Diskot) und unterstreicht 
die polyvalente Bindungsstärke der Diskoten. Die Mannose-modifizierten, 
supramolekularen Dikoten ermöglichen effiziente, polyvalente Bindungen mit 
hohen Valenzen und entwickeln ein starkes Bindungspotential pro 
Mannoseligand. Aufgrund seiner polymeren Eigenschaften, ist der Mannose-
modifizierte Diskot scheinbar in der Lage, die Distanz zwischen den 
verschiedenen Bindungsstellen des Concanavalin A zu überbrücken und  
multivalent zu binden.  
Mischungen des Texas-Red-modifizierten Diskoten und des Biotin-
modifizierten Diskoten wurden eingesetzt, um Zugang zu heterovalenten 
Verbindungen, die mehr als eine Art Ligand tragen, zu erhalten. Die 
Evaluierung dieser diskotischen Mischungen zeigte, dass Texas-Red-
modifizierte-Diskoten in Anwesenheit von Biotin-modifizierten Diskoten auf der 
Oberfläche von Straptavidin-beschichteten Kugeln lokalisiert werden können. 
Offensichtlich integrieren die Biotin-modifizierten Diskoten die Texas-Red-
modifizierten Diskoten in ihre Säulen und halten so die Texas-Red-
modifizierten Diskoten in der supramolekularen Struktur, wenn Biotin an 
Streptavidin bindet. Diese Resultate zeigen, dass die supramolekularen 
Diskoten einen unkomplizierten Zugang zu heterovalenten Grundgerüsten 
durch einfaches Mischen von fuktionalisierten Diskoten ermöglichen. Dieser 
supramolekulare Ansatz erlaubt den Aufbau hochflexibler, heterovalenter 
Substanzen.  
 
Zusätzlich zu Ihrer Fähigkeit multivalente Interaktionen mit bakteriellen 
Aggregaten zu kontrollieren, wurden die Diskoten als Plattform für Protein-
Zusammenlagerungen verwendet. Biotin-modifizierte Diskoten wurden 
eingesetzt, um die Interaktion des diskotischen Grundgerüsts mit Streptavidin 
zu evaluieren. FRET-Experimente mit Cy3-markiertem Streptavidin (SA-Cy3) 
wurden duchgeführt. Hierbei führte die Überlappung des Fluoreszenzsignals 
des diskotischen Grundgerüsts  (FRET-Donor) mit Cy3 (FRET-Akzeptor) zu 
der FRET-Interaktion.  Der Vergleich des FRET-Signals in Gegenwart des 
Biotin-modifizierten Diskoten mit dem FRET-Signal in Gegenwart des inerten 
Diskoten zeigte, dass das FRET-Signal aus der räumlichen Annäherung der 
fluoreszierenden Partner durch Bindung von Biotin an Straptavidin 
hervorgerufen wird. Experimente mit Mischungen des inerten Diskoten und 
des Biotin-modifizierten Diskoten ergaben, dass in Anwesenheit des inerten 
Diskoten als Platzhalter die relative Menge an Streptavidin Cy3, das mit den 
Supramolekülen agiert von 7.5 mol-% auf 15 mol-% angehoben wird (Abb. 4). 
Der inerte Diskot schafft somit Raum zwischen den funktionalisierten Diskoten 
und ermöglicht es, einem größeren prozentualen Anteil an Biotinen an 
Straptavidin zu binden. Das beste Mischungsverhältniss an inerten Diskoten 
zu Biotin-modifizierten Diskoten für optimalen FRET-Austausch scheint bei 
etwa einer bis zwei inerten Diskoten pro Biotin-modifiziertem Diskot zu liegen. 
In weiteren Studien wurde untersucht, ob die Reihenfolge der Zugabe der 
Interaktionspartner einen Einfluss auf den Aufbau der Säulen hat. Hierbei 
zeigte sich, dass supramolekulare Säulen aus Biotin-modifizierten Diskoten, 
die mit SA-Cy3 inkubiert wurden, nachträglich keine inerten Diskoten mehr in 
die supramolekularen Säulen aufnehmen. Scheinbar werden die 
Supramoleküle aus Biotin-modifizierten Diskoten durch die Bindung an 
Streptavidin blockiert und ergeben undynamische polymere Strukturen, die 
das Protein auf der Oberfläche tragen. 
 
  
Abb. 4.: Experimente zur Protein-Aggregation mit Streptavidin-Cy3 (SA-Cy3) und Mischungen 
aus Biotin-modifizierte Diskoten und inerten Diskoten. FRET-Interaktion des diskotischen 
Grundgerüsts mit Cy3 wurde detektiert. Das FRET-Verhältnis von verschiedenen Mischungen 
von Biotin-modifizierten Diskoten/inerten Diskoten bei 1/0 (blau), 1/1 (lila), 1/2 (grün) und 1/5 
(rot) aufgetragen gegen c[SA-Cy3] im Vergleich zu c[disc total]  (= c[53] + c[53]). Der Graf 
zeigt, dass die prozentuale Menge an SA-Cy3, das mit den diskotischen Säulen interagiert, im 
Fall von 1/1- und 1/2-Mischungen am höchsten ist. 
 
Dasselbe supramolekulare Polymer wurde verwendet, um die 
Zusammenlagerung zweier unterschiedlicher Proteine zu untersuchen. Diese 
Experimente zur supramolekularen Steuerung von Protein-Interaktionen 
wurden mit Alexa-Fluor-633-markiertem Streptavidin (SA-AF633) und mit 
Texas-Red-markiertem Streptavidin (SA-TR) durchgeführt Dabei wurde die 
Überlappung des Fluoreszenzsignals von TR und AF633 genutzt. Die 
Ergebnisse zeigen, dass der Biotin-modifizierte Diskot beide Proteine bindet 
und die Zusammenlagerung der beiden Streptavidine von SA-AF633 und SA-
TR bewirkt. Dies kann durch die resultierende FRET-Interaktion belegt 
werden. Diese Experimente mit SA-TR/SA-AF633 und Studien mit einem 
weiteren FRET-Paar  SA-AF514/SA-TR zeigen, dass die Anwesenheit des 
Biotin-modifizierten Diskoten die Zusammenlagerung von zwei verschiedenen 
Proteinen auslöst. 
 
 
Abb. 5.: Studien zur Beeinflussung von Protein-Aggregation durch den Biotin-modifizierten 
Diskoten. Der Graph zeigt die Experimente in Anwesenheit des Biotin-modifizierten Diskoten 
(grün), mit dem inerten Diskoten (blau), mit dem reinen Proteingemisch SA-TR/SA-AF633 (lila) 
und mit dem reinen FRET Akzeptor SA-AF633 (hellblau). Die Spektren wurden bei einer 
Anregungswellenlänge von 584 nm aufgenommen. Nur in Gegenwart der Biotin-modifizierten 
Diskoten geht das Emissionssignal des FRET-Donors SA-TR signifikant zurück. Offensichtlich 
lagern sich die Proteine auf der Oberfläche der Supramoleküle aus Biotin-modifizierten 
Diskoten zusammen. 
 
Supramolekulare Polymere stellen ideale Grundgerüste zur Generierung 
polyvalenter Strukturen dar, die zur Bindung und Modulierung biologischer 
Interaktionen genuzt werden können. Die Eigenschaft der Monomere durch 
eigenständige Aggregation reversible, supramolekulare Polymere zu bilden, 
ermöglicht es, Kontrolle über die Ligandendichte, die Reaktion auf äußere 
Einflüsse und den polymeren Aufbau zu erhalten. Dies ist mit kovalenten 
polymeren Systemen nicht möglich. Die Flexibilität trägt dazu bei, dass 
supramolekulare Polymere ein hohes Potential als polyvalente Grundgerüste 
zur Beeinflussung unterschiedlicher biologischer Wechselwirkungen besitzen, 
in denen polyvalente Effekte eine Rolle spielen. Die Eigenschaft der selbst-
Aggregation zu polymeren Säulen ermöglicht die reversible Ausstattung mit 
Liganden und die dynamische Anpassung des Systems an den 
Interaktionspartner. Nicht zuletzt erlaubt es die supramolekulare Natur des 
Systems, bislang noch nicht zugängliche Topologien mit neuen Eigenschaften 
zu generieren. Dies kann durch einfaches Mischen unterschiedlich 
funktionalisierter diskotischer Monomere erreicht werden und ermöglicht es, 
Bindungsvorgänge zu optimieren. 
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